<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">109466</article-id>
<article-id pub-id-type="doi">10.7554/eLife.109466</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.109466.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Cell Biology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Roles of G-protein coupled receptors and mechanosensitive ion channels in pressure-induced chronotropy of lymphatic vessels</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7992-9300</contrib-id>
<name>
<surname>Davis</surname>
<given-names>Michael J</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<email>davismj@health.missouri.edu</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Hae Jin</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Min</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Castorena-Gonzalez</surname>
<given-names>Jorge A</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pal</surname>
<given-names>Soumiya</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Domeier</surname>
<given-names>Timothy L</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scallan</surname>
<given-names>Joshua P</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Earley</surname>
<given-names>Scott</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zawieja</surname>
<given-names>Scott D</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02ymw8z06</institution-id><institution>Department of Medical Pharmacology &amp; Physiology, University of Missouri</institution></institution-wrap>, <city>Columbia</city>, <country country="US">United States</country></aff>
<aff id="a2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04vmvtb21</institution-id><institution>Department of Pharmacology, Tulane University School of Medicine</institution></institution-wrap>, <city>New Orleans</city>, <country country="US">United States</country></aff>
<aff id="a3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/032db5x82</institution-id><institution>Department of Molecular Pharmacology &amp; Physiology, University of South Florida, Morisani School of Medicine</institution></institution-wrap>, <city>Tampa</city>, <country country="US">United States</country></aff>
<aff id="a4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00trqv719</institution-id><institution>Department of Pharmacology and Physiology, University of Rochester Medical Center</institution></institution-wrap>, <city>Rochester</city>, <country country="US">United States</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Trebak</surname>
<given-names>Mohamed</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/01an3r305</institution-id><institution>University of Pittsburgh</institution>
</institution-wrap>
<city>Pittsburgh</city>
<country>United States of America</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Maduke</surname>
<given-names>Merritt</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Stanford University</institution>
</institution-wrap>
<city>Stanford</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="coi-statement"><p>Competing interests: No competing interests declared</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2025-11-18">
<day>18</day>
<month>11</month>
<year>2025</year>
</pub-date>
<volume>14</volume>
<elocation-id>RP109466</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2025-10-07">
<day>07</day>
<month>10</month>
<year>2025</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2025-10-07">
<day>07</day>
<month>10</month>
<year>2025</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2025.10.07.681001"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2025, Davis et al</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Davis et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-109466-v1.pdf"/>
<abstract><p>Active lymph pumping relies on the spontaneous contractions of collecting lymphatic vessels, with frequencies that are exquisitely sensitive to changes in intraluminal pressure. This homeostatic and mechanosensitive mechanism, termed pressure-induced lymphatic chronotropy, enables lymph transport to be matched to the filling state of the lymphatic capillaries. We investigated the mechanistic basis of pressure-induced chronotropy using ex vivo contraction assays of mouse popliteal collecting vessels, in which contraction frequency increased &gt;10-fold with a 5 cmH<sub>2</sub>O pressure change. The contractile, electrophysiological and transcriptional similarities between lymphatic muscle and arterial smooth muscle led us to hypothesize that pressure-dependent chronotropy shares a parallel signaling process to pressure-induce arterial depolarization/constriction. Thus, we investigated two major mechanisms: 1) pressure-induced activation of mechanosensitive cation channels, including TRPC6, TRPM4, PKD1/2, TRPV2 and ENaC, and 2) mechano-activation of GNAQ/GNA11-coupled GPCRs that would generate second messengers to activate those channels. We combined contraction assays with scRNAseq analysis of the respective targets and made maximum use of transgenic mice to avoid non-specific effects of pharmacological inhibitors, particularly those used to block TRP channels. Our findings rule out significant roles for TRP and other mechanosensitive channels implicated in myogenic constriction, as well as channels implicated in ionic pacemaking of other tissues, and instead support a scheme whereby mechano-activation of GNAQ/GNA11-coupled GPCRs generates IP<sub>3</sub>, which induces SR Ca<sup>2+</sup> release through IP<sub>3</sub>R1 and drives depolarization through the activation of ANO1 Cl<sup>−</sup> channels.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Key words</title>
<kwd>TRP channels</kwd>
<kwd>PIEZO1</kwd>
<kwd>ANO1</kwd>
<kwd>G proteins</kwd>
<kwd>mechanotransduction</kwd>
</kwd-group>
<funding-group>
<award-group id="par-1">
<funding-source>
<institution-wrap>
<institution>National Institutes of Health</institution>
</institution-wrap>
</funding-source>
<award-id>R01-HL122578</award-id>
<principal-award-recipient>
<name>
<surname>Davis</surname>
<given-names>Michael J</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="par-2">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id>
<institution>National Institutes of Health</institution>
</institution-wrap>
</funding-source>
<award-id>R01-HL168568</award-id>
<principal-award-recipient>
<name>
<surname>Castorena-Gonzalez</surname>
<given-names>Jorge A</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="par-3">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id>
<institution>National Institutes of Health</institution>
</institution-wrap>
</funding-source>
<award-id>R35-HL155008</award-id>
<principal-award-recipient>
<name>
<surname>Earley</surname>
<given-names>Scott</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="par-4">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id>
<institution>National Institutes of Health</institution>
</institution-wrap>
</funding-source>
<award-id>R01-HL136292</award-id>
<principal-award-recipient>
<name>
<surname>Domeier</surname>
<given-names>Timothy</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="par-5">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id>
<institution>National Institutes of Health</institution>
</institution-wrap>
</funding-source>
<award-id>R01-HL143198</award-id>
<principal-award-recipient>
<name>
<surname>Zawieja</surname>
<given-names>Scott D</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="par-6">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id>
<institution>National Institutes of Health</institution>
</institution-wrap>
</funding-source>
<award-id>R01-HL142905</award-id>
<principal-award-recipient>
<name>
<surname>Scallan</surname>
<given-names>Joshua</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>

</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The lymphatic system is critically important for the maintenance of interstitial fluid balance. Because the Starling forces governing fluid movement across blood capillaries favor net filtration in most tissues (<xref ref-type="bibr" rid="c58">Levick &amp; Michel, 2010</xref>), filtered fluid and protein will accumulate in the interstitium unless it is removed by the lymphatic system. Lymphatic capillaries are optimized to reabsorb that fluid, which can exceed 8 L·day<sup>−1</sup> (<xref ref-type="bibr" rid="c88">Renkin, 1986</xref>). Once reabsorbed, lymph is transported by a combination of passive and active transport mechanisms through the collecting lymphatic vessel network, first to lymph nodes and eventually back into the venous system. Active lymph pumping relies on the spontaneous contractions of collecting lymphatic vessels—events that are initiated by action potentials (APs) in lymphatic muscle cells (LMCs). These contractions are relatively large in amplitude, with ejection fractions often exceeding 80% and sufficient to propel lymph through a system of one-way valves that ensure its unidirectional movement (<xref ref-type="bibr" rid="c27">Davis <italic>et al</italic>., 2025</xref>). Active pumping accounts for the majority of lymphatic transport in the lower legs of humans during quiet standing (<xref ref-type="bibr" rid="c83">Olszewski &amp; Engeset, 1980</xref>) and facilitates lymph return against adverse hydrostatic pressure gradients that develop under gravitational loads (<xref ref-type="bibr" rid="c29">Davis <italic>et al</italic>., 2012</xref>; <xref ref-type="bibr" rid="c96">Scallan <italic>et al</italic>., 2016</xref>; <xref ref-type="bibr" rid="c59">Li <italic>et al</italic>., 2022</xref>). An important feature of the active lymph pump system is the exquisite sensitivity of the spontaneous contraction frequency of collecting lymphatic vessels to changes in their intraluminal pressure, enabling lymph transport to be matched to the filling state of the lymphatic capillary network (<xref ref-type="bibr" rid="c95">Scallan <italic>et al</italic>., 2012</xref>). This homeostatic mechanism is termed “pressure-induced lymphatic chronotropy” (<xref ref-type="bibr" rid="c119">Zawieja <italic>et al</italic>., 2019</xref>). In popliteal collecting vessels of the mouse hindlimb, the spontaneous contraction frequency can increase from 2 to 20 contractions·min<sup>−1</sup> as pressure is elevated from 0.5 to 10 cmH<sub>2</sub>O, i.e., a 10-fold increase over the physiological pressure range of those vessels (<xref ref-type="bibr" rid="c26">Davis <italic>et al</italic>., 2020</xref>; <xref ref-type="bibr" rid="c21">Davis <italic>et al</italic>., 2023a</xref>; <xref ref-type="bibr" rid="c22">Davis <italic>et al</italic>., 2023b</xref>). Contraction amplitude increases modestly over a portion of the same pressure range (<xref ref-type="bibr" rid="c95">Scallan <italic>et al</italic>., 2012</xref>), but modulation of contraction frequency is the primary determinant of active lymph transport.</p>
<p>Pressure-induced chronotropy reflects an underlying mechanotransduction process that ultimately involves control of an intrinsic pacemaker in LMCs by intraluminal pressure. Although the specific force sensing mechanism is unknown, contractile, electrophysiological and transcriptional similarities between LMCs and vascular smooth muscle cells (VSMCs) support the hypothesis that pressure-dependent chronotropy shares a parallel signaling process to the myogenic response of VSMCs. The myogenic response refers to in rapid increase in arterial pressure induces distention of a small artery / arteriole, which then constricts over time until a new, stable diameter lower than the original diameter is reached (<xref ref-type="bibr" rid="c18">Davis, 2012</xref>). A similar constriction often occurs in collecting lymphatic vessels simultaneously with pressure-induced chronotropy (<xref ref-type="bibr" rid="c23">Davis <italic>et al</italic>., 2009</xref>). Pressure-induced arterial constriction is preceded by VSM depolarization (<xref ref-type="bibr" rid="c46">Harder, 1984</xref>) and several lines of evidence support a critical role for the activation of (putative) mechanosensitive cation channels in that process—in particular the involvement of three TRP channel family members: TRPC6, TRPM4 and PKD1/2.</p>
<p>The first evidence for a molecularly identified ion channel involved in myogenic constriction came from the demonstration that single channel currents in VSMCs isolated from rat cerebral arteries were activated by patch pipette suction and those currents, along with pressure-induced cerebral artery constrictions and depolarizations, were attenuated after downregulation of TRPC6with antisense oligonucleotides (<xref ref-type="bibr" rid="c110">Welsh <italic>et al</italic>., 2002</xref>). TRPM4 channels were likewise implicated after inward, TRPM4-like currents in rat pial artery myocytes were found to be activated by membrane stretch, and because antisense- or siRNA-mediated knock down of TRPM4 significantly attenuated pressure-induced depolarization and myogenic tone development in those arteries (<xref ref-type="bibr" rid="c37">Earley <italic>et al</italic>., 2004b</xref>; <xref ref-type="bibr" rid="c41">Gonzales <italic>et al</italic>., 2014</xref>). However, results from <italic>Trpc6</italic><sup>−/−</sup> and <italic>Trpm4<sup>−/−</sup></italic> mice tended to contradict the above studies in finding no differences or even <italic>enhanced</italic> arterial myogenic constriction in the global knock out animals (<xref ref-type="bibr" rid="c33">Dietrich <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="c69">Mathar <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="c97">Schleifenbaum <italic>et al</italic>., 2014</xref>). Evidence also supports roles for PKD2 (previously described as TRPP1) channels in myogenic constriction, but it, too, is controversial. Jaggar and colleagues reported that shRNA-mediated down-regulation of <italic>Pkd2</italic>attenuated pressure-induced depolarization and myogenic tone in rat pial arteries (<xref ref-type="bibr" rid="c78">Narayanan <italic>et al</italic>., 2013</xref>) and that pressure-induced constriction was blunted in hindlimb arteries isolated from Myh11-CreER<sup>T2</sup>;<italic>Pkd2<sup>f/f</sup></italic> (smooth muscle knockout, smKO) mice (<xref ref-type="bibr" rid="c9">Bulley <italic>et al</italic>., 2018</xref>). However, a study by Honoré and coworkers suggested that stretch-activated cation currents and myogenic constriction in mouse mesenteric artery smooth muscle were mediated by PKD1 channels (previously termed TRPP2), and that PKD2 channels played a counteracting role (<xref ref-type="bibr" rid="c99">Sharif-Naeini <italic>et al</italic>., 2009</xref>). Myogenic responses could not be tested in global <italic>Pkd2</italic> KO mice because constitutive deletion of <italic>Pkd2</italic> is embryonically lethal (<xref ref-type="bibr" rid="c113">Wu <italic>et al</italic>., 1998</xref>).</p>
<p>More recent work points to G-protein-coupled receptors (GPCRs) rather than TRP or other ion channels as the primary mechanosensing elements in the arterial myogenic response. Studies of cardiomyocyctes first demonstrated that the angiotensin receptor, AT<sub>1</sub>R, a GNAQ/GNA11-coupled GPCR, could be activated by mechanical stress through a mechanism independent of its ligand (<xref ref-type="bibr" rid="c124">Zou <italic>et al</italic>., 2004</xref>). Gudermann and coworkers provided compelling support for this mechanism using patch-clamped HEK293 cells, co-expressing AT<sub>1</sub>R and TRPC6 channels, with hypoosmotic swelling as a mechanical stimulus (<xref ref-type="bibr" rid="c73">Mederos y Schnitzler <italic>et al</italic>., 2008</xref>). Two critical findings were 1) that TRPC6 current was activated by hypoosmotic swelling <italic>only</italic> if the cells co-expressed <italic>Agtr1</italic> (<xref ref-type="bibr" rid="c73">Mederos y Schnitzler <italic>et al</italic>., 2008</xref>) and 2) that the swelling-induced currents were largely prevented by inverse AT<sub>1</sub>R agonists. <italic>Agtr1</italic> could be replaced by another GNAQ/GNA11-coupled GPCR, or <italic>Trpc6</italic> by another DAG-sensitive TRP channel (<xref ref-type="bibr" rid="c73">Mederos y Schnitzler <italic>et al</italic>., 2008</xref>). Subsequent studies from multiple laboratories, using selective pharmacological inhibitors of AT<sub>1</sub>R, acute <italic>Agtr1</italic> knockdown, and/or mice deficient in <italic>Agtr1</italic> or other GNAQ/GNA11-coupled GPCRs, confirmed that basic principle in VSMCs: that pressure-induced constriction of many different types of arteries is transduced primarily, or exclusively, by GNAQ/GNA11-coupled GPCRs (<xref ref-type="bibr" rid="c6">Blodow <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="c47">Harraz <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="c61">Li <italic>et al</italic>., 2014b</xref>; <xref ref-type="bibr" rid="c97">Schleifenbaum <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="c86">Pires <italic>et al</italic>., 2017</xref>; <xref ref-type="bibr" rid="c5">Bjorling <italic>et al</italic>., 2018</xref>). Helix 8 in the GPCR c-terminus was subsequently identified as the essential structural motif endowing mechanosensitivity (<xref ref-type="bibr" rid="c38">Erdogmus <italic>et al</italic>., 2019</xref>). The collective data support a model in which phospholipase C is activated downstream from GNAQ/GNA11-coupled GPCRs in response to elevated pressure, leading to increased production of DAG and IP<sub>3</sub>/Ca<sup>2+</sup> release, which activate TRPC6 and TRPM4 channels, respectively, to depolarize the cell and increase the open probability of L-type voltage-gated Ca<sup>2+</sup> channels, thereby promoting global Ca<sup>2+</sup> influx and contraction (<xref ref-type="bibr" rid="c24">Davis <italic>et al</italic>., 2023c</xref>). In a similar manner, TRPM4 and PKD2/2 channels might be activated by Ca<sup>2+</sup> influx/release downstream from mechano-activation of a GPCR or another Ca<sup>2+</sup>-permeable ion channel such as PIEZO1 (<xref ref-type="bibr" rid="c84">Peyronnet <italic>et al</italic>., 2013</xref>) or TRPV4 (<xref ref-type="bibr" rid="c103">Swain &amp; Liddle, 2021</xref>).</p>
<p>Whether a similar scheme is operative in LMCs is unknown. Each lymphatic contraction is preceded by a near-linear depolarization from the “resting” potential to threshold potential, termed the diastolic depolarization, which is the primary determinant of AP/contraction frequency (<xref ref-type="bibr" rid="c121">Zawieja <italic>et al</italic>., 2025</xref>). Thus, lymphatic pressure elevation manifests not as a stepwise increase in baseline potential LMCs (<xref ref-type="bibr" rid="c108">von der Weid <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="c30">Davis &amp; Zawieja, 2018</xref>) but rather as an increase in the diastolic depolarization slope and a reduction in time required to reach threshold for AP firing (<xref ref-type="bibr" rid="c118">Zawieja <italic>et al</italic>., 2018b</xref>; <xref ref-type="bibr" rid="c119">Zawieja <italic>et al</italic>., 2019</xref>). Previously, we found that regulation of the diastolic depolarization slope was mediated largely by activation of the Ca<sup>2+</sup> activated chloride channel ANOCTAMIN 1 (ANO1, also referred to as TMEM16A). ANO1 is not intrinsically mechanosensitive, but is regulated by Ca<sup>2+</sup> and, in LMCs specifically, by IP<sub>3</sub> receptor 1-mediated Ca<sup>2+</sup> release from sarcoplasmic reticulum (<xref ref-type="bibr" rid="c119">Zawieja <italic>et al</italic>., 2019</xref>; <xref ref-type="bibr" rid="c120">Zawieja <italic>et al</italic>., 2023</xref>), possibly downstream from one or more mechanosensitive GPCRs. However, other mechanisms are also involved because <italic>Ano1</italic> deletion from smooth muscle or pharmacological inhibition of ANO1 does not completely eliminate spontaneous APs or contractions (<xref ref-type="bibr" rid="c119">Zawieja <italic>et al</italic>., 2019</xref>). The primary goal of the present study was to test the roles of putative VSMC mechanosensitive ion channels, channels implicated in the regulation of pacemaking in other cell types, and GNAQ/GNA11-coupled GPCRs in pressure-induced chronotropy of popliteal lymphatic vessels. An advantage in studying this particular aspect of lymphatic vessel mechanotransduction is the high sensitivity of the spontaneous contraction frequency to pressure, increasing ∼10-fold over only a 5 cmH<sub>2</sub>O pressure range in popliteal lymphatics compared to relatively modest levels of myogenic constriction (50% change) over a 60 mmHg pressure range, even in the most myogenically reactive arteries (<xref ref-type="bibr" rid="c24">Davis <italic>et al</italic>., 2023c</xref>). As part of our strategy, we sought to make maximum use of transgenic mice to avoid non-specific effects of pharmacological inhibitors, particularly those used to block TRP channels.</p>
</sec>
<sec id="s2">
<title>Materials and Methods</title>
<sec id="s2a">
<title>Protocol approval</title>
<p>All procedures were reviewed and approved by the animal care committee at the University of Missouri and complied with the standards stated in the “Guide for the Care and Use of Laboratory Animals” (National Institutes of Health, revised 2011).</p>
</sec>
<sec id="s2b">
<title>Mice</title>
<p><italic>WT</italic> mice [C57Bl/6 (#000664) and SVF129 (#101043) strains], <italic>Slc8a1<sup>−/−</sup></italic> (#025943) mice and <italic>AT<sub>1a</sub>R<sup>−/−</sup></italic>(#002682) mice were purchased from The Jackson Laboratory (Bar Harbor, Maine). Myh11-CreER<sup>T2</sup>mice were gifts from Stefan Offermans (Max Plank Institute, GDR). Sperm from <italic>Gna<sub>12</sub><sup>−/−</sup>;Gna<sub>13</sub><sup>f/f</sup></italic> and <italic>Gna<sub>11</sub><sup>−/−</sup> ;Gna<sub>q</sub><sup>f/f</sup></italic> mice were gifts from Stefan Offermanns, after which the respective mice were rederived at MMRC, Columbia, MO to generate Myh11-CreER<sup>T2</sup><italic>;Gna<sub>13</sub><sup>f/f</sup>;Gna<sub>12</sub><sup>−/−</sup></italic>mice <italic>and</italic> Myh11-CreER<sup>T2</sup><italic>;Gna<sub>q</sub><sup>f/f</sup>;Gna<sub>11</sub><sup>−/−</sup></italic>mice. <italic>Trpc6<sup>−/−</sup></italic> and <italic>Trpc3<sup>−/−</sup></italic> mice were gifts from Lutz Birnbaumer (NIH); <italic>Trpc6<sup>−/−</sup> ;Trpc3<sup>−/−</sup></italic> double KO mice were generated by crossing those two strains. Myh11-CreER<sup>T2</sup><italic>;Kcnq4<sup>f/f</sup> (encoding Kv7.4)</italic> mice were a gift of Thomas Jentsch (Free Univ. of Berlin, GDR). <italic>Piezo1<sup>f/f</sup></italic> mice were a gift from Ardem Pataputian (UCSD) and were bred to Myh11-CreER<sup>T2</sup> mice to generate Myh11-CreER<sup>T2</sup><italic>; Piezo1<sup>f/f</sup></italic> mice. <italic>Ano1<sup>f/f</sup></italic>mice, generated in the lab of Jonathan Jaggar (Leo <italic>et al</italic>., 2021) were bred to Myh11-CreER<sup>T2</sup> mice to obtain Myh11-CreER<sup>T2</sup><italic>;Ano1<sup>f/f</sup></italic> mice. <italic>Itpr1<sup>f/f</sup></italic> mice were obtained from Ju Chen (UCSD) and bred to Myh11-CreER<sup>T2</sup>mice to generate Myh11-CreER<sup>T2</sup><italic>;Itpr1<sup>f/f</sup></italic>mice. <italic>Pkd2<sup>f/f</sup></italic> mice were generated in the University of Maryland PKD Core by Jonathan Jaggar, as previously described (<xref ref-type="bibr" rid="c9">Bulley <italic>et al</italic>., 2018</xref>), and bred in the Jaggar laboratory to Myh11-CreER<sup>T2</sup>mice to generate Myh11-CreER<sup>T2</sup><italic>;Pkd2<sup>f/f</sup></italic> mice. <italic>Trpm4<sup>f/f</sup></italic>mice were generated in the laboratory of Scott Earley and bred to Myh11-CreER<sup>T2</sup> mice to produce Myh11-CreER<sup>T2</sup><italic>;Trpm4<sup>f/f</sup></italic>mice. <italic>Trpv4<sup>f/f</sup></italic> mice were generated in the laboratory of Timothy Domeier (University of Missouri) and bred to Myh11-CreER<sup>T2</sup> mice to produce Myh11-CreER<sup>T2</sup><italic>;Trpv4<sup>f/f</sup></italic> mice. <italic>Rosa26mTmG</italic><sup>f/f</sup> mice were purchased from JAX (#007676) and bred to Myh11-CreER<sup>T2</sup> and Myh11-CreER<sup>T2</sup><italic>;Ano1<sup>f/f</sup></italic> mice to produce Myh11-CreER<sup>T2</sup><italic>;Rosa26mTmG<sup>f/f</sup> and</italic> Myh11-CreER<sup>T2</sup><italic>;Ano1<sup>f/f</sup>; Rosa26mTmG<sup>f/f</sup></italic>mice.</p>
<p>For genotyping, genomic DNA was extracted from tail clips using the HotSHOT method. Genotypes were determined by PCR with 2x PCR Super Master Polymerase Mix (Catalog # B46019, Bimake, Houston, TX) according to the provider’s instructions. Mice containing Myh11-CreER<sup>T2</sup> were induced with five consecutive daily injections of 100 mg tamoxifen (10mg/kg i.p.; in safflower oil). Those mice were studied a minimum of 2 weeks after induction. All floxed control mice were subjected to the same induction protocol. Because the Myh11-CreER<sup>T2</sup> used for SM-specific deletion of floxed genes is carried on the y chromosome, only male mice were used for experiments involving Myh11-CreER<sup>T2</sup> mice or their floxed controls. For other strains, both male and female animals were used.</p>
</sec>
<sec id="s2c">
<title>Vessel isolation, pressure myography, and data acquisition</title>
<p>Mice were anesthetized with ketamine/xylazine (100/10 mg/kg, i.p.) and placed face down on a heated tissue dissection/isolation pad. The saphenous vein was exposed by a proximal-to-distal incision along the skin of the calf and the popliteal afferent lymphatic vessels on each side of the vein were isolated as previously described (<xref ref-type="bibr" rid="c93">Scallan &amp; Davis, 2013</xref>). Each vessel was then pinned with short segments of 40 µm stainless steel wire onto the SYLGARD-coated surface of a dissection chamber filled with BSA-supplemented Krebs buffer at room temperature. Once secured, the surrounding adipose and connective tissue were removed by microdissection. An isolated popliteal lymphatic vessel was then transferred to a 3-mL observation chamber, cannulated, pressurized to 3 cmH<sub>2</sub>O using two glass micropipettes (50-60 µm outside diameter) and moved to the stage of a Zeiss inverted microscope. Lymphatic segments used in these studies typically contained a single valve. Polyethylene tubing attached to the back of each glass micropipette was connected to a two-channel computerized pressure controller (<xref ref-type="bibr" rid="c94">Scallan <italic>et al</italic>., 2013</xref>). To minimize diameter-tracking artifacts associated with longitudinal bowing at higher intraluminal pressures, input and output pressures were briefly set to 10 cmH<sub>2</sub>O at the beginning of every experiment, and the vessel segment was stretched axially to remove longitudinal slack. The lymphatic vessel was then allowed to equilibrate at 37°C with inflow and outflow pressures set to 3 cmH<sub>2</sub>O. Constant exchange of Krebs buffer was maintained using a peristaltic pump at a rate of 0.5 mL/min. After temperature stabilized, popliteal lymphatics typically began to exhibit spontaneous contractions within 10-15 min and stabilized in a consistent contraction pattern within ∼30 minutes. Custom LabVIEW programs (National Instruments; Austin, TX) acquired real-time analog data and digital video through an A-D interface (USB-6216, National Instruments) and detected the inner diameter of the vessel at 30 fps using a Basler A641fm firewire camera (<xref ref-type="bibr" rid="c17">Davis, 2005</xref>). Videos of the contractile activity of lymphatic vessels were recorded for further analysis, if needed.</p>
</sec>
<sec id="s2d">
<title>Assessment of ex vivo contractile function</title>
<p>The contractile parameters of each vessel were characterized at different levels of intraluminal pressure spanning the physiological range from 0.5 to 10 cmH<sub>2</sub>O (in successive steps as follows: 3, 2, 1, 0.5, 3, 5, 8, and 10 cmH<sub>2</sub>O). Spontaneous contractions were recorded at each pressure in typical intervals of 2 minutes, although a period of 4-5 min was sometimes required at the lowest pressure to obtain multiple contractions. During the pressure response protocol, both the input and output pressures were maintained at equal levels so that there was no imposed pressure gradient for forward flow. At the end of every experiment, all vessels were equilibrated by perfusion with calcium-free Krebs buffer containing 3 mM EGTA for 30 minutes, after which passive diameters were obtained at each level of intraluminal pressure.</p>
</sec>
<sec id="s2e">
<title>Contractile function parameters</title>
<p>Once an experiment was completed, internal diameter traces and/or 30-fps brightfield videos of spontaneous contractions were analyzed using custom-written LabVIEW programs (<xref ref-type="bibr" rid="c20">Davis, 2023b</xref>, <xref ref-type="bibr" rid="c19">a</xref>) to detect end diastolic diameter (EDD), end systolic diameter (ESD), and contraction frequency (FREQ, computed on a contraction-by-contraction basis), with each parameter averaged over a 2-5 min period. These data were used to calculate the following commonly reported parameters that characterize the contractile function of lymphatic vessels:
<disp-formula id="eqn1">
<graphic xlink:href="681001v1_eqn1.gif" mime-subtype="gif" mimetype="image"/>
</disp-formula>
<disp-formula id="eqn2">
<graphic xlink:href="681001v1_eqn2.gif" mime-subtype="gif" mimetype="image"/>
</disp-formula>
<disp-formula id="eqn3">
<graphic xlink:href="681001v1_eqn3.gif" mime-subtype="gif" mimetype="image"/>
</disp-formula>
<disp-formula id="eqn4">
<graphic xlink:href="681001v1_eqn4.gif" mime-subtype="gif" mimetype="image"/>
</disp-formula>
<disp-formula id="eqn5">
<graphic xlink:href="681001v1_eqn5.gif" mime-subtype="gif" mimetype="image"/>
</disp-formula></p>
<p>where D<sub>MAX</sub> represents the maximum passive diameter (obtained after incubation with calcium-free Krebs solution) at a given level of intraluminal pressure. When frequency was zero, a value for amplitude was omitted. The relative paucity of some amplitude data at low pressures in some genotypes reflects the fact that this parameter could not be determined when frequency was zero. Each of the contractile parameters represented the average of all the recorded contractions during the measurement period at each intraluminal pressure.</p>
<sec id="s2e1">
<title>Analysis of pressure-induced chronotropy</title>
<p>Quantification of the frequency-pressure (F-P) relationship for comparisons across genotypes required additional analysis steps, as illustrated in <xref rid="fig1" ref-type="fig">Fig. 1</xref>. Raw recordings of pressure and diameter (<xref rid="fig1" ref-type="fig">Fig. 1A</xref>) show the responses of a WT popliteal vessel to descending pressure steps from 5 to 0.5 cmH<sub>2</sub>O, with the average frequency stated for each pressure. The frequency data were then plotted as a function of pressure (<xref rid="fig1" ref-type="fig">Fig. 1B</xref>). As evident from the behavior of this representative vessel, frequency tended to plateau above 5 cmH<sub>2</sub>O, so the subset of data in which the response was nearly linear over the pressure range 0.5-5 cmH<sub>2</sub>O was fitted with a first-order polynomial to obtain the slope and intercept (<xref rid="fig1" ref-type="fig">Fig. 1C</xref>). As an alternative method, we considered calculating the ratio of the respective contraction frequencies at 0.5 and 5 cmH<sub>2</sub>O; however, in many cases no contractions occurred at P = 0.5 cmH<sub>2</sub>O, which would equate to a ratio of infinity. To avoid this problem, we computed the difference (ΔF) between the frequencies at 5 and 0.5 cmH<sub>2</sub>O. This approach gave consistent values that, like the slope, could detect blunting of the F-P relationship, but in essentially every case the results matched those of the curve fitting procedure; thus, only the F-P slope was used for statistical analyses and shown in subsequent figure plots. To enable a more comprehensive assessment of contractile function, full plots of amplitude, frequency, FPF and tone were also plotted as a function of pressure for each genotype (<xref rid="fig1" ref-type="fig">Fig. 1D</xref>).</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Quantification of the F-P relationship.</title>
<p>Steps for quantitative assessment of pressure-induced chronotropy. <bold>A</bold>) Representative recording of pressure and diameter changes in a WT popliteal lymphatic vessel during inflow (Pin) and outflow (Pout) pressure steps between 0.5 and 5 cmH<sub>2</sub>O. Frequencies stated at the bottom of the trace were determined off-line using a custom peak detection program written in LabVIEW. <bold>B</bold>) Plot of frequency vs pressure for the vessel in A, showing how frequency reaches a plateau above 5 cmH<sub>2</sub>O. <bold>C</bold>) Fit of the frequency data with a first-order equation and calculation of the frequency difference (ΔF) between 5 and 0.5 cmH<sub>2</sub>O. <bold>D</bold>) Summary of contraction data for this representative WT vessel over the stated pressure range; see Methods for description of parameter calculations.</p></caption>
<graphic xlink:href="681001v1_fig1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2e2">
<title>FACS</title>
<p>Inguinal-axillary lymphatic vessels from tamoxifen-treated Myh11-CreER<sup>T2</sup><italic>;mTmG<sup>f/f</sup> and</italic> Myh11-CreER<sup>T2</sup><italic>;Ano1<sup>f/f</sup>;mTmG<sup>f/f</sup></italic>mice were dissected and cleaned of fat and connective tissue as described previously (<xref ref-type="bibr" rid="c117">Zawieja <italic>et al</italic>., 2018a</xref>). Cleaned vessel segments were transferred to a 1-ml tube of low-Ca<sup>2+</sup> PSS containing (in mM): 137 NaCl, 5.0 KCl, 0.1CaCl<sub>2</sub>, 1.0 MgCl<sub>2</sub>, 10 HEPES, 10 Glucose, and 1 mg/ml BSA at room temperature for 10 min. The solution was decanted and replaced with a similar solution containing 26 U/ml papain (Sigma, St. Louis, MO) and 1 mg/ml dithioerythritol. The vessels were incubated for 30 min at 37°C with occasional agitation, then transferred to a new tube containing low-Ca<sup>2+</sup> PSS containing 25 mg/ml collagenase H (FALGPA U/ml, Sigma), 0.7 mg/ml collagenase F (Sigma), 20 mg/ml trypsin inhibitor (Sigma), 1mg/ml elastase (Worthington), and incubated for 6 min at 37°C. The dispersed cells were sedimented by centrifugation (300 g, 4 min), resuspended in 0.6 ml PSS containing 1mM Ca solution, and filtered through a 35-µm mesh nylon filter to obtain a single cell suspension. GFP+ LMCs were sorted by fluorescence-activated cell sorting (FACS) using a Beckman-Coulter MoFlo XDP instrument with excitation laser (488 nm) and emission filter (530 ± 40 nm), a 70 µm nozzle, a sheath pressure of 45 psi and sort rate of 100 events per second. Sorting was performed at the Cell and Immunobiology Core facility at the University of Missouri.</p>
</sec>
<sec id="s2e3">
<title>RNA isolation and quantitative, real-time PCR</title>
<p>Total RNA was extracted from FACS-sorted cells using the Arcturus PicoPure RNA isolation kit (ThermoFisher Scientific, Waltham, MA) with on-column DNase I treatment (Qiagen, Valencia, CA) according to manufacturer’s instructions. RNA was eluted with nuclease-free water. Purified RNA was transcribed into cDNA using High-Capacity cDNA Reverse Transcription kit (ThermoFisher Scientific, Waltham, MA). Real-time PCR (qPCR) was performed on cDNAs prepared from each sample using 2x PrimeTime Gene Expression Master Mix (IDT, Coralville, IA) with predesigned TaqMan probes as listed in <xref ref-type="tbl" rid="tbls1">Suppl. Table 1</xref> (IDT, Coralville, IA). Real-time PCR protocols were as follows: preheating at 95°C for 3 min, 45 cycles of two-step cycling of denaturation at 95°C for 15 sec and annealing/extension steps of 30 sec at 60°C. Data collection was carried out using a Bio-Rad CFX 96 Real-Time Detection System (software version Bio-Rad CFX Manager 3.1; Bio-Rad, Hercules, CA, USA). For analysis, the result was expressed as a ratio of target gene/reference gene (β-actin).</p>
</sec>
<sec id="s2e4">
<title>scRNAseq analysis</title>
<p>A total of 10 <italic>Rosa26mTmG</italic> mice (5 males and 5 females), without Cre and without tamoxifen treatment were used for scRNAseq analysis. Inguinal-axillary lymphatic vessels (IALVs) from both sides of each mouse were isolated and cleaned of connective and adipose tissue. The pooled vessels were digested into a single cell suspension and the cells were kept on ice until all tissues had been processed. Cells from all vessels were combined and sorted for tdTomato expression to remove debris and concentrate the cells for downstream single cell 3’ RNA-Seq libraries creation with 10x Genomics Chromium Chip and Chromium Next GEM Single Cell 3’ RNA-Seq reagents (<xref ref-type="bibr" rid="c121">Zawieja <italic>et al</italic>., 2025</xref>). Samples were sequenced with the NovaSeq 6000 S4-PE100 flow cell.</p>
<p>Mus musculus genome GRCm39 and annotation GTF (v106) from Ensembl (<ext-link ext-link-type="uri" xlink:href="https://useast.ensembl.org/Mus_musculus/Info/Index">https://useast.ensembl.org/Mus_musculus/Info/Index</ext-link>) were used to build the reference index and the reads were processed using Cell Ranger (v7.0.1) using the default parameters. The quality control and filtering steps were performed using R (v4.2.1; <ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/">https://www.r-project.org/</ext-link>). Ambient RNA was removed from the Cell Ranger output with SoupX (<xref ref-type="bibr" rid="c116">Young &amp; Behjati, 2020</xref>). A doublet score for each cell was estimated using scDBlFinder [v1.12.0; (<xref ref-type="bibr" rid="c39">Germain <italic>et al</italic>., 2021</xref>)]. Non-expressed genes (sum zero across all samples) and low-quality cells (&gt;10% mitochondrial genes, &lt; 500 genes, &lt; 1,000 UMIs per cell and doublet score &lt;0.5) were removed with custom R scripts. Cells passing filtering were normalized/scaled (SCTransformation), dimensionally reduced (t-distributed stochastic neighbor embedding (t-SNE), uniform manifold approximation and projection (UMAP)) clustered, and hierarchically analyzed with Seurat (<xref ref-type="bibr" rid="c44">Hao <italic>et al</italic>., 2021</xref>; <xref ref-type="bibr" rid="c45">Hao <italic>et al</italic>., 2024</xref>) using the default parameters. Marker gene expression profile on cell clusters and gene co-expression were visualized using Seurat and ShinyCell R app (Ouyang et al., 2021 PMID: 33774659). The raw scRNAseq dataset is available on the NIH GEO #GSE277843 (eLIFE ref).</p>
</sec>
<sec id="s2e5">
<title>Solutions and chemicals</title>
<p>Krebs buffer contained: 146.9 mM NaCl, 4.7 mM KCl, 2 mM CaCl<sub>2</sub>·2H<sub>2</sub>O, 1.2 mM MgSO<sub>4</sub>, 1.2 mM NaH<sub>2</sub>PO<sub>4</sub>·H<sub>2</sub>O, 3 mM NaHCO<sub>3</sub>, 1.5 mM Na-HEPES, and 5 mM D-glucose (pH = 7.4). An identical buffer was prepared with the addition of 0.5% bovine serum albumin (“Krebs-BSA”). During cannulation Krebs-BSA buffer was present both luminally and abluminally; however, during the experiment the abluminal solution was constantly exchanged with plain Krebs. Ca<sup>2+</sup>-free Krebs was Krebs with 3 mM EGTA replacing CaCl<sub>2</sub>·2H<sub>2</sub>O. All chemicals were obtained from Sigma-Aldrich (St. Louis, MO), with the following exceptions: BSA (US Biochemicals; Cleveland, OH), MgSO<sub>4</sub> and Na-HEPES (ThermoFisher Scientific; Pittsburgh, PA), ivabradine, zatebradine and losartan (Tocris). Amiloride, benzamil, ivabradine, zatebradine, BaCl<sub>2</sub> and losartan were dissolved in water to make stock solutions. Ani9, tranilast and SET2 were dissolved in DMSO to make stock solutions. Each inhibitor was then further diluted in Krebs solution to reach the final concentrations stated.</p>
</sec>
<sec id="s2e6">
<title>Statistical analysis</title>
<p>The data were analyzed in LabVIEW, compiled in Excel and statistical analyses were performed using Prism (v.10.2; Graphpad, San Diego, CA). Statistical differences in the slopes of the F-P relationships between two groups were assessed by an unpaired, two-tailed t-test, and differences between three or more groups were tested using a one-way ANOVA with Dunnett’s post-hoc tests. Comparisons between contraction parameters as a function of pressure were made using two-way or mixed-model ANOVAs with repeated measures and Sidák’s post-hoc tests. Data are plotted as mean ± SEM. Significance levels (compared to the control group) are either stated or indicated as follows: *<italic>p</italic>&lt;0.05; **<italic>p</italic>&lt;0.01; ***<italic>p</italic>&lt;0.001; ****<italic>p</italic>&lt;0.0001; “n.s.” p≥0.05, with the color-coding of the symbols matching the respective group. In the figure legends, N refers to the number of animals and <italic>n</italic> refers to the number of vessels per group.</p>
</sec>
</sec>
</sec>
<sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Role of ANO1 in pressure-induced chronotropy</title>
<p>Single cell RNAseq analyses from dissected IALVs revealed 19 distinct cell clusters (<xref rid="fig2" ref-type="fig">Fig. 2A</xref>), segregating into prominent clusters/subclusters of lymphatic endothelial cells (LECs), LMCs, adventitial cells (AdvCs) and immune cells. Further analysis confirmed that <italic>Ano1</italic> was expressed at moderate levels (relative to <italic>Acta2</italic>) in &gt;75% of LMCs and to a lesser extent in AdvCs, but not in LECs (<xref rid="fig2" ref-type="fig">Fig. 2A</xref>). AdvCs contained subclusters of adventitial fibroblasts and other cell types expressing multiple stem cell markers (<xref ref-type="bibr" rid="c119">Zawieja <italic>et al</italic>., 2019</xref>).</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Consequences of ANO1 deletion and/or inhibition.</title>
<p><bold>A</bold>) UMAP plot of <italic>Ano1</italic> expression in the various cell populations within the walls of murine IALVs that were thoroughly cleaned prior to dissociation and scRNAseq analysis, as described in (<xref ref-type="bibr" rid="c121">Zawieja <italic>et al</italic>., 2025</xref>). The LMC cluster (composed of at least two subclusters of 978 cells) was identified by the expression of canonical smooth muscle cell markers <italic>Acta2</italic> (SM α-actin), <italic>Myh11</italic> (myosin heavy chain 11), <italic>Itga8</italic> (integrin alpha 8). Gray color in this and subsequent figures represents <italic>Acta2</italic> expression, red/brown in this panel indicates <italic>Ano1</italic> expression. Bubble plot shows Ano1 expression in the LMC and other cell clusters in terms of percent cells in an individual cluster expressing <italic>Ano1</italic> (size of dot) and the <italic>Ano1</italic> expression level relative to <italic>Acta2</italic> (color of dot). <bold>B</bold>) Slope of frequency vs pressure (F-P) for WT (C57Bl/6) vessels with / without treatment by the ANO1 inhibitor Ani9 (1 μM), for <italic>Ano1<sup>f/f</sup></italic> control vessels, for <italic>Ano1 smKO</italic> vessels and for the latter treated with Ani9. <bold>C</bold>) Summary plots of contraction parameters as a function of pressure for the 5 respective groups of vessels. WT N=15, n=20; WT+Ani9 N=5, n=6; <italic>Ano1 smKO</italic> N=14, n=23; <italic>Ano1<sup>f/f</sup></italic> N=8, n=16.</p></caption>
<graphic xlink:href="681001v1_fig2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>Previously, we reported that ANO1 inhibition or SM-specific <italic>Ano1</italic> deletion caused a nearly complete abrogation of pressure-induced chronotropy in mouse IALVs. However, the contraction frequency of IALVs changes only ∼1.7 fold over the pressure range from 0.5 to 10 cmH<sub>2</sub>O (<xref ref-type="bibr" rid="c119">Zawieja <italic>et al</italic>., 2019</xref>), compared to the much larger dynamic range (≥ 10-fold) characteristic of popliteal lymphatics (<xref rid="fig1" ref-type="fig">Fig. 1</xref>). Thus, we used popliteal lymphatics throughout this study to assess pressure-induced chronotropy, in anticipation that we would be able to detect even subtle changes in the response after deletion of specific genes. The F-P analysis for 20 WT popliteal lymphatic vessels is shown in <xref rid="fig2" ref-type="fig">Fig. 2</xref>. C57Bl/6 mice served as the WT control group for many comparisons because all transgenic strains used in the present study (with one exception) were derived from, or backcrossed into, that background. The average slope (± SEM) of the F-P relationship between 0.5 and 5 cmH<sub>2</sub>O was 2.8 ± 0.3 for WT vessels (<xref rid="fig2" ref-type="fig">Fig. 2B</xref>), equating to an average frequency difference of 12.1 ± 1.0 contractions·min<sup>−1</sup> over that pressure range. The average r<sup>2</sup> value for the linear regressions was 0.93 ± 0.02, indicating a consistently high quality of the curve fits and confirming that the slope was approximately linear between 0.5 and 5 cmH<sub>2</sub>O. The role of ANO1 in pressure-induced chronotropy of mouse popliteal lymphatic vessels was then tested after pharmacologic inhibition of ANO1 with Ani9, one of the most selective small molecule inhibitors of ANO1 (<xref ref-type="bibr" rid="c48">Hwang <italic>et al</italic>., 2016</xref>). Initial assessment of the Ani9 concentration-response relationship (from 30 nM to 10 μM) in WT popliteal vessels revealed that 3 μM Ani9, the concentration previously used to inhibit ANO1 in IALVs (<xref ref-type="bibr" rid="c119">Zawieja <italic>et al</italic>., 2019</xref>; <xref ref-type="bibr" rid="c120">Zawieja <italic>et al</italic>., 2023</xref>), did indeed reduce the basal contraction frequency of popliteal lymphatics (in the lower pressure range), but also caused a loss of tone and marked reduction in their contraction amplitude (not shown)—suggestive of possible off-target effects; therefore, for subsequent F-P protocols we used a lower concentration (1 μM) of Ani9, which had insignificant effects on contraction amplitude and tone (<xref rid="fig2" ref-type="fig">Fig. 2C</xref>) but significantly reduced the average slope of the F-P relationship from 2.8 ± 0.3 to 0.3 ± 0.2 (p&lt;0.001; <xref rid="fig2" ref-type="fig">Fig. 2B</xref>).</p>
<p>We then tested the effects of SM-specific <italic>Ano1</italic> deletion by comparing the F-P relationship of popliteal lymphatic vessels from tamoxifen-treated Myh11-CreER<sup>T2</sup><italic>;Ano1<sup>f/f</sup></italic> (<italic>Ano1 smKO</italic>) mice to <italic>Ano1<sup>f/f</sup></italic> control mice. The results are also shown in <xref rid="fig2" ref-type="fig">Fig. 2B</xref>. The average slope of the F-P relationship between 0.5 and 5 cmH<sub>2</sub>O for <italic>Ano1 smKO</italic> vessels was 0.4 ± 0.2, significantly lower (p&lt;0.001) than that (2.8 ± 0.2) for <italic>Ano1<sup>f/f</sup></italic> vessels. Complete sets of contraction data for untreated and Ani9-treated WT popliteal lymphatics, Myh11-CreER<sup>T2</sup><italic>;Ano1<sup>f/f</sup></italic> and <italic>Ano1<sup>f/f</sup></italic>popliteal vessels, are shown in <xref rid="fig2" ref-type="fig">Fig. 2C</xref>. The frequency of Ani9-treated vessels was significantly reduced at most pressures but increased at higher pressures. Normalized contraction amplitudes were unchanged by Ani9. Tone was slightly but not significantly higher in Ani9-treated vessels. After <italic>Ano1</italic> deletion, frequency was reduced to &lt;3 contractions·min<sup>−1</sup> at all pressures, in contrast to Ani9-treated WT vessels in which frequency was comparably reduced at low pressures but not at elevated pressures (<xref rid="fig2" ref-type="fig">Fig. 2C</xref>). <italic>Ano1 smKO</italic> vessels had significantly elevated levels of tone at 5 of 7 pressures, suggesting that Ani9 treatment may have interfered with tone development in a way that <italic>Ano1</italic> deletion did not. Collectively, these results show that deletion / inhibition of ANO1 significantly impaired pressure-induced chronotropy in popliteal lymphatic vessels; however, SM-specific <italic>Ano1</italic> deletion failed to completely abolish spontaneous contractions in 16 of 21 <italic>Ano1 smKO</italic> vessels. To test the possibility that residual pacemaking activity in <italic>Ano1 smKO</italic> vessels might be due to incomplete recombination by the inducible Myh11-CreER<sup>T2</sup> driver, <italic>Ano1</italic> mRNA levels in IALVs were quantified using qPCR analysis. Smooth muscle cells were digested from IALVs of Myh11-CreER<sup>T2</sup><italic>;mTmG<sup>f/f</sup></italic>or Myh11-CreER<sup>T2</sup><italic>;mTmG<sup>f/f</sup>;Ano1<sup>f/f</sup></italic> mice and purified by FACS using the GFP signal. <italic>Ano1</italic> message (referenced to α-actin levels) in LMCs from Myh11-CreER<sup>T2</sup><italic>;mTmG<sup>f/f</sup>;Ano1<sup>f/f</sup></italic> vessels was undetectable compared to that in LMCs from Myh11-CreER<sup>T2</sup><italic>;mTmG<sup>f/f</sup></italic> vessels (0 ± 0 and 1006 ± 80, respectively; mean ± SD, n=3). As a further test for possible residual ANO1 activity in <italic>Ano1 smKO</italic> vessels, we treated another group of <italic>Ano1 smKO</italic> vessels with Ani9 (1 μM), and those results are shown in <xref rid="fig2" ref-type="fig">Fig. 2B-C</xref>. Pacemaking activity persisted even after combined deletion and inhibition of ANO1, without significant further reductions in frequency at any pressure, suggesting that residual pacemaking in <italic>Ano1</italic> KO vessels was <italic>not</italic> due to incomplete ANO1 knock down. Collectively, these results point to ANO1 as the major component of pressure-induced lymphatic chronotropy but also to the involvement of one or more additional mechanisms, possibly involving other LMC ion channels.</p>
</sec>
<sec id="s3b">
<title>Role of PIEZO1</title>
<p>PIEZO1 and PIEZO2 are two ion channels that satisfy the full set of criteria for true mechanosensitivity (<xref ref-type="bibr" rid="c15">Coste <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="c24">Davis <italic>et al</italic>., 2023c</xref>). PIEZO2 is expressed primarily in neurons (<xref ref-type="bibr" rid="c112">Woo <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="c111">Woo <italic>et al</italic>., 2015</xref>) whereas PIEZO1 is more widely expressed (<xref ref-type="bibr" rid="c77">Murthy <italic>et al</italic>., 2017</xref>). PIEZO1 is critically important for shear-stress induced Ca<sup>2+</sup> signaling in endothelium (<xref ref-type="bibr" rid="c60">Li <italic>et al</italic>., 2014a</xref>), for lymphatic valve and vessel development (<xref ref-type="bibr" rid="c82">Nonomura <italic>et al</italic>., 2018</xref>; <xref ref-type="bibr" rid="c14">Choi <italic>et al</italic>., 2019</xref>; <xref ref-type="bibr" rid="c13">Choi <italic>et al</italic>., 2024</xref>) and for hypertension-dependent arterial wall remodeling (<xref ref-type="bibr" rid="c89">Retailleau <italic>et al</italic>., 2015</xref>). The role of PIEZO1 in the arterial myogenic response has not been systematically tested, except for a single report showing that SM-specific <italic>Piezo1</italic> deletion did not alter myogenic tone development in either caudal and rostral cerebellar arteries of mice [Suppl. Figs. 2-3 in (<xref ref-type="bibr" rid="c89">Retailleau <italic>et al</italic>., 2015</xref>)]. The possible involvement of PIEZO1 in lymphatic vessel contractility has not been reported. Our scRNAseq analysis revealed strong expression of <italic>Piezo1</italic> message in LECs but very weak expression in LMCs (<xref rid="fig3" ref-type="fig">Fig. 3A</xref>). <italic>Piezo2</italic> expression was barely detectable in either cell type. Popliteal lymphatic vessels from Myh11-CreER<sup>T2</sup><italic>;Piezo1<sup>f/f</sup></italic> (<italic>Piezo1 smKO</italic>) and <italic>Piezo1<sup>f/f</sup></italic>control mice were subjected to the protocol for assessing pressure-induced chronotropy. However, the data revealed no significant difference in the F-P slope between <italic>Piezo1 smKO</italic> vessels and <italic>Piezo1<sup>f/f</sup></italic> control vessels (<xref rid="fig3" ref-type="fig">Fig. 3B</xref>), suggesting that PIEZO1 channels in LMCs are not required for pressure-induced lymphatic chronotropy. As a further test, we used Nestin-Cre to generate Nestin-Cre<italic>;Piezo1<sup>f/f</sup> (Piezo1 nestinKO)</italic> mice with constitutive deletion of <italic>Piezo1</italic> both in smooth muscle and other cells expressing intermediate filaments. An analysis of vessel responses from <italic>Piezo1 nestinKO</italic> mice indicated that there was no significant impairment in pressure-induced chronotropy (<xref rid="fig3" ref-type="fig">Fig. 3B</xref>). Although we did not suspect the endothelium would be involved in pressure-induced chronotropy, we also generated and tested Prox1-CreER<sup>T2</sup><italic>;Piezo1<sup>f/f</sup> (Piezo1 lecKO)</italic> mice. As expected, there was no significant difference in the average F-P slope of vessels from <italic>Piezo1 lecKO</italic> mice compared to tamoxifen-treated <italic>Piezo1<sup>f/f</sup></italic> controls (<xref rid="fig3" ref-type="fig">Fig. 3B</xref>). Complete sets of contraction data for popliteal vessels from <italic>Piezo1 smKO</italic> are shown in <xref rid="fig3" ref-type="fig">Fig. 3C</xref> and revealed no significant differences in any of the lymphatic contractile parameters at any pressure compared to their floxed controls.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>Consequences of <italic>Piezo1</italic> deletion.</title>
<p><bold>A</bold>) UMAP and bubble plots of <italic>Piezo1 and Piezo2</italic> expression in the various IALV cell clusters. <bold>B</bold>) Slope of F-P relationship for popliteal lymphatics from <italic>Piezo1<sup>f/f</sup>, Piezo1 smKO</italic>, <italic>Piezo1 nestin KO</italic>, <italic>Piezo1 lecKO</italic> mice. <bold>C</bold>) Summary plots of contraction parameters as a function of pressure for the 4 respective groups of vessels. <italic>Piezo1<sup>f/f</sup></italic> N=9, n=17; <italic>Piezo1 smKO</italic> N=7, n=13; <italic>Piezo1 nestin KO</italic> N=5, n=10; <italic>Piezo1 lecKO</italic> N=5, n=6.</p></caption>
<graphic xlink:href="681001v1_fig3.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3c">
<title>Roles of TRPC6 and TRPC3</title>
<p>TRPC6 is thought to be a mechanosensitive cation channel whose activation underlies pressure-induced constriction in cerebral arteries (<xref ref-type="bibr" rid="c110">Welsh <italic>et al</italic>., 2002</xref>). However, studies of other arteries from <italic>Trpc6<sup>−/−</sup></italic> mice found either no differences from control vessels or even <italic>enhanced</italic> myogenic responsiveness (<xref ref-type="bibr" rid="c33">Dietrich <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="c97">Schleifenbaum <italic>et al</italic>., 2014</xref>). Because global TRPC6 deletion results in compensatory upregulation of TRPC3 (<xref ref-type="bibr" rid="c33">Dietrich <italic>et al</italic>., 2005</xref>), a related TRPC family member with similar properties and which is also activated by DAG, it is possible that TRPC3 could compensate for loss of TRPC6. The expression patterns for TRPC6 and TRPC3, based on scRNAseq analyses, are shown in <xref rid="fig4" ref-type="fig">Fig. 4A</xref>. TRPC6 was expressed at modest levels in ∼50% of LMCs and was almost exclusively confined to LMCs. TRPC3 was expressed at very low levels in only a few LMCs (from control mice). We tested the effects of global TRPC6 deletion (<italic>Trpc6<sup>−/−</sup></italic>), global TRPC3 deletion (<italic>Trpc3<sup>−/−</sup></italic>) and global deletion of both isoforms (<italic>Trpc6<sup>−/−</sup>;Trpc3<sup>−/−</sup></italic>) on pressure-induced lymphatic chronotropy. As these mice were all generated in the SV129 background, control measurements were performed on popliteal vessels from SV129 mice, which showed a <italic>lower</italic> average F-P slope than WT (C57Bl/6) popliteal vessels. There were no significant differences in F-P slope between SV129 controls and <italic>Trpc6<sup>−/−</sup></italic> or <italic>Trpc3<sup>−/−</sup></italic> vessels, but the F-P slope of <italic>Trpc6<sup>−/−</sup>;Trpc3<sup>−/−</sup></italic> vessels was significantly <italic>higher</italic> than that of the SV129 controls (<xref rid="fig4" ref-type="fig">Fig. 4B</xref>). Complete sets of contraction data for <italic>Trpc6<sup>−/−</sup>;Trpc3<sup>−/−</sup></italic> vessels, compared to their <italic>SV129</italic> controls, are shown in <xref rid="fig4" ref-type="fig">Fig. 4C</xref>. <italic>Trpc6<sup>−/−</sup>;Trpc3<sup>−/−</sup></italic>double knock-out vessels had significantly impaired contraction amplitudes at several pressures and <italic>increased</italic> frequencies and <italic>increased</italic> levels of tone at most pressures. However, relevant to the main objective of this study, there were no significant <italic>impairments</italic> in pressure-induced chronotropy in vessels deficient in TRPC6, TRPC3 or both TRPC6 and TRPC3 (<xref rid="fig4" ref-type="fig">Fig. 4B-C</xref>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Consequences of <italic>Trpc6</italic> and/or <italic>Trpc3</italic> deletion.</title>
<p><bold>A</bold>) UMAP and bubble plots of <italic>Trpc6 and Trpc3</italic> expression in the various IALV cell clusters. <bold>B</bold>) Slope of F-P relationship for popliteal lymphatics from SV129 controls, <italic>Trpc6<sup>−/−</sup>, Trpc3<sup>−/−</sup> and Trpc6<sup>−/−</sup>;Trpc3<sup>−/−</sup></italic> mice. <bold>C</bold>) Summary plots of contraction parameters as a function of pressure for the 4 respective groups of vessels. SV129 control N=8, n=11; <italic>Trpc6<sup>−/−</sup></italic> N=5, n=10; <italic>Trpc3<sup>−/−</sup></italic> N=7, n=11; <italic>Trpc6<sup>−/−</sup>;Trpc3<sup>−/−</sup></italic> N=5, n=10.</p></caption>
<graphic xlink:href="681001v1_fig4.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3d">
<title>Role of TRPM4</title>
<p>Multiple studies have implicated TRPM4 channels in the arterial myogenic response (<xref ref-type="bibr" rid="c40">Gonzales &amp; Earley, 2013</xref>; <xref ref-type="bibr" rid="c35">Earley &amp; Brayden, 2015</xref>), but to date no published studies have examined the role of TRPM4 in lymphatic vessel contractility. scRNAseq analysis revealed that <italic>Trpm4</italic> was expressed at modest levels in only ∼10% of LMCs, and in a subset of LECs, but at higher levels in some AdvCs (<xref rid="fig5" ref-type="fig">Fig. 5A</xref>). We tested the role of TRPM4 in pressure-induced lymphatic chronotropy by comparing the responses of Myh11-CreER<sup>T2</sup><italic>;Trpm4<sup>f/f</sup></italic> vessels to <italic>Trpm4<sup>f/f</sup></italic>vessels. The lack of significant reductions in F-P slope of <italic>Trpm4 smKO</italic> vessels (<xref rid="fig5" ref-type="fig">Fig. 5B</xref>) suggests that TRPM4 is not required for pressure-induced lymphatic chronotropy. Contraction data comparing <italic>Trpm4 smKO</italic> vessels to <italic>Trpm4<sup>f/f</sup></italic> popliteal vessels are shown in <xref rid="fig4" ref-type="fig">Fig. 4C</xref>. There were no significant differences between the contraction parameters of <italic>Trpm4 smKO</italic> and <italic>Trpm4<sup>f/f</sup></italic> vessels at any pressure.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>Consequences of <italic>Trpm4</italic> deletion.</title>
<p><bold>A</bold>) UMAP and bubble plots of <italic>Trpm4</italic> expression in the various IALV cell clusters. <bold>B</bold>) Slope of F-P relationship for popliteal lymphatics from <italic>Trpm4<sup>f/f</sup> and Trpm4 smKO</italic> mice. <bold>C</bold>) Summary plots of contraction parameters as a function of pressure for the two respective groups of vessels. <italic>Trpm4 smKO</italic> N=6, n=13; <italic>Trpm4<sup>f/f</sup></italic> N=4, n=7.</p></caption>
<graphic xlink:href="681001v1_fig5.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3e">
<title>Role of PKD2</title>
<p>Studies by Jaggar and colleagues indicate that SM-specific deletion of PKD2 attenuates pressure-induced depolarization and myogenic tone in rat pial arteries (<xref ref-type="bibr" rid="c78">Narayanan <italic>et al</italic>., 2013</xref>) and blunts pressure-induced constriction in hindlimb arteries (<xref ref-type="bibr" rid="c9">Bulley <italic>et al</italic>., 2018</xref>). The roles of PKD2/2 channels in lymphatic vessel contractility are not known. scRNAseq analysis revealed modest <italic>Pkd2</italic> and <italic>Pkd1</italic> expression in LMCs and AdvCs (<xref rid="fig6" ref-type="fig">Fig. 6A</xref>). We tested the possible involvement of PKD2 channels in pressure-induced lymphatic chronotropy by comparing the responses of Myh11-CreER<sup>T2</sup><italic>;Pkd2<sup>f/f</sup></italic>(<italic>Pkd2 smKO</italic>) vessels to <italic>Pkd2<sup>f/f</sup></italic> vessels (<xref rid="fig6" ref-type="fig">Fig. 6B</xref>). The lack of a significant reduction in the F-P slope for <italic>Pkd2 smKO</italic> vessels suggests that PKD2 is not required for pressure-induced lymphatic chronotropy. Contraction data comparing <italic>Pkd2 smKO</italic> vessels to <italic>Pkd2<sup>f/f</sup></italic> popliteal vessels are shown in <xref rid="fig6" ref-type="fig">Fig. 6C</xref>. There were no significant differences between the contraction parameters of <italic>Pkd2 smKO</italic> and <italic>Pkd2<sup>f/f</sup></italic> vessels at any pressure.</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title>Consequences of <italic>Pkd2</italic> (TRPP1) deletion.</title>
<p>UMAP and bubble plots of <italic>Pkd2</italic> expression in the various IALV cell clusters. <bold>B</bold>) Slope of F-P relationship for popliteal lymphatics from <italic>Pkd2 <sup>f/f</sup> and Pkd2 smKO</italic> mice. <bold>C</bold>) Summary plots of contraction parameters as a function of pressure for the two respective groups of vessels. <italic>Pkd2 smKO</italic> N=6, n=13; <italic>Pkd2 <sup>f/f</sup></italic> N=4, n=8.</p></caption>
<graphic xlink:href="681001v1_fig6.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3f">
<title>Role of TRPV4</title>
<p>In the blood vasculature, TPRV4 has been studied extensively in the context of Ca<sup>2+</sup> influx pathways in endothelium (<xref ref-type="bibr" rid="c11">Chen &amp; Sonkusare, 2020</xref>). However, TRPV4 is also expressed in VSM cells of some arteries (<xref ref-type="bibr" rid="c74">Mercado <italic>et al</italic>., 2014</xref>) and one report indicates that pharmacological inhibition of TRPV4 channels blunts pressure-induced VSM cell depolarization and myogenic vasoconstriction of preglomerular arteries from neonatal pigs (<xref ref-type="bibr" rid="c100">Soni <italic>et al</italic>., 2017</xref>). Our scRNAseq analysis revealed that TRPV4 was largely undetectable in LMCs but expressed at higher levels in almost all LECs, macrophages and some AdvCs (<xref rid="fig7" ref-type="fig">Fig. 7A</xref>). Nonetheless, we tested the role of TRPV4 channels in pressure-induced lymphatic chronotropy by comparing the responses of Myh11-CreER<sup>T2</sup><italic>;Trpv4<sup>f/f</sup></italic> vessels to <italic>Trpv4<sup>f/f</sup></italic> vessels. The lack of a significant reduction in the F-P slope for <italic>Trpv4 smKO</italic> vessels suggests that TRPV4 is not required for pressure-induced lymphatic chronotropy (<xref rid="fig7" ref-type="fig">Fig. 7B</xref>). Contraction data comparing <italic>Trpv4 smKO</italic> and <italic>Trpv4<sup>f/f</sup></italic> popliteal vessels are shown in <xref rid="fig7" ref-type="fig">Fig. 7C</xref>. Contraction amplitude was impaired at several pressures in <italic>Trpv4 smKO</italic> vessels, suggesting some involvement of TRPV4 channels in control of contractile strength, possibly as a result of macrophage-released products (<xref ref-type="bibr" rid="c98">Schulz <italic>et al</italic>., 2025</xref>). Frequency was significantly different at two lower pressures in <italic>Trpv4 smKO</italic> vessels (<xref rid="fig7" ref-type="fig">Fig. 7C</xref>), where it was <italic>elevated</italic> rather than reduced. We also tested the F-P relationship in <italic>Trpv4<sup>−/−</sup></italic> (global KO) vessels and confirmed that there was no significant impairment in pressure-induced lymphatic chronotropy (average slope = 2.7 ± 0.2; n=18) compared to WT vessels (average slope = 2.8 ± 0.3; data not shown). Collectively, these results indicate that TRPV4 channels are not required for pressure-induced lymphatic chronotropy.</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><title>Consequences of <italic>Trpv4</italic> deletion.</title>
<p>UMAP and bubble plots of <italic>Trpv4</italic> expression in the various IALV cell clusters. <bold>B</bold>) Slope of F-P relationship for popliteal lymphatics from <italic>Trpv4<sup>f/f</sup> and Trpv4 smKO</italic> mice. <bold>C</bold>) Summary plots of contraction parameters as a function of pressure for the two respective groups of vessels. <italic>TRPV4 smKO</italic> N=5, n=10; <italic>TRPV4<sup>f/f</sup></italic> N=3, n=7.</p></caption>
<graphic xlink:href="681001v1_fig7.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3g">
<title>Role of TRPV2</title>
<p>TRPV2 is an osmosensitive cation channel (<xref ref-type="bibr" rid="c81">Nilius &amp; Droogmans, 2001</xref>). Down-regulation of TRPV2 expression in mouse aortic VSM cells reduced the amplitude of cation currents activated by hypotonic swelling (<xref ref-type="bibr" rid="c76">Muraki <italic>et al</italic>., 2003</xref>). In another study, application of a hypotonic bath solution stimulated TRPV2-like whole-cell cation currents and Ca<sup>2+</sup> influx in VSMCs isolated from rat retinal arteries—responses that were attenuated by the TRPV2 inhibitor tranilast (<xref ref-type="bibr" rid="c71">McGahon <italic>et al</italic>., 2016</xref>). Additionally, the administration of tranilast to rat retinal arteries resulted in loss of pre-existing myogenic tone whereas pre-incubation with a TRPV2 blocking antibody prevented the development of myogenic tone (<xref ref-type="bibr" rid="c71">McGahon <italic>et al</italic>., 2016</xref>). Our scRNAseq analysis revealed that TRPV2 was highly expressed in 63% of <italic>Myh11</italic>-expressing LMCs (<xref rid="fig8" ref-type="fig">Fig. 8A</xref>). As we did not have access to TRPV2 null or floxed mice, we tested the potential role of TRPV2 channels in pressure-induced lymphatic chronotropy by bath application of tranilast (100 μM) to WT popliteal lymphatic vessels. There was no significant reduction in the F-P slope for tranilast-treated vessels (<xref rid="fig8" ref-type="fig">Fig. 8B</xref>). We also tested the effects of SET2, a recently reported TRPV2 inhibitor with a lower IC<sub>50</sub> (460 nM) than tranilast. The application of SET2 (1 μM) caused a transient cessation of spontaneous contractions for 2-5 min in 5 of 6 vessels, but the contractions returned within 10 min in the continued presence of SET2. Subsequent pressure steps revealed that SET2 did not significantly alter the F-P slope (<xref rid="fig8" ref-type="fig">Fig. 8B</xref>). Contraction data comparing WT and tranilast-and SET2-treated WT popliteal vessels are shown in <xref rid="fig8" ref-type="fig">Figs. 8C</xref>. These results suggest that TRPV2 is not required for pressure-induced lymphatic chronotropy.</p>
<fig id="fig8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8.</label>
<caption><title>Consequences of Trpv2 inhibition.</title>
<p>UMAP and bubble plots of <italic>Trpv2</italic> expression in the various IALV cell clusters. <bold>B</bold>) Slope of F-P relationship for popliteal lymphatics from WT mice with/without treatment with the TRPV2 inhibitors tranilast (10 μM) and SET2 (1 μM). <bold>C</bold>) Summary plots of contraction parameters as a function of pressure for the three respective groups of vessels. WT+tranilast N=5, n=10; WT+SET2 N=3, n=6.</p></caption>
<graphic xlink:href="681001v1_fig8.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3h">
<title>Role of ENaC</title>
<p>The epithelial Na<sup>+</sup> channel (ENaC), comprised of a heterotrimer under the expression of the genes <italic>Scnn1a</italic>, <italic>Scnn1b</italic>, <italic>Scnn1g</italic>, <italic>Scnn1d</italic>, is expressed in both the endothelial and smooth muscle layers of arteries. αENaC is the principal isoform in endothelium and studies of native epithelial or heterologous channels reconstituted into bilayers suggest that αENaC is intrinsically mechanosensitive (<xref ref-type="bibr" rid="c87">Price <italic>et al</italic>., 2000</xref>; <xref ref-type="bibr" rid="c4">Benos, 2004</xref>). Work from the Drummond laboratory suggests that the βENaC isoform is expressed in VSM cells and plays a critically important role in myogenic constriction (<xref ref-type="bibr" rid="c34">Drummond, 2012</xref>). However, our scRNAseq analysis revealed almost no expression of αENaC subunits in LMCs and only weak expression in the LEC population (<xref rid="fig9" ref-type="fig">Fig. 9A</xref>); βENaC was essentially undetectable. Nevertheless, we tested the possible role of ENaC in pressure-induced lymphatic chronotropy by administering two widely used ENaC inhibitors, amiloride and benzamil, to WT popliteal lymphatic vessels. The data in <xref rid="fig9" ref-type="fig">Fig. 9B</xref> show that neither amiloride nor benzamil, at concentrations known to inhibit arterial myogenic constriction [5 and 1 μM, respectively (<xref ref-type="bibr" rid="c51">Jernigan &amp; Drummond, 2006</xref>)], caused a significant impairment in pressure-induced lymphatic chronotropy. Contraction data for amiloride- and benzamil-treated WT popliteal vessels are shown in <xref rid="fig9" ref-type="fig">Fig. 9C</xref>. Both ENaC inhibitors tended to impair contraction amplitude to some degree (significant only for amiloride), with benzamil also significantly increasing tone at almost all pressure levels. However, the F-P relationships were nearly identical between WT and amiloride- or benzamil-treated vessels, reinforcing the conclusion that ENaC is not involved in pressure-induced lymphatic chronotropy.</p>
<fig id="fig9" position="float" orientation="portrait" fig-type="figure">
<label>Figure 9.</label>
<caption><title>Consequences of ENaC inhibition.</title>
<p>UMAP and bubble plots of <italic>ENaC</italic> subsunit expression in the various IALV cell clusters. <bold>B</bold>) Slope of F-P relationship for popliteal lymphatics from WT mice with/without treatment with the ENaC inhibitors amiloride (5 μM) and benzamil (1 μM). WT N=15, n=20, WT+amiloride N=5, n=9; WT+benzamil N=6, n=11.</p></caption>
<graphic xlink:href="681001v1_fig9.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3i">
<title>Role of NCX1</title>
<p>The sodium-calcium exchanger (NCX) has a well-documented role in controlling the pacemaker activity of sinoatrial nodal cells, where it couples SR calcium oscillations, termed local calcium releases (LCRs) caused by calcium movement through ryanodine channels (<xref ref-type="bibr" rid="c107">Vinogradova <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="c106">Vinogradova <italic>et al</italic>., 2005</xref>), to AP ignition. LCRs may occur throughout diastole (<xref ref-type="bibr" rid="c75">Monfredi <italic>et al</italic>., 2013</xref>), but their role is particularly critical in late diastole where LCRs activate NCX and the ensuing addition of inward current, and positive feedback of further calcium influx through L-type channels, provides sufficient depolarization to cross the voltage threshold for initiating AP firing (<xref ref-type="bibr" rid="c8">Bogdanov <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="c64">Lyashkov <italic>et al</italic>., 2018b</xref>). This process is possibly analogous to the electrophysiological pacemaking mechanism in LMCs. scRNAseq analysis revealed strong expression of <italic>Slc8a</italic>, which encodes NCX1, in &gt;80% of both LMCs and expression was also noted in LECs and some immune cells (<xref rid="fig10" ref-type="fig">Fig. 10A</xref>). We tested the role of NCX1 in pressure-induced chronotropy by comparing the responses of Myh11-CreER<sup>T2</sup><italic>;Slc8a1<sup>f/f</sup></italic> (<italic>Slc8a1 smKO</italic>) and <italic>Slc8a1<sup>f/f</sup></italic> vessels. The lack of a significant reduction in the F-P slope for <italic>Slc8a1 smKO</italic> vessels suggests that NCX1 is not required for pressure-induced lymphatic chronotropy (<xref rid="fig10" ref-type="fig">Fig. 10B</xref>). Contraction data for <italic>Slc8a1 smKO</italic> and <italic>Slc8a1<sup>f/f</sup></italic> popliteal vessels are shown in <xref rid="fig10" ref-type="fig">Fig. 10C</xref> and reveal no significant differences between the contraction parameters of <italic>Slc8a1 smKO</italic> and <italic>Slc8a1<sup>f/f</sup></italic> vessels.</p>
<fig id="fig10" position="float" orientation="portrait" fig-type="figure">
<label>Figure 10.</label>
<caption><title>Consequences of <italic>Slc8a1</italic> (NCX1) deletion.</title>
<p>UMAP and bubble plots of <italic>Slc8a1</italic> expression in the various IALV cell clusters. <bold>B</bold>) Slope of F-P relationship for popliteal lymphatics from <italic>Slc8a1<sup>f/f</sup> and Slc8a1 smKO</italic> mice. <bold>C</bold>) Summary plots of contraction parameters as a function of pressure for the two respective groups of vessels. <italic>Slc8a1<sup>f/f</sup></italic> N=7, n=12; <italic>Slc8a1 smKO</italic> N=7, n=13.</p></caption>
<graphic xlink:href="681001v1_fig10.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3j">
<title>Role of HCN</title>
<p>HCN (Hyperpolarization-activated cyclic-nucleotide-gated) channels contribute an inward “funny” current (I<sub>f</sub>) to the diastolic pacemaking potential of sinoatrial node cells (<xref ref-type="bibr" rid="c1">Accili <italic>et al</italic>., 2002</xref>) and are also involved in the intrinsic rhythmicity of bladder and uterine smooth muscle (<xref ref-type="bibr" rid="c3">Alotaibi <italic>et al</italic>., 2017</xref>; <xref ref-type="bibr" rid="c65">Mader <italic>et al</italic>., 2018</xref>). In LMCs they could potentially contribute to diastolic depolarization. The HCN blockers CsCl, ZD7288 and ivabradine all lower the rate of spontaneous contractions of lymphatic vessels in rat diaphragm (<xref ref-type="bibr" rid="c80">Negrini <italic>et al</italic>., 2016</xref>), but inhibition requires substantially higher concentrations than the documented IC<sub>50</sub> values for HCN channel blockade [see discussion in (<xref ref-type="bibr" rid="c31">Davis &amp; Zawieja, 2024</xref>)]. In contrast, all three inhibitors <italic>increase</italic> the spontaneous contraction frequency of human lymphatic vessels at concentrations near or slightly higher than the IC<sub>50</sub> values for HCN inhibition (<xref ref-type="bibr" rid="c66">Majgaard <italic>et al</italic>., 2022</xref>), suggesting off-target effects in some lymphatic vessels. Our scRNAseq analysis revealed essentially no expression of any of the four HCN isoforms in LMCs (<xref rid="fig11" ref-type="fig">Fig. 11A</xref>), however it is possible the expression is too low to detect without deep sequencing. Due to the proven role of HCN channels in cardiac pacemaking, we tested the role of HCN channels in pressure-induced lymphatic chronotropy of WT mouse popliteal lymphatics using the HCN inhibitor ivabradine (at a concentration of 3 μM, which is slightly higher than the IC<sub>50</sub> of 2.5 μM), and the more effective inhibitor, zatebradine, at a concentration of 3 μM (IC<sub>50</sub> = 480 nM). The lack of significant reductions in the F-P slope for ivabradine- or zatebradine-treated WT vessels suggests that HCN channels are not required for pressure-induced lymphatic chronotropy (<xref rid="fig11" ref-type="fig">Fig. 11B</xref>). Contraction data for ivabradine- and zatebradine-treated WT vessels are shown in <xref rid="fig11" ref-type="fig">Fig. 11C</xref> and reveal no substantial differences from WT vessels, except for a single pressure in which each HCN channel inhibitor actually <italic>increased</italic> the contraction frequency. Collectively, these results recapitulate the findings of Majgaard et al (<xref ref-type="bibr" rid="c66">Majgaard <italic>et al</italic>., 2022</xref>) and reinforce the conclusion that HCN channels are not required for pressure-induced lymphatic chronotropy.</p>
<fig id="fig11" position="float" orientation="portrait" fig-type="figure">
<label>Figure 11.</label>
<caption><title>Consequences of HCN inhibition.</title>
<p>UMAP and bubble plots of <italic>Hcn gene</italic> family expression in the various IALV cell clusters. <bold>B</bold>) Slope of F-P relationship for popliteal lymphatics from WT mice with/without treatment with the HCN inhibitors ivabradine (3 μM) and zatebradine (3 μM). WT N=15, n=20, WT+zatebradine. N=5, n=10; WT+ivabradine N=5, n=10.</p></caption>
<graphic xlink:href="681001v1_fig11.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3k">
<title>Role of Kv7.4</title>
<p>Kv7 channels are activated at more negative membrane potentials than Kv1-family delayed rectifier K<sup>+</sup> channels and thus are implicated in control of VSMC excitability near the resting membrane potential (<xref ref-type="bibr" rid="c115">Yeung &amp; Greenwood, 2005</xref>; <xref ref-type="bibr" rid="c122">Zhong <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="c67">Mani &amp; Byron, 2011</xref>). The Kv7 blocker XE991 enhances myogenic tone in isolated mesenteric and renal arteries and hypotonic swelling suppresses an XE991-sensitive Kv current in patch-clamped VSM cells (<xref ref-type="bibr" rid="c97">Schleifenbaum <italic>et al</italic>., 2014</xref>). The collective implication from these studies is that mechanosensitive <italic>inhibition</italic> of Kv7.4 may increase VSM excitability. The effects of Kv7 channel inhibition on lymphatic function are unknown but the pan-Kv7 channel inhibitors linopirdine and XE991 cause concentration-dependent increases in lymphatic contraction frequency while the Kv7 activator ML-277 inhibits spontaneous lymphatic contractions (our unpublished observations in rat mesenteric lymphatic vessels). Our scRNAseq analysis revealed moderately strong expression of <italic>Kcnq4</italic> in &gt;50% LMCs and in some AdvCs (<xref rid="fig12" ref-type="fig">Fig. 12A</xref>). We tested whether pressure-induced lymphatic chronotropy was altered in Myh11-CreER<sup>T2</sup><italic>;Kcnq4<sup>f/f</sup></italic> (<italic>Kcnq4 smKO)</italic> mice. However, the lack of a significant reduction in the F-P slope for <italic>Kcnq4 smKO</italic> vessels suggests that Kv7.4 channels are not required for pressure-induced lymphatic chronotropy (<xref rid="fig12" ref-type="fig">Fig. 12B</xref>). Contraction data for <italic>Kcnq4 smKO</italic> and <italic>WT</italic> vessels are compared in <xref rid="fig12" ref-type="fig">Fig. 12C</xref>. There were no significant differences in any of the parameters at any pressure.</p>
<fig id="fig12" position="float" orientation="portrait" fig-type="figure">
<label>Figure 12.</label>
<caption><title>Consequences of <italic>Kcnq1</italic> deletion.</title>
<p>UMAP and bubble plots of <italic>Kcnq4</italic> expression in the various IALV cell clusters. <bold>B</bold>) Slope of F-P relationship for popliteal lymphatics from WT <italic>and Kcnq4 smKO</italic> mice. <bold>C</bold>) Summary plots of contraction parameters as a function of pressure for the two respective groups of vessels. <italic>Kcnq4 smKO</italic> N=5, n=7.</p></caption>
<graphic xlink:href="681001v1_fig12.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3l">
<title>Role of Kir channels</title>
<p>Inwardly rectifying K<sup>+</sup> channels, including Kir2.1 and Kir2.2 which are encoded by <italic>Kcnj2</italic> and <italic>Kcnj12</italic> respectively, have been implicated in shear-stress-induced responses of arterial endothelium (<xref ref-type="bibr" rid="c2">Ahn <italic>et al</italic>., 2017</xref>) and swelling-induced currents in arterial smooth muscle cells (<xref ref-type="bibr" rid="c90">Sancho <italic>et al</italic>., 2019</xref>). However, their potential roles in controlling LMC membrane potential and pressure-induced lymphatic chronotropy are unknown. Our scRNAseq analysis revealed modest expression of <italic>Kcnj8</italic> (Kir6.1), an inward rectifier which forms the pore forming unit of the K<sub>ATP</sub> channel, in &gt;50% LMCs (<xref rid="fig13" ref-type="fig">Fig. 13A</xref>), but very little expression of <italic>Kcnj2</italic> or <italic>Kcnj12</italic> in LMCs. We previously showed that deletion of <italic>Kcnj8</italic> does not alter the F-P relationship in popliteal lymphatics (<xref ref-type="bibr" rid="c26">Davis <italic>et al</italic>., 2020</xref>). Here, we tested the effects of BaCl<sub>2</sub>, a selective inhibitor of Kir2.1/2.2 at a concentration of 100 μM (<xref ref-type="bibr" rid="c62">Longden <italic>et al</italic>., 2017</xref>; <xref ref-type="bibr" rid="c91">Sancho <italic>et al</italic>., 2017</xref>; <xref ref-type="bibr" rid="c90">Sancho <italic>et al</italic>., 2019</xref>), on the F-P relationship of WT popliteal lymphatic vessels. Kir inhibition resulted in a significantly reduced slope of the F-P relationship compared to WT vessels (<xref rid="fig13" ref-type="fig">Fig. 13B</xref>), but the consistent effect of Ba<sup>2+</sup> was to flatten the slope of the F-P relationship by substantially <italic>increasing</italic> the contraction frequency at low pressures while only slightly <italic>increasing</italic> the contraction frequency at elevated pressures (<xref rid="fig13" ref-type="fig">Fig. 13C</xref>). This contrasts with the effect of ANO1 inhibition or deletion: in the absence of ANO1 activity, the contraction frequency was significantly reduced at all pressures, particularly at low pressures (<xref rid="fig2" ref-type="fig">Fig. 2C</xref>). Thus, the inhibition of Kir channels does impair pressure-induced chronotropy but does so by differentially <italic>elevating</italic> contraction frequency as a function of pressure.</p>
<fig id="fig13" position="float" orientation="portrait" fig-type="figure">
<label>Figure 13.</label>
<caption><title>Consequences of Kir2.x inhibition.</title>
<p>UMAP and bubble plots of <italic>Kcnj2</italic> (Kir2.1<italic>), Kcnj12 (</italic>Kir2.2<italic>)</italic> and <italic>Kcnj8</italic> (<italic>Kir6.1)</italic> expression in various IALV cell clusters. <bold>B</bold>) Slope of F-P relationship for popliteal lymphatics from WT mice with/without treatment with the Kir2 inhibitor BaCl<sub>2</sub> (100 μM). WT N=15, n=20, WT+BaCl<sub>2</sub> N=4, n=11.</p></caption>
<graphic xlink:href="681001v1_fig13.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3m">
<title>Roles of L- and T-type Ca<sup>2+</sup> channels</title>
<p>The L-type, voltage-gated Ca<sup>2+</sup> channel (Cav1.2) carries the majority of current contributing to the action potential in LMCs (<xref ref-type="bibr" rid="c105">van Helden, 1993</xref>; <xref ref-type="bibr" rid="c104">To <italic>et al</italic>., 2020</xref>). scRNAseq analysis confirmed that &gt;90% of LMCs expressed message for the pore forming subunit of Cav1.2 (<italic>Cacna1c</italic>), along with other accessory subunits of the channel responsible for either gating characteristics (α2δ) or membrane targeting (β) (<xref rid="fig14" ref-type="fig">Fig. 14A</xref>). SM-specific knockout of <italic>Cacna1</italic>, using either the Myh11-CreER<sup>T2</sup> or Itga8-CreER<sup>T2</sup>, eliminated essentially all propulsive contractions from popliteal lymphatic vessels (<xref ref-type="bibr" rid="c109">Warthi <italic>et al</italic>., 2022</xref>; <xref ref-type="bibr" rid="c25">Davis <italic>et al</italic>., 2023d</xref>). Residual activity in some vessels was limited to small, localized diameter oscillations (&lt;5 μm in amplitude) with irregular frequencies that were largely independent of pressure. As expected, the slope of the F-P relationship for <italic>Cacna1c smKO</italic> vessels was significantly reduced compared to <italic>Cacna1c<sup>f/f</sup></italic> control vessels (<xref rid="fig14" ref-type="fig">Fig. 14B</xref>).</p>
<fig id="fig14" position="float" orientation="portrait" fig-type="figure">
<label>Figure 14.</label>
<caption><title>Consequences of <italic>Cacna1c</italic> (Cav1.2) and <italic>Cacna1g/Cacna1h</italic> (Cav3.1/3.2) deletion.</title>
<p>UMAP and bubble plots of the expression of voltage-gated Ca<sup>2+</sup> channels and their accessory subunits in the various IALV cell clusters. <bold>B</bold>) Slope of F-P relationship for popliteal lymphatics from <italic>Cacan1c<sup>f/f</sup>, Cacna1c smKO</italic> and <italic>Cacna1g<sup>−/−</sup>;Cacna1h<sup>−/−</sup></italic> mice. <bold>C</bold>) Summary plots of contraction parameters as a function of pressure for the three respective groups of vessels. <italic>Cacna1c</italic>: alpha-1c, <italic>Cacna2d1</italic>: α2/δ1, <italic>Cacnb2</italic>: β2, <italic>Cacnb3</italic>: β3, <italic>Cacna1d</italic>: alpha-1d (Ca<sub>v</sub>1.3), <italic>Cacna1a</italic>: Ca<sub>v</sub>2.1 (P/Q), <italic>Cacna1g</italic>: Ca<sub>v</sub>3.1, <italic>Cacna1h</italic>: Ca<sub>v</sub>3.2. <italic>Cacna1c<sup>f/f</sup></italic> N=10, n=20; <italic>Cacna1c smKO</italic> N=14, n=24; <italic>Cacna1g<sup>−/−</sup>;Cacna1h<sup>−/−</sup></italic> N=16, n=25.</p></caption>
<graphic xlink:href="681001v1_fig14.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>The T-type Ca<sup>2+</sup> channel (Cav3.x) is critical for pacemaking in SA node (<xref ref-type="bibr" rid="c63">Lyashkov <italic>et al</italic>., 2018a</xref>), GI smooth muscle (<xref ref-type="bibr" rid="c92">Sanders, 2019</xref>) and renal pelvis smooth muscle (<xref ref-type="bibr" rid="c43">Grainger <italic>et al</italic>., 2022</xref>). Two Cav3 isoforms are expressed in LMCs: <italic>Cacna1g</italic> and <italic>Cacna1h,</italic> encoding Cav3.1 and Cav3.2 respectively (<xref ref-type="bibr" rid="c56">Lee <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="c104">To <italic>et al</italic>., 2020</xref>). One report suggests that Cav3 channels are selectively involved in regulating the contraction frequency (but not amplitude) of rat mesenteric lymphatic collectors (<xref ref-type="bibr" rid="c56">Lee <italic>et al</italic>., 2014</xref>). We previously tested the roles of Cav3.1 and Cav3.2 in mouse lymphatic collectors and isolated LMCs after generating <italic>Cacna1g<sup>−/−</sup>;Cacna1h<sup>−/−</sup></italic> double KO mice (<xref ref-type="bibr" rid="c104">To <italic>et al</italic>., 2020</xref>). Here, we analyzed the slope of the F-P relationship in popliteal lymphatics from <italic>Cacna1g<sup>−/−</sup>;Cacna1h<sup>−/−</sup></italic> mice but found no significant differences from either WT or <italic>Cav1.2<sup>f/f</sup></italic> control vessels (<xref rid="fig14" ref-type="fig">Fig. 14B</xref>), indicating that Cav3 channels are not involved in determining the F-P relationship.</p>
</sec>
<sec id="s3n">
<title>Upstream pathways mediating pressure-induced chronotropy</title>
<p>Having established that ANO1, out of all the cation and K<sup>+</sup> channels tested, is the only current mediating pressure-induced lymphatic chronotropy, we then turned to an investigation of mechanosensitive pathways upstream from ANO1 channel activation.</p>
<sec id="s3n1">
<title>Role of IP<sub>3</sub>R in pressure-induced chronotropy</title>
<p>Calcium release as a consequence of IP<sub>3</sub> generation is known to activate a number of ion channels and other proteins, including ANO1. We recently showed that genetic deletion of <italic>Itpr1</italic> (encoding IP<sub>3</sub>R1) from mouse IALVs results in a reduction in spontaneous contraction frequency and a blunting of pressure-induced chronotropy similar to what is observed after <italic>Ano1</italic> deletion (<xref ref-type="bibr" rid="c120">Zawieja <italic>et al</italic>., 2023</xref>). scRNAseq analysis confirmed expression of <italic>Itpr1</italic> in &gt;50% of LMCs (<xref rid="fig15" ref-type="fig">Fig. 15A</xref>). Here, we examined the consequences of <italic>Itpr1</italic> deletion in popliteal lymphatics by comparing the F-P relationship for vessels from Myh11-CreER<sup>T2</sup><italic>;Itpr1<sup>f/f</sup></italic> (<italic>Itpr1 smKO</italic>) and <italic>Itpr1<sup>f/f</sup></italic>mice. SM-specific deletion of <italic>Itpr1</italic> resulted in a significant reduction in the slope of the F-P relationship from 2.6 ± 0.3 to 0.6 ± 0.1 (<xref rid="fig15" ref-type="fig">Fig. 15B</xref>). Contraction data for <italic>Itpr1 smKO</italic> and <italic>Itpr1<sup>f/f</sup></italic> control vessels are shown in <xref rid="fig15" ref-type="fig">Fig. 15C</xref>. The most striking features are 1) the significant reductions in frequency at all pressures and 2) a significant reduction in tone at elevated pressures in <italic>Itpr1 smKO</italic> vessels. The latter effect contrasts with the <italic>increases</italic> in tone observed after ANO1 inhibition or deletion (<xref rid="fig2" ref-type="fig">Fig. 2C</xref>). Collectively, these results show that IP<sub>3</sub>R1 is critically important for pressure-induced lymphatic chronotropy in popliteal collecting vessels in much the same way it was previously documented in IALVs. Deletion of <italic>Itpr1</italic> in LMCs produces an effect on pressure-induced chronotropy similar to that of ANO1 deletion.</p>
<fig id="fig15" position="float" orientation="portrait" fig-type="figure">
<label>Figure 15.</label>
<caption><title>Consequences of <italic>Itpr1</italic> (IP<sub>3</sub>R1) deletion.</title>
<p>UMAP and bubble plots of <italic>Ip3r1</italic> expression in the various IALV cell clusters. <bold>B</bold>) Slope of F-P relationship for popliteal lymphatics from <italic>Itpr1<sup>f/f</sup> and Itpr1 smKO</italic> mice. <bold>C</bold>) Summary plots of contraction parameters as a function of pressure for the two respective groups of vessels. <italic>Itpr1 smKO</italic> N=5, n=8; <italic>Itpr1<sup>f/f</sup></italic> N=5, n=10.</p></caption>
<graphic xlink:href="681001v1_fig15.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3n2">
<title>Role of GNAQ/GNA11 in pressure-induced chronotropy</title>
<p>Evidence from multiple studies specifically points to GNAQ/GNA11-coupled GPCRs as the upstream mechanosensing elements of myogenic constriction in arteries (<xref ref-type="bibr" rid="c73">Mederos y Schnitzler <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="c6">Blodow <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="c47">Harraz <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="c61">Li <italic>et al</italic>., 2014b</xref>; <xref ref-type="bibr" rid="c97">Schleifenbaum <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="c86">Pires <italic>et al</italic>., 2017</xref>; <xref ref-type="bibr" rid="c5">Bjorling <italic>et al</italic>., 2018</xref>). Mechanosensitive activation of one or more GPCRs independent of ligand binding (<xref ref-type="bibr" rid="c124">Zou <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="c38">Erdogmus <italic>et al</italic>., 2019</xref>) could account for pressure-induced increases in IP<sub>3</sub> levels in LMCs. Our scRNAseq analysis revealed strong expression of <italic>Gnaq</italic> and <italic>Gna11</italic> in ∼75% of LMCs, LECs, and AdvCs as well as very strong expression of <italic>Gnaq</italic> in some immune cell clusters (<xref rid="fig16" ref-type="fig">Fig. 16A</xref>). We tested the effects of SM-specific <italic>Gnaq</italic> knock out (Myh11-CreER<sup>T2</sup><italic>;Gnaq<sup>f/f</sup></italic>), global <italic>Gna11</italic> knock out (<italic>Gna11<sup>−/−</sup></italic>) and <italic>Gnaq</italic>/<italic>Gna11</italic> double knock out (Myh11-CreER<sup>T2</sup><italic>;Gnaq<sup>f/f</sup>;Gna11<sup>−/−</sup></italic>) on pressure-induced lymphatic chronotropy. There was a trend for <italic>Gnaq smKO</italic> vessels to have a reduced slope in the F-P relationship in comparison to <italic>Gnaq<sup>f/f</sup>;Gna11<sup>+/+</sup></italic> control vessels, but it did not reach statistical significance (p=0.1296). However, global deletion of <italic>Gna11</italic> significantly reduced the slope of the F-P relationship and the reduction was even more significant and pronounced in <italic>Gnaq/Gna11</italic> double KO vessels (<xref rid="fig16" ref-type="fig">Fig. 16B</xref>). However, even combined knock out of both proteins did not cause an attenuation of pressure-induced chronotropy that was comparable to that observed after SM-specific <italic>Itpr1</italic> or <italic>Ano1</italic> deletion, particularly at pressures &gt; 2 cmH<sub>2</sub>O (compare <xref rid="fig16" ref-type="fig">Fig. 16B</xref> to <xref rid="fig2" ref-type="fig">Figs. 2B</xref>, <xref rid="fig15" ref-type="fig">15B</xref>). Contraction data for <italic>Gnaq smKO</italic>, <italic>Gna11<sup>−/−</sup></italic> and <italic>Gna<sub>q</sub>/Gna<sub>11</sub></italic>double KO vessels, compared to tamoxifen-treated <italic>Gnaq<sup>f/f</sup>;Gna11<sup>+/+</sup></italic>controls, are shown in <xref rid="fig16" ref-type="fig">Fig. 16C</xref>. The full F-P relationships for each genotype showed significant reductions in frequency at a few pressures for <italic>Gnaq smKO</italic> vessels compared to <italic>Gnaq<sup>f/f</sup>;Gna11<sup>+/+</sup></italic> controls, significant differences for <italic>Gna11<sup>−/−</sup></italic> vessels at more pressures and significant differences at even more pressures for <italic>Gnaq</italic>/<italic>Gna11</italic> DKO vessels. Collectively, these results suggest that both GNAQ and GNA11-coupled G-proteins are involved in pressure-induced lymphatic chronotropy, with G11 being more important. However, the escape from inhibition at higher pressures points to the possible involvement of other mechanisms activating phospholipase(s) to generate IP<sub>3</sub>.</p>
<fig id="fig16" position="float" orientation="portrait" fig-type="figure">
<label>Figure 16.</label>
<caption><title>Consequences of <italic>Gnaq</italic> and/or <italic>Gna11</italic> deletion.</title>
<p>UMAP and bubble plots of <italic>Gnaq</italic> and <italic>Gna11</italic> expression in the various IALV cell clusters. <bold>B</bold>) Slope of F-P relationship for popliteal lymphatics from <italic>Gnaq<sup>f/f</sup>;Gna11<sup>+/+</sup>,</italic> Myh11-CreER<sup>T2</sup><italic>;Gnaq<sup>f/f</sup></italic> (Gnaq smKO<italic>), Gna11<sup>−/−</sup> and</italic> Myh11-CreER<sup>T2</sup><italic>;Gnaq<sup>f/f</sup>;Gna11<sup>−/−</sup> DKO</italic> mice. <bold>C</bold>) Summary plots of contraction parameters as a function of pressure for the four respective groups of vessels. <italic>Gnaq<sup>f/f</sup>;Gna11<sup>+/+</sup></italic> control N=3, n=6; <italic>Gnaq smKO</italic> N=4, n=8; <italic>Gna11<sup>−/−</sup></italic> N=3, n=6; Myh11-CreER<sup>T2</sup><italic>;Gnaq<sup>f/f</sup>;Gna11<sup>−/−</sup></italic>N=8, n=13.</p></caption>
<graphic xlink:href="681001v1_fig16.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3n3">
<title>Role of GNA12/GNA13 in pressure-induced chronotropy</title>
<p>Chennupati et al. (<xref ref-type="bibr" rid="c12">Chennupati <italic>et al</italic>., 2019</xref>) made the surprising finding that GNA12/GNA13-coupled GPCRs, rather than GNAQ/GNA11-coupled GPCRs, mediated myogenic constrictions in mesenteric and cerebral arteries of mice. GNA12/GNA13-coupled GPCRs are known to regulate contraction through Rho kinase (<xref ref-type="bibr" rid="c70">McDuffie <italic>et al</italic>., 2024</xref>) and one study of rat mesenteric lymphatics suggests that RhoK is essential for phasic lymphatic contractions (<xref ref-type="bibr" rid="c55">Kurtz <italic>et al</italic>., 2014</xref>). We investigated the effects of deleting both <italic>Gna12</italic> and <italic>Gna13</italic> from LMCs (Myh11-Cre<sup>T2</sup><italic>;Gna12<sup>f/f</sup>;Gna13<sup>−/−</sup></italic> mice) on the F-P relationship of popliteal lymphatics. In the <italic>Gna12</italic>/<italic>Gna13</italic> double knock out, contraction amplitude was significantly blunted and tone was significantly elevated at several pressures, but the F-P relationship was nearly identical to that of vessels from control <italic>Gna12<sup>f/f</sup>;Gna13<sup>+/+</sup></italic> mice (<xref rid="fig17" ref-type="fig">Fig. 17B-C</xref>).</p>
<fig id="fig17" position="float" orientation="portrait" fig-type="figure">
<label>Figure 17.</label>
<caption><title>Consequences of <italic>Gna12</italic>/<italic>Gna13</italic> deletion.</title>
<p>UMAP and bubble plots of <italic>Gna12</italic> and <italic>Gna13</italic> expression in the various IALV cell clusters. <bold>B</bold>) Slope of F-P relationship for popliteal lymphatics from <italic>Gna12<sup>f/f</sup>;Gna13<sup>+/+</sup> and</italic> Myh11-CreER<sup>T2</sup><italic>;Gna12<sup>f/f</sup>;Gna13<sup>−/−</sup> DKO</italic> mice. <bold>C</bold>) Summary plots of contraction parameters as a function of pressure for the two respective groups of vessels. <italic>Gna12<sup>f/f</sup>;Gna13<sup>+/+</sup></italic> controls N=5, n=10; Myh11-CreER<sup>T2</sup><italic>;Gna12<sup>f/f</sup>;Gna13<sup>−/−</sup></italic>N=7, N=15.</p></caption>
<graphic xlink:href="681001v1_fig17.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3n4">
<title>Role of AT<sub>1</sub>R in pressure-induced chronotropy</title>
<p>In many arteries, AT<sub>1</sub>R is one of the predominantly expressed GPCRs and deletion of <italic>Agtr1</italic> results in loss or impairment of myogenic constriction in several types of arteries (<xref ref-type="bibr" rid="c73">Mederos y Schnitzler <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="c102">Storch <italic>et al</italic>., 2012</xref>; <xref ref-type="bibr" rid="c6">Blodow <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="c97">Schleifenbaum <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="c101">Storch <italic>et al</italic>., 2015</xref>; <xref ref-type="bibr" rid="c86">Pires <italic>et al</italic>., 2017</xref>; <xref ref-type="bibr" rid="c114">Yamasaki <italic>et al</italic>., 2020</xref>). Selective deletion of the AT<sub>1</sub>R isoform (AT<sub>1a</sub>R or AT<sub>1b</sub>R) is sufficient to abrogate myogenic constriction in some arteries (<xref ref-type="bibr" rid="c97">Schleifenbaum <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="c86">Pires <italic>et al</italic>., 2017</xref>). However, our scRNAseq analysis revealed almost no <italic>Agtr1a</italic> expression in LMCs, except in one possible subcluster (<xref rid="fig18" ref-type="fig">Fig. 18A</xref>). Pressure-induced chronotropy was measured in popliteal vessels from <italic>Agtr1a<sup>−/−</sup></italic> mice and in vessels from WT mice treated with the AT<sub>1</sub>R inhibitor losartan, which blocks both AT<sub>1a</sub>R and AT<sub>1b</sub>R. We used a concentration of losartan (10 μM) known to be sufficient to block myogenic constriction in several types of arteries (<xref ref-type="bibr" rid="c6">Blodow <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="c49">Jackson &amp; Boerman, 2017</xref>; <xref ref-type="bibr" rid="c114">Yamasaki <italic>et al</italic>., 2020</xref>). However, neither inhibition of AT<sub>1</sub>R nor deletion of <italic>Agtr1a</italic> impaired pressure-induced chronotropy, as evident by the absence of significant reductions in slope of the F-P relationship (<xref rid="fig18" ref-type="fig">Fig. 18B</xref>). Contraction data for these three groups are shown in <xref rid="fig18" ref-type="fig">Fig. 18C</xref>. Losartan treatment caused a slight impairment of contraction amplitude at several pressures but neither AT<sub>1</sub>R blockade nor <italic>Agtr1a</italic> deletion significantly inhibited the F-P relationship, suggesting that AT<sub>1</sub>R is not required for pressure-induced lymphatic chronotropy.</p>
<fig id="fig18" position="float" orientation="portrait" fig-type="figure">
<label>Figure 18.</label>
<caption><title>Consequences of <italic>Agtr1</italic> (AT<sub>1</sub>R) deletion/inhibition.</title>
<p>UMAP and bubble plots of <italic>Agtr1a</italic> expression in the various IALV cell clusters. <bold>B</bold>) Slope of F-P relationship for popliteal lymphatics from WT mice with/without treatment with the AT<sub>1</sub>R inhibitor losartan (10 μM) and <italic>Agtr1a<sup>−/−</sup></italic> vessels. WT+losartan N=5, n=10; <italic>Agtr1a<sup>−/−</sup></italic> N=3, n=6.</p></caption>
<graphic xlink:href="681001v1_fig18.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
</sec>
</sec>
<sec id="s4">
<title>Discussion</title>
<sec id="s4a">
<title>Summary</title>
<p>The major goal of this study was to investigate the mechanistic basis of the F-P relationship in lymphatic muscle. The primary means by which lymphatic pumping is matched to excess filling of the interstitium is pressure-induced chronotropy—a &gt;10-fold or more increase in contraction frequency with over the physiological pressure range (<xref ref-type="bibr" rid="c27">Davis <italic>et al</italic>., 2025</xref>). Because little was previously known regarding the mechanisms of mechanosensitivity underlying pressure-induced lymphatic chronotropy, we took cues from a well-studied mechanosensitive mechanism in vascular smooth muscle—the arterial myogenic response. In both arteries and collecting lymphatic vessels (<xref ref-type="bibr" rid="c23">Davis <italic>et al</italic>., 2009</xref>; <xref ref-type="bibr" rid="c24">Davis <italic>et al</italic>., 2023c</xref>), pressure elevation leads to vascular muscle cell depolarization and constriction, reflecting the activation of a depolarizing current that triggers Ca<sup>2+</sup> entry through the opening of L-type, voltage-gated Ca<sup>2+</sup> channels. Several ionic mechanisms have been previously implicated in this process for arterial smooth muscle, specifically the activation of TRPC6, TRPM4, PKD2, TRPV2 and ENaC cation channels (<xref ref-type="bibr" rid="c110">Welsh <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="c36">Earley <italic>et al</italic>., 2004a</xref>; <xref ref-type="bibr" rid="c50">Jernigan &amp; Drummond, 2005</xref>; <xref ref-type="bibr" rid="c99">Sharif-Naeini <italic>et al</italic>., 2009</xref>; <xref ref-type="bibr" rid="c71">McGahon <italic>et al</italic>., 2016</xref>), with supporting evidence for each obtained from gene knockdown / knockout studies. Additional ion channels may also be involved, including the activation of channels promoting Cl<sup>−</sup> efflux (<xref ref-type="bibr" rid="c7">Boedtkjer <italic>et al</italic>., 2008</xref>) and the inhibition of constitutively active K<sup>+</sup> channels (<xref ref-type="bibr" rid="c90">Sancho <italic>et al</italic>., 2019</xref>), but evidence for those is based largely on the use of pharmacological inhibitors and therefore subject to concerns about off-target effects (<xref ref-type="bibr" rid="c68">Maroto <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="c32">Dietrich <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="c42">Gottlieb <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="c90">Sancho <italic>et al</italic>., 2019</xref>). In the present study, we primarily used genetic knock out approaches to test the possible roles of the major ion channels contributing to the mechanosensitive chronotropy of lymphatic vessels from the mouse. Our results strongly support the conclusion that pressure-induced lymphatic chronotropy does <italic>not</italic> involve acute activation of any of the putative mechanosensitive (and/or second-messenger gated) cation channels previously implicated in myogenic constriction (TRPC6, TRPM4, PKD2, TRPV2, ENaC), nor does it require PIEZO1, the bona fide mechanosensitive cation channel implicated in other aspects of mechanotransduction in the cardiovascular system [see references in (<xref ref-type="bibr" rid="c24">Davis <italic>et al</italic>., 2023c</xref>)]. Rather, our results align with evidence from related studies of arterial smooth muscle showing that mechanotransduction of stretch/pressure is mediated by GNAQ/GNA11-coupled GPCRs, leading to downstream activation of second messenger-gated channels. In the case of LMCs, mechano-activation of GNAQ/GNA11-coupled GPCRs promotes IP<sub>3</sub> production that triggers Ca<sup>2+</sup> release from stores through IP<sub>3</sub>R1; Ca<sup>2+</sup> then activates ANO1 Cl<sup>−</sup> channels, which accelerate the rate of spontaneous diastolic depolarization, increasing the firing rate of action potentials that control phasic lymphatic contractions (<xref rid="fig19" ref-type="fig">Fig. 19</xref>). Repolarization is controlled in part by Kv channels (<xref ref-type="bibr" rid="c16">Cotton <italic>et al</italic>., 1997</xref>), including Kv11 channels (<xref ref-type="bibr" rid="c53">Kim <italic>et al</italic>., 2023</xref>). As summarized in <xref rid="tbl1" ref-type="table">Table 1</xref>, knockout of each element in the GNAQ/GNA11-IP<sub>3</sub>-IP<sub>3</sub>R1/Ca<sup>2+</sup>-ANO1-Cav1.2 pathway (and only those elements out of all that were tested, except <italic>Kcnj2/ Kcnj12</italic>, which can be alternatively explained) abrogated or significantly attenuated pressure-induced chronotropy. Mechanosensitive regulation of ANO1 in this context is likely mediated by Ca<sup>2+</sup> release from stores rather than possible direct (Ca<sup>2+</sup>-independent) mechanosensitivity of ANO1 (<xref ref-type="bibr" rid="c123">Zou <italic>et al</italic>., 2025</xref>), because the similar degree of attenuation in the F-P relationship with <italic>Iptr1</italic> knockout as with <italic>Ano1</italic> smKO knock out shown here points to the involvement of an upstream mechanosensor.</p>
<fig id="fig19" position="float" orientation="portrait" fig-type="figure">
<label>Figure 19.</label>
<caption><title>Proposed mechanotransduction mechanism underlying pressure-induced chronotropy.</title>
<p>Summary diagram depicting the primary signaling pathway through which changes in pressure regulate the frequency of the ionic pacemaker. GNAQ/GNA11-coupled GPCRs are the primary, but not exclusive mechanosensor. ANO1 is the primary, but not exclusive effector. Kv11 provides at least one source of repolarizing signal (<xref ref-type="bibr" rid="c53">Kim <italic>et al</italic>., 2023</xref>).</p></caption>
<graphic xlink:href="681001v1_fig19.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption><title>Genes for which deletion/inhibition produced significant attenuation or enhancement of the F-P relationship.</title></caption>
<graphic xlink:href="681001v1_tbl1.tif" mime-subtype="tiff" mimetype="image"/>
</table-wrap>
</sec>
<sec id="s4b">
<title>Possible involvement of other G-coupled proteins</title>
<p>One inconsistency with the scheme suggested in <xref rid="tbl1" ref-type="table">Table 1</xref> is that combined knock out of <italic>Gnaq/Gna11</italic> did not cause an attenuation of pressure-induced chronotropy comparable to that observed after SM-specific <italic>Itpr1</italic> or <italic>Ano1</italic> deletion, particularly at pressures &gt; 2 cmH<sub>2</sub>O (compare <xref rid="fig16" ref-type="fig">Fig. 16B</xref> to <xref rid="fig2" ref-type="fig">Figs. 2B</xref>, <xref rid="fig15" ref-type="fig">15B</xref>). A possible explanation is that other G-coupled proteins are involved in mechanosensitive regulation of the GPCR-IP<sub>3</sub>R1-Ca<sup>2+</sup>-ANO1 signaling in LMCs. Indeed, two other G protein-coupled effectors, <italic>Gna14</italic> and <italic>Gna15</italic> in the GNAQ family, could also be activated downstream of pressure-induced GPCR activation and potentially mediate IP<sub>3</sub>/DAG production. We have included <italic>Gna14</italic> (<italic>Gna14</italic> is expressed in 28% of LMCs in our dataset) in the summary scheme shown in <xref rid="fig19" ref-type="fig">Fig. 19</xref> but its role in IP<sub>3</sub> production and ANO1 activation remains to be investigated. Even so, inclusion of other G protein-coupled effectors would still fail to account for the residual pacemaking observed after apparently complete deletion of ANO1. We use the phrase “apparently complete” because incomplete recombination by the inducible Myh11-CreER<sup>T2</sup> remains a possibility. Although we could not detect residual message for <italic>Ano1</italic> in Myh11-CreER<sup>T2</sup><italic>;Ano1<sup>f/f</sup></italic> mice after tamoxifen treatment (<xref rid="fig3" ref-type="fig">Fig. 3B</xref>), that message was measured in LMCs digested from IALVs inguinal-axillary lymphatic vessels (chosen because of a higher cell yield), whereas the F-P relationship was measured in popliteal lymphatic vessels (chosen because of the greater dynamic range in F-P).</p>
<p>We also investigated the possible role of GNA12/GNA13-coupled GPCRs in the F-P relationship, based on a study showing that GNA12/GNA13, rather than GNAQ/GNA11, is required for myogenic constriction in arterial smooth muscle (<xref ref-type="bibr" rid="c12">Chennupati <italic>et al</italic>., 2019</xref>) and a paper showing that RhoK (known to be activated downstream from GNA12/GNA13 activation) is critical for phasic lymphatic contractions and associated phasic LMC Ca<sup>2+</sup> signaling (<xref ref-type="bibr" rid="c55">Kurtz <italic>et al</italic>., 2014</xref>). However, <italic>Gna12/Gna13</italic> double knock out resulted in no significant change in the F-P slope (<xref rid="fig17" ref-type="fig">Fig. 17B</xref>), and there were no differences in frequency at any pressure compared to <italic>Gna12</italic><sup>f/f</sup><italic>; Gna13</italic><sup>+/+</sup> control vessels (<xref rid="fig17" ref-type="fig">Fig. 17C</xref>).</p>
</sec>
<sec id="s4c">
<title>Roles for ion channels in other aspects of LMC contractile function</title>
<p>Originally, we hypothesized that an ion channel (other than ANO1) was involved in LMC pacemaking. If IP<sub>3</sub> production in LMCs is enhanced after pressure elevation, as it is in arterial smooth muscle (<xref ref-type="bibr" rid="c79">Narayanan <italic>et al</italic>., 1994</xref>; <xref ref-type="bibr" rid="c73">Mederos y Schnitzler <italic>et al</italic>., 2008</xref>), then concomitant increases in DAG, the other product of PIP<sub>2</sub> hydrolysis, would also be predicted to occur, and DAG should then activate TRP6C and related channels. However, if this occurs in popliteal lymphatic vessels, the activation of those channels apparently does not significantly influence the F-P relationship (<xref rid="fig4" ref-type="fig">Fig. 4</xref>). Likewise, the Ca<sup>2+</sup> increase resulting from mechanosensitive activation of the GNAQ/GNA11-IP<sub>3</sub>-IP<sub>3</sub>R1 signaling axis would potentially activate TRPM4 and/or PKD2 (assuming those channels are localized to the appropriate LMC microdomains), but we find that their deletion does not alter the F-P relationship (<xref rid="fig5" ref-type="fig">Figs. 5</xref>-<xref rid="fig6" ref-type="fig">6</xref>). Because TRPM4, PKD2 and PIEZO1 expression levels are very low in LMCs (<xref rid="fig3" ref-type="fig">Figs. 3A</xref>,<xref rid="fig4" ref-type="fig">4A</xref>, <xref rid="fig5" ref-type="fig">5A</xref>), further activation of those channels may have little effect. It is possible that another unidentified ion channel could be mediating the pressure-driven frequency changes at higher pressures—perhaps a channel with a higher mechanosensitive threshold or requiring higher levels of IP<sub>3,</sub> DAG or Ca<sup>2+</sup>. Candidates include TRPV1, which has also been implicated in arterial myogenic constriction (<xref ref-type="bibr" rid="c85">Phan <italic>et al</italic>., 2022</xref>).</p>
<p>Although the deletion/inhibition of several TRP channel family members and other channels did not significantly impact pressure-induced chronotropy, it did impact other aspects of lymphatic contractile function, namely contraction amplitude and/or tone. The respective channels and their statistically significant contraction effects are summarized in <xref rid="tbl2" ref-type="table">Table 2</xref>. Deletion of TRPC6/TRPC3 impaired contraction amplitude by ∼40% and increased tone by ∼2.5-fold (<xref rid="fig4" ref-type="fig">Fig. 4C</xref>). Deletion of TRPV4 from LMCs impaired contraction amplitude by ∼45% without an effect on tone (<xref rid="fig7" ref-type="fig">Fig. 7C</xref>). TRPV4 channel activation has recently been implicated in the regulation of lymphatic contraction, but primarily via the production of vasoactive products from LECs and resident macrophages (<xref ref-type="bibr" rid="c98">Schulz <italic>et al</italic>., 2025</xref>). There were three other channels whose inhibition led to significant changes in amplitude and/or tone. Specifically, one of the two TRPV2 inhibitors (SET2) inhibited tone at 4 of the 5 lowest pressures. One of the two ENaC inhibitors (amiloride) inhibited amplitude by 20-30% while the other one (benzamil) enhanced tone by ∼2-fold (<xref rid="fig9" ref-type="fig">Fig. 9C</xref>). The Kir2 blocker Ba<sup>2+</sup> impaired amplitude by ∼40% and increased tone by 2-fold (<xref rid="fig13" ref-type="fig">Fig. 13C</xref>). Collectively, these effects suggest that the respective channels are each involved in some aspect of lymphatic contractile function (other than pressure-induced chronotropy), with the more compelling evidence being that obtained after by gene deletion rather than after acute application of soluble inhibitors, which may have off-target effects.</p>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2.</label>
<caption><title>Consequences of deletion/inhibition of ion channels on contraction amplitude and/or tone.*</title></caption>
<graphic xlink:href="681001v1_tbl2.tif" mime-subtype="tiff" mimetype="image"/>
</table-wrap>
</sec>
<sec id="s4d">
<title>Future directions</title>
<p>Lastly, the critical mechanosensitive GNAQ/GNA11-coupled GPCR(s) in LMCs remain(s) to be identified. Although evidence points to AT<sub>1</sub>R as the key GNAQ/GNA11 –coupled mechanosensitive GPCR in arterial smooth muscle (<xref ref-type="bibr" rid="c72">Mederos y Schnitzler <italic>et al</italic>., 2011</xref>; <xref ref-type="bibr" rid="c24">Davis <italic>et al</italic>., 2023c</xref>), message for AT<sub>1</sub>R is negligible in LMCs (<xref rid="fig18" ref-type="fig">Fig. 18A</xref>) and neither <italic>Agtr1</italic> knock out or pharmacologic AT<sub>1</sub>R blockade altered pressure-induced chronotropy (<xref rid="fig18" ref-type="fig">Fig. 18B-C</xref>). No studies to date have attempted to identify the major GPCRs expressed in LMCs, e.g., by analyzing the various published scRNAseq databases for LMCs (<xref ref-type="bibr" rid="c52">Kenney <italic>et al</italic>., 2022</xref>; <xref ref-type="bibr" rid="c57">Lei <italic>et al</italic>., 2025</xref>; <xref ref-type="bibr" rid="c98">Schulz <italic>et al</italic>., 2025</xref>; <xref ref-type="bibr" rid="c121">Zawieja <italic>et al</italic>., 2025</xref>), but doing so might provide a starting point for identifying the specific mechanosensitive GNAQ/GNA11 - coupled (and other) GPCRs that mediate pressure-induced chronotropy.</p>
</sec>
<sec id="s4e">
<title>Physiological Relevance</title>
<p>LMC function is impaired in Cantú syndrome, the only known example of primary lymphedema produced by a gene mutation (<italic>Kcnj8/Abbc9</italic>) in LMCs (<xref ref-type="bibr" rid="c22">Davis <italic>et al</italic>., 2023b</xref>). This impairment is evident both in lower contraction frequencies and amplitudes at multiple pressure levels. The lower frequency is consistent with parallel observations that gain-of-function mutations in K<sub>ATP</sub> channels increase metabolic stress (<xref ref-type="bibr" rid="c54">Kim <italic>et al</italic>., 2024</xref>), whereas the lower amplitude suggests that other aspects of LMC function are altered as a consequence of chronic K<sub>ATP</sub> channel hyperactivation. It is interesting that lymphatic contraction frequency and amplitude are also impaired in secondary lymphedema, in aging and in various models of metabolic disease [(<xref ref-type="bibr" rid="c10">Castorena-Gonzalez <italic>et al</italic>., 2025</xref>) and see discussion and references in (<xref ref-type="bibr" rid="c28">Davis <italic>et al</italic>., 2023e</xref>)]. Potential therapies for reversing LMC dysfunction under these conditions will depend on identifying the key ion channels and signaling pathways that drive pacemaking and control contraction amplitude. The present study represents a major step forward in the identification of specific LMC targets that could be used for that purpose.</p>
</sec>
</sec>
</body>
<back>
<sec id="s8" sec-type="supplementary">
<table-wrap id="tbls1" orientation="portrait" position="float">
<label>Suppl. Table 1.</label>
<caption><title>Primers used for qPCR.</title></caption>
<graphic xlink:href="681001v1_tbls1.tif" mime-subtype="tiff" mimetype="image"/>
</table-wrap>
</sec>
<ack>
<title>Acknowledgements</title>
<p>The authors are grateful for the technical assistance of Shanyu Ho. We acknowledge the kind gifts of <italic>Kcnq4<sup>−/−</sup></italic> mice from Thomas Jentsch (Free University of Berlin), <italic>Trpc6<sup>−/−</sup></italic> and <italic>Trpc3<sup>−/−</sup></italic> mice from Lutz Birnbaumer (NIH), <italic>Piezo1<sup>f/f</sup></italic> mice from Ardem Patapoutian (USCD), and <italic>Itpr1<sup>f/f</sup></italic> mice from Ju Chen (UCSD). <italic>Ano1</italic><sup>f/f</sup> and Myh11-CreER<sup>T2</sup><italic>;Pkd2<sup>f/f</sup></italic> mice were gifts from Jonathan Jaggar (University of Tennessee HSC). Stefan Offermanns (Max-Planck-Institute, Bad Nauheim) kindly provided sperm from <italic>Gna<sub>12</sub><sup>−/−</sup>;Gna <sup>f/f</sup></italic> and <italic>Gna <sup>−/−</sup>;Gna <sup>f/f</sup></italic> mice. This work was supported by National Institutes of Health grants (R01-HL122578 to MJD; R01-HL168568 to JAC-G; R35-HL155008 to SE; R01-HL136292 to TLD; R01-HL142905 to JPS; R01-HL143198 to SDZ).</p>
</ack>
<sec id="additional-info" sec-type="additional-information">
<title>Additional information</title>
<sec id="das" sec-type="data-availability">
<title>Data availability</title>
<p>RNA sequence data were deposited in GEO (accession number GSE277843). All data generated or analyzed during this study are included in the manuscript and supporting files; source data files have been provided for all figures.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>MJD and SDZ designed the experiments. MJD, JAC-G, ML, SDZ and JK performed the experiments and analyzed the results. ML bred, managed and genotyped the mouse lines. TLD and SE generated and provided mouse lines. MJD drafted the manuscript. All authors edited the manuscript and approved the final version.</p>
</sec>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Accili</surname> <given-names>EA</given-names></string-name>, <string-name><surname>Proenza</surname> <given-names>C</given-names></string-name>, <string-name><surname>Baruscotti</surname> <given-names>M</given-names></string-name> &amp; <string-name><surname>DiFrancesco</surname> <given-names>D</given-names></string-name></person-group>. (<year>2002</year>). <article-title>From funny current to HCN channels: 20 years of excitation</article-title>. <source>News in Physiological Science</source> <volume>17</volume>, <fpage>32</fpage>–<lpage>37</lpage>.</mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ahn</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Fancher</surname> <given-names>IS</given-names></string-name>, <string-name><surname>Bian</surname> <given-names>JT</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>CX</given-names></string-name>, <string-name><surname>Schwab</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gaffin</surname> <given-names>R</given-names></string-name>, <string-name><surname>Phillips</surname> <given-names>SA</given-names></string-name> &amp; <string-name><surname>Levitan</surname> <given-names>I</given-names></string-name></person-group>. (<year>2017</year>). <article-title>Inwardly rectifying K(+) channels are major contributors to flow-induced vasodilatation in resistance arteries</article-title>. <source>J Physiol</source> <volume>595</volume>, <fpage>2339</fpage>–<lpage>2364</lpage>.</mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Alotaibi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kahlat</surname> <given-names>K</given-names></string-name>, <string-name><surname>Nedjadi</surname> <given-names>T</given-names></string-name> &amp; <string-name><surname>Djouhri</surname> <given-names>L</given-names></string-name></person-group>. (<year>2017</year>). <article-title>Effects of ZD7288, a hyperpolarization-activated cyclic nucleotide-gated (HCN) channel blocker, on term-pregnant rat uterine contractility in vitro</article-title>. <source>Theriogenology</source> <volume>90</volume>, <fpage>141</fpage>–<lpage>146</lpage>.</mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Benos</surname> <given-names>DJ</given-names></string-name></person-group>. (<year>2004</year>). <article-title>Sensing tension: recognizing ENaC as a stretch sensor</article-title>. <source>Hypertension</source> <volume>44</volume>, <fpage>616</fpage>–<lpage>617</lpage>.</mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bjorling</surname> <given-names>K</given-names></string-name>, <string-name><surname>Joseph</surname> <given-names>PD</given-names></string-name>, <string-name><surname>Egebjerg</surname> <given-names>K</given-names></string-name>, <string-name><surname>Salomonsson</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hansen</surname> <given-names>JL</given-names></string-name>, <string-name><surname>Ludvigsen</surname> <given-names>TP</given-names></string-name> &amp; <string-name><surname>Jensen</surname> <given-names>LJ</given-names></string-name></person-group>. (<year>2018</year>). <article-title>Role of age, Rho-kinase 2 expression, and G protein-mediated signaling in the myogenic response in mouse small mesenteric arteries</article-title>. <source>Physiol Rep</source> <volume>6</volume>, <fpage>e13863</fpage>.</mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blodow</surname> <given-names>S</given-names></string-name>, <string-name><surname>Schneider</surname> <given-names>H</given-names></string-name>, <string-name><surname>Storch</surname> <given-names>U</given-names></string-name>, <string-name><surname>Wizemann</surname> <given-names>R</given-names></string-name>, <string-name><surname>Forst</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Gudermann</surname> <given-names>T</given-names></string-name> &amp; <string-name><surname>Mederos y Schnitzler</surname> <given-names>M.</given-names></string-name></person-group> (<year>2014</year>). <article-title>Novel role of mechanosensitive AT1B receptors in myogenic vasoconstriction</article-title>. <source>Pflugers Arch</source> <volume>466</volume>, <fpage>1343</fpage>–<lpage>1353</lpage>.</mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Boedtkjer</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Matchkov</surname> <given-names>VV</given-names></string-name>, <string-name><surname>Boedtkjer</surname> <given-names>E</given-names></string-name>, <string-name><surname>Nilsson</surname> <given-names>H</given-names></string-name> &amp; <string-name><surname>Aalkjaer</surname> <given-names>C</given-names></string-name></person-group>. (<year>2008</year>). <article-title>Vasomotion has chloride-dependency in rat mesenteric small arteries</article-title>. <source>Pflugers Arch</source> <volume>457</volume>, <fpage>389</fpage>–<lpage>404</lpage>.</mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bogdanov</surname> <given-names>KY</given-names></string-name>, <string-name><surname>Vinogradova</surname> <given-names>TM</given-names></string-name> &amp; <string-name><surname>Lakatta</surname> <given-names>EG</given-names></string-name></person-group>. (<year>2001</year>). <article-title>Sinoatrial nodal cell ryanodine receptor and Na(+)-Ca(2+) exchanger: molecular partners in pacemaker regulation</article-title>. <source>Circ Res</source> <volume>88</volume>, <fpage>1254</fpage>–<lpage>1258</lpage>.</mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bulley</surname> <given-names>S</given-names></string-name>, <string-name><surname>Fernandez-Pena</surname> <given-names>C</given-names></string-name>, <string-name><surname>Hasan</surname> <given-names>R</given-names></string-name>, <string-name><surname>Leo</surname> <given-names>MD</given-names></string-name>, <string-name><surname>Muralidharan</surname> <given-names>P</given-names></string-name>, <string-name><surname>Mackay</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Evanson</surname> <given-names>KW</given-names></string-name>, <string-name><surname>Moreira-Junior</surname> <given-names>L</given-names></string-name>, <string-name><surname>Mata-Daboin</surname> <given-names>A</given-names></string-name>, <string-name><surname>Burris</surname> <given-names>SK</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Kuruvilla</surname> <given-names>KP</given-names></string-name> &amp; <string-name><surname>Jaggar</surname> <given-names>JH</given-names></string-name></person-group>. (<year>2018</year>). <article-title>Arterial smooth muscle cell PKD2 (TRPP1) channels regulate systemic blood pressure</article-title>. <source>eLife</source> <volume>7</volume>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Castorena-Gonzalez</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>HJ</given-names></string-name> &amp; <string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name></person-group>. (<year>2025</year>). <article-title>Chronic metabolic stress impairs lymphatic contractility via activation of KATP channels in a mouse model of Type-2 diabetes</article-title>. <source>Front Physiol</source> <volume>16</volume>, <fpage>1558763</fpage>.</mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname> <given-names>YL</given-names></string-name> &amp; <string-name><surname>Sonkusare</surname> <given-names>SK</given-names></string-name></person-group>. (<year>2020</year>). <article-title>Endothelial TRPV4 channels and vasodilator reactivity</article-title>. <source>Curr Top Membr</source> <volume>85</volume>, <fpage>89</fpage>–<lpage>117</lpage>.</mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chennupati</surname> <given-names>R</given-names></string-name>, <string-name><surname>Wirth</surname> <given-names>A</given-names></string-name>, <string-name><surname>Favre</surname> <given-names>J</given-names></string-name>, <string-name><surname>Li</surname> <given-names>R</given-names></string-name>, <string-name><surname>Bonnavion</surname> <given-names>R</given-names></string-name>, <string-name><surname>Jin</surname> <given-names>YJ</given-names></string-name>, <string-name><surname>Wietelmann</surname> <given-names>A</given-names></string-name>, <string-name><surname>Schweda</surname> <given-names>F</given-names></string-name>, <string-name><surname>Wettschureck</surname> <given-names>N</given-names></string-name>, <string-name><surname>Henrion</surname> <given-names>D</given-names></string-name> &amp; <string-name><surname>Offermanns</surname> <given-names>S</given-names></string-name></person-group>. (<year>2019</year>). <article-title>Myogenic vasoconstriction requires G12/G13 and LARG to maintain local and systemic vascular resistance</article-title>. <source>eLife</source> <volume>8</volume>.</mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Choi</surname> <given-names>D</given-names></string-name>, <string-name><surname>Park</surname> <given-names>E</given-names></string-name>, <string-name><surname>Choi</surname> <given-names>J</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>R</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>C</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>L</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Nakashima</surname> <given-names>B</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>S</given-names></string-name>, <string-name><surname>Singhal</surname> <given-names>D</given-names></string-name>, <string-name><surname>Scallan</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>B</given-names></string-name>, <string-name><surname>Koh</surname> <given-names>CJ</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>E</given-names></string-name> &amp; <string-name><surname>Hong</surname> <given-names>YK</given-names></string-name></person-group>. (<year>2024</year>). <article-title>Piezo1 regulates meningeal lymphatic vessel drainage and alleviates excessive CSF accumulation</article-title>. <source>Nat Neurosci</source>.</mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Choi</surname> <given-names>D</given-names></string-name>, <string-name><surname>Park</surname> <given-names>E</given-names></string-name>, <string-name><surname>Jung</surname> <given-names>E</given-names></string-name>, <string-name><surname>Cha</surname> <given-names>B</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>S</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>PM</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hong</surname> <given-names>YJ</given-names></string-name>, <string-name><surname>Koh</surname> <given-names>CJ</given-names></string-name>, <string-name><surname>Cho</surname> <given-names>CW</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Jeon</surname> <given-names>NL</given-names></string-name>, <string-name><surname>Wong</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Shin</surname> <given-names>L</given-names></string-name>, <string-name><surname>Kumar</surname> <given-names>SR</given-names></string-name>, <string-name><surname>Bermejo-Moreno</surname> <given-names>I</given-names></string-name>, <string-name><surname>Srinivasan</surname> <given-names>RS</given-names></string-name>, <string-name><surname>Cho</surname> <given-names>IT</given-names></string-name> &amp; <string-name><surname>Hong</surname> <given-names>YK</given-names></string-name></person-group>. (<year>2019</year>). <article-title>Piezo1 incorporates mechanical force signals to genetic program that governs lymphatic valve development and maintenance</article-title>. <source>JCI Insight</source>.</mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Coste</surname> <given-names>B</given-names></string-name>, <string-name><surname>Mathur</surname> <given-names>J</given-names></string-name>, <string-name><surname>Schmidt</surname> <given-names>M</given-names></string-name>, <string-name><surname>Earley</surname> <given-names>TJ</given-names></string-name>, <string-name><surname>Ranade</surname> <given-names>S</given-names></string-name>, <string-name><surname>Petrus</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Dubin</surname> <given-names>AE</given-names></string-name> &amp; <string-name><surname>Patapoutian</surname> <given-names>A</given-names></string-name></person-group>. (<year>2010</year>). <article-title>Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels</article-title>. <source>Science</source> <volume>330</volume>, <fpage>55</fpage>–<lpage>60</lpage>.</mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cotton</surname> <given-names>KD</given-names></string-name>, <string-name><surname>Hollywood</surname> <given-names>MA</given-names></string-name>, <string-name><surname>McHale</surname> <given-names>NG</given-names></string-name> &amp; <string-name><surname>Thorbury</surname> <given-names>KD</given-names></string-name></person-group>. (<year>1997</year>). <article-title>Outward currents in smooth muscle cells isolated from sheep mesenteric lymphatics</article-title>. <source>Journal of Physiology</source> <volume>503</volume>, <fpage>1</fpage>–<lpage>11</lpage>.</mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name></person-group>. (<year>2005</year>). <article-title>An improved, computer-based method to automatically track internal and external diameter of isolated microvessels</article-title>. <source>Microcirculation</source> <volume>12</volume>, <fpage>361</fpage>–<lpage>372</lpage>.</mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name></person-group>. (<year>2012</year>). <article-title>Physiological role(s) of the vascular myogenic response</article-title>. <source>Microcirculation</source> <volume>19</volume>, <fpage>99</fpage>–<lpage>114</lpage>.</mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="software"><person-group person-group-type="author"><string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name></person-group>. (<year>2023a</year>). <article-title>Diameter tracking program for quantitative assessment of lymphatic vessel contractions</article-title>. <source>Zenodo</source> <pub-id pub-id-type="doi">10.5281/zenodo.8286119</pub-id>.</mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="software"><person-group person-group-type="author"><string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name></person-group>. (<year>2023b</year>). <article-title>Pressure acquisition and control program for quantitative assessment of lymphatic vessel function</article-title>. <source>Zenodo</source> <pub-id pub-id-type="doi">10.5281/zenodo.8286107</pub-id>.</mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Castorena-Gonzalez</surname> <given-names>J</given-names></string-name> &amp; <string-name><surname>Zawieja</surname> <given-names>SD</given-names></string-name></person-group>. (<year>2023a</year>). <article-title>Electric field stimulation unmasks a subtle role for T-type calcium channels in regulating lymphatic contraction</article-title>. <source>Scientific Reports</source> <volume>13</volume>, <fpage>15862</fpage>.</mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Castorena-Gonzalez</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>HJ</given-names></string-name>, <string-name><surname>Li</surname> <given-names>M</given-names></string-name>, <string-name><surname>Remedi</surname> <given-names>M</given-names></string-name> &amp; <string-name><surname>Nichols</surname> <given-names>CG.</given-names></string-name></person-group> (<year>2023b</year>). <article-title>Lymphatic contractile dysfunction in mouse models of Cantu Syndrome with K(ATP) channel gain-of-function</article-title>. <source>Function (Oxf)</source> <volume>4</volume>, <fpage>zqad017</fpage>.</mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Davis</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Ku</surname> <given-names>CW</given-names></string-name> &amp; <string-name><surname>Gashev</surname> <given-names>AA</given-names></string-name></person-group>. (<year>2009</year>). <article-title>Myogenic constriction and dilation of isolated lymphatic vessels</article-title>. <source>American Journal of Physiology (Heart and Circulatory Physiology)</source> <volume>296</volume>, <fpage>H293</fpage>–<lpage>H302</lpage>.</mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Earley</surname> <given-names>S</given-names></string-name>, <string-name><surname>Li</surname> <given-names>YS</given-names></string-name> &amp; <string-name><surname>Chien</surname> <given-names>S</given-names></string-name></person-group>. (<year>2023c</year>). <article-title>Vascular mechanotransduction</article-title>. <source>Physiol Rev</source> <volume>103</volume>, <fpage>1247</fpage>–<lpage>1421</lpage>.</mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>HJ</given-names></string-name>, <string-name><surname>Li</surname> <given-names>M</given-names></string-name> &amp; <string-name><surname>Zawieja</surname> <given-names>SD</given-names></string-name></person-group>. (<year>2023d</year>). <article-title>A vascular smooth muscle-specific integrin alpha8 Cre mouse for lymphatic contraction studies that allows male-female comparisons and avoids lethal visceral myopathy</article-title>. <source>Frontiers in Physiology</source> <volume>13</volume>, <fpage>1060146</fpage>.</mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>HJ</given-names></string-name>, <string-name><surname>Zawieja</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Castorena-Gonzalez</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Gui</surname> <given-names>P</given-names></string-name>, <string-name><surname>Li</surname> <given-names>M</given-names></string-name>, <string-name><surname>Saunders</surname> <given-names>BT</given-names></string-name>, <string-name><surname>Zinselmeyer</surname> <given-names>BH</given-names></string-name>, <string-name><surname>Randolph</surname> <given-names>GJ</given-names></string-name>, <string-name><surname>Remedi</surname> <given-names>MS</given-names></string-name> &amp; <string-name><surname>Nichols</surname> <given-names>CG</given-names></string-name></person-group>. (<year>2020</year>). <article-title>Kir6.1-dependent K(ATP) channels in lymphatic smooth muscle and vessel dysfunction in mice with Kir6.1 gain-of-function</article-title>. <source>J Physiol</source> <volume>598</volume>, <fpage>3107</fpage>–<lpage>3127</lpage>.</mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>King</surname> <given-names>PD</given-names></string-name> &amp; <string-name><surname>Zawieja</surname> <given-names>SD</given-names></string-name></person-group>. (<year>2025</year>). <article-title>Transport and immune functions of the lymphatic system</article-title>. <source>Annual Review of Physiology</source> <volume>87</volume>, <fpage>151</fpage>–<lpage>172</lpage>.</mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Scallan</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Castorena-Gonzalez</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>HJ</given-names></string-name>, <string-name><surname>Ying</surname> <given-names>LH</given-names></string-name>, <string-name><surname>Pin</surname> <given-names>YK</given-names></string-name> &amp; <string-name><surname>Angeli</surname> <given-names>V</given-names></string-name></person-group>. (<year>2023e</year>). <article-title>Multiple aspects of lymphatic dysfunction in an ApoE (-/-) mouse model of hypercholesterolemia</article-title>. <source>Front Physiol</source> <volume>13</volume>, <fpage>1098408</fpage>.</mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Scallan</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Wolpers</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Muthuchamy</surname> <given-names>M</given-names></string-name>, <string-name><surname>Gashev</surname> <given-names>AA</given-names></string-name> &amp; <string-name><surname>Zawieja</surname> <given-names>DC</given-names></string-name></person-group>. (<year>2012</year>). <article-title>Intrinsic increase in lymphangion muscle contractility in response to elevated afterload</article-title>. <source>Am J Physiol Heart Circ Physiol</source> <volume>303</volume>, <fpage>H795</fpage>–<lpage>H808</lpage>.</mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name> &amp; <string-name><surname>Zawieja</surname> <given-names>SD.</given-names></string-name></person-group> (<year>2018</year>). <chapter-title>Electrical pacemaking in lymphatic vessels</chapter-title>. In <source>Signal Transduction and Smooth Muscle</source>, ed. <person-group person-group-type="editor"><string-name><surname>Earley</surname> <given-names>S</given-names></string-name> &amp; <string-name><surname>Trebak</surname> <given-names>M</given-names></string-name></person-group>, pp. <fpage>323</fpage>–<lpage>359</lpage>. <publisher-name>CRC Press</publisher-name>, <publisher-loc>Boca Raton</publisher-loc>.</mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name> &amp; <string-name><surname>Zawieja</surname> <given-names>SD</given-names></string-name></person-group>. (<year>2024</year>). <article-title>Pacemaking in the lymphatic system</article-title>. <source>Journal of Physiology</source> Mar 23. Online ahead of print.</mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dietrich</surname> <given-names>A</given-names></string-name>, <string-name><surname>Kalwa</surname> <given-names>H</given-names></string-name>, <string-name><surname>Storch</surname> <given-names>U</given-names></string-name>, <string-name><surname>Mederos y Schnitzler</surname> <given-names>M</given-names></string-name>, <string-name><surname>Salanova</surname> <given-names>B</given-names></string-name>, <string-name><surname>Pinkenburg</surname> <given-names>O</given-names></string-name>, <string-name><surname>Dubrovska</surname> <given-names>G</given-names></string-name>, <string-name><surname>Essin</surname> <given-names>K</given-names></string-name>, <string-name><surname>Gollasch</surname> <given-names>M</given-names></string-name>, <string-name><surname>Birnbaumer</surname> <given-names>L</given-names></string-name> &amp; <string-name><surname>Gudermann</surname> <given-names>T.</given-names></string-name></person-group> (<year>2007</year>). <article-title>Pressure-induced and store-operated cation influx in vascular smooth muscle cells is independent of TRPC1</article-title>. <source>Pflugers Arch</source> <volume>455</volume>, <fpage>465</fpage>–<lpage>477</lpage>.</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dietrich</surname> <given-names>A</given-names></string-name>, <string-name><surname>Mederos</surname> <given-names>YSM</given-names></string-name>, <string-name><surname>Gollasch</surname> <given-names>M</given-names></string-name>, <string-name><surname>Gross</surname> <given-names>V</given-names></string-name>, <string-name><surname>Storch</surname> <given-names>U</given-names></string-name>, <string-name><surname>Dubrovska</surname> <given-names>G</given-names></string-name>, <string-name><surname>Obst</surname> <given-names>M</given-names></string-name>, <string-name><surname>Yildirim</surname> <given-names>E</given-names></string-name>, <string-name><surname>Salanova</surname> <given-names>B</given-names></string-name>, <string-name><surname>Kalwa</surname> <given-names>H</given-names></string-name>, <string-name><surname>Essin</surname> <given-names>K</given-names></string-name>, <string-name><surname>Pinkenburg</surname> <given-names>O</given-names></string-name>, <string-name><surname>Luft</surname> <given-names>FC</given-names></string-name>, <string-name><surname>Gudermann</surname> <given-names>T</given-names></string-name> &amp; <string-name><surname>Birnbaumer</surname> <given-names>L</given-names></string-name></person-group>. (<year>2005</year>). <article-title>Increased vascular smooth muscle contractility in TRPC6-/- mice</article-title>. <source>Mol Cell Biol</source> <volume>25</volume>, <fpage>6980</fpage>–<lpage>6989</lpage>.</mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Drummond</surname> <given-names>HA</given-names></string-name></person-group>. (<year>2012</year>). <article-title>betaENaC is a molecular component of a VSMC mechanotransducer that contributes to renal blood flow regulation, protection from renal injury, and hypertension</article-title>. <source>Front Physiol</source> <volume>3</volume>, <fpage>341</fpage>.</mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Earley</surname> <given-names>S</given-names></string-name> &amp; <string-name><surname>Brayden</surname> <given-names>JE</given-names></string-name></person-group>. (<year>2015</year>). <article-title>Transient receptor potential channels in the vasculature</article-title>. <source>Physiol Rev</source> <volume>95</volume>, <fpage>645</fpage>–<lpage>690</lpage>.</mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Earley</surname> <given-names>S</given-names></string-name>, <string-name><surname>Waldron</surname> <given-names>BJ</given-names></string-name> &amp; <string-name><surname>Brayden</surname> <given-names>JE</given-names></string-name></person-group>. (<year>2004a</year>). <article-title>Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries</article-title>. <source>Circulation Research</source> <volume>95</volume>, <fpage>922</fpage>–<lpage>929</lpage>.</mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Earley</surname> <given-names>S</given-names></string-name>, <string-name><surname>Waldron</surname> <given-names>BJ</given-names></string-name> &amp; <string-name><surname>Brayden</surname> <given-names>JE</given-names></string-name></person-group>. (<year>2004b</year>). <article-title>Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries</article-title>. <source>Circ Res</source> <volume>95</volume>, <fpage>922</fpage>–<lpage>929</lpage>.</mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Erdogmus</surname> <given-names>S</given-names></string-name>, <string-name><surname>Storch</surname> <given-names>U</given-names></string-name>, <string-name><surname>Danner</surname> <given-names>L</given-names></string-name>, <string-name><surname>Becker</surname> <given-names>J</given-names></string-name>, <string-name><surname>Winter</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ziegler</surname> <given-names>N</given-names></string-name>, <string-name><surname>Wirth</surname> <given-names>A</given-names></string-name>, <string-name><surname>Offermanns</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hoffmann</surname> <given-names>C</given-names></string-name>, <string-name><surname>Gudermann</surname> <given-names>T</given-names></string-name> &amp; <string-name><surname>Mederos</surname> <given-names>YSM</given-names></string-name></person-group>. (<year>2019</year>). <article-title>Helix 8 is the essential structural motif of mechanosensitive GPCRs</article-title>. <source>Nat Commun</source> <volume>10</volume>, <fpage>5784</fpage>.</mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Germain</surname> <given-names>PL</given-names></string-name>, <string-name><surname>Lun</surname> <given-names>A</given-names></string-name>, <string-name><surname>Garcia Meixide</surname> <given-names>C</given-names></string-name>, <string-name><surname>Macnair</surname> <given-names>W</given-names></string-name> &amp; <string-name><surname>Robinson</surname> <given-names>MD</given-names></string-name></person-group>. (<year>2021</year>). <article-title>Doublet identification in single-cell sequencing data using scDblFinder</article-title>. <source>F1000Res</source> <volume>10</volume>, <fpage>979</fpage>.</mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gonzales</surname> <given-names>AL</given-names></string-name> &amp; <string-name><surname>Earley</surname> <given-names>S</given-names></string-name></person-group>. (<year>2013</year>). <article-title>Regulation of cerebral artery smooth muscle membrane potential by Ca(2)(+)-activated cation channels</article-title>. <source>Microcirculation</source> <volume>20</volume>, <fpage>337</fpage>–<lpage>347</lpage>.</mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gonzales</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Sullivan</surname> <given-names>MN</given-names></string-name>, <string-name><surname>Sanders</surname> <given-names>L</given-names></string-name>, <string-name><surname>Dabertrand</surname> <given-names>F</given-names></string-name>, <string-name><surname>Hill-Eubanks</surname> <given-names>DC</given-names></string-name>, <string-name><surname>Nelson</surname> <given-names>MT</given-names></string-name> &amp; <string-name><surname>Earley</surname> <given-names>S</given-names></string-name></person-group>. (<year>2014</year>). <article-title>A PLCgamma1-dependent, force-sensitive signaling network in the myogenic constriction of cerebral arteries</article-title>. <source>Sci Signal</source> <volume>7</volume>, <fpage>ra49</fpage>.</mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gottlieb</surname> <given-names>P</given-names></string-name>, <string-name><surname>Folgering</surname> <given-names>J</given-names></string-name>, <string-name><surname>Maroto</surname> <given-names>R</given-names></string-name>, <string-name><surname>Raso</surname> <given-names>A</given-names></string-name>, <string-name><surname>Wood</surname> <given-names>TG</given-names></string-name>, <string-name><surname>Kurosky</surname> <given-names>A</given-names></string-name>, <string-name><surname>Bowman</surname> <given-names>C</given-names></string-name>, <string-name><surname>Bichet</surname> <given-names>D</given-names></string-name>, <string-name><surname>Patel</surname> <given-names>A</given-names></string-name>, <string-name><surname>Sachs</surname> <given-names>F</given-names></string-name>, <string-name><surname>Martinac</surname> <given-names>B</given-names></string-name>, <string-name><surname>Hamill</surname> <given-names>OP</given-names></string-name> &amp; <string-name><surname>Honore</surname> <given-names>E</given-names></string-name></person-group>. (<year>2008</year>). <article-title>Revisiting TRPC1 and TRPC6 mechanosensitivity</article-title>. <source>Pflugers Arch</source> <volume>455</volume>, <fpage>1097</fpage>–<lpage>1103</lpage>.</mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grainger</surname> <given-names>N</given-names></string-name>, <string-name><surname>Shonnard</surname> <given-names>CC</given-names></string-name>, <string-name><surname>Quiggle</surname> <given-names>SK</given-names></string-name>, <string-name><surname>Fox</surname> <given-names>EB</given-names></string-name>, <string-name><surname>Presley</surname> <given-names>H</given-names></string-name>, <string-name><surname>Daugherty</surname> <given-names>R</given-names></string-name>, <string-name><surname>Shonnard</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Drumm</surname> <given-names>BT</given-names></string-name> &amp; <string-name><surname>Sanders</surname> <given-names>KM.</given-names></string-name></person-group> (<year>2022</year>). <article-title>Propagation of Pacemaker Activity and Peristaltic Contractions in the Mouse Renal Pelvis Rely on Ca(2+)-activated Cl(-) Channels and T-Type Ca(2+) Channels</article-title>. <source>Function (Oxf)</source> <volume>3</volume>, <fpage>zqac041</fpage>.</mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hao</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Hao</surname> <given-names>S</given-names></string-name>, <string-name><surname>Andersen-Nissen</surname> <given-names>E</given-names></string-name>, <string-name><surname>Mauck</surname> <given-names>WM</given-names>, <suffix>3rd</suffix></string-name>, <string-name><surname>Zheng</surname> <given-names>S</given-names></string-name>, <string-name><surname>Butler</surname> <given-names>A</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Wilk</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Darby</surname> <given-names>C</given-names></string-name>, <string-name><surname>Zager</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hoffman</surname> <given-names>P</given-names></string-name>, <string-name><surname>Stoeckius</surname> <given-names>M</given-names></string-name>, <string-name><surname>Papalexi</surname> <given-names>E</given-names></string-name>, <string-name><surname>Mimitou</surname> <given-names>EP</given-names></string-name>, <string-name><surname>Jain</surname> <given-names>J</given-names></string-name>, <string-name><surname>Srivastava</surname> <given-names>A</given-names></string-name>, <string-name><surname>Stuart</surname> <given-names>T</given-names></string-name>, <string-name><surname>Fleming</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Yeung</surname> <given-names>B</given-names></string-name>, <string-name><surname>Rogers</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>McElrath</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Blish</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Gottardo</surname> <given-names>R</given-names></string-name>, <string-name><surname>Smibert</surname> <given-names>P</given-names></string-name> &amp; <string-name><surname>Satija</surname> <given-names>R.</given-names></string-name></person-group> (<year>2021</year>). <article-title>Integrated analysis of multimodal single-cell data</article-title>. <source>Cell</source> <volume>184</volume>, <fpage>3573</fpage>–<lpage>3587.</lpage> </mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hao</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Stuart</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kowalski</surname> <given-names>MH</given-names></string-name>, <string-name><surname>Choudhary</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hoffman</surname> <given-names>P</given-names></string-name>, <string-name><surname>Hartman</surname> <given-names>A</given-names></string-name>, <string-name><surname>Srivastava</surname> <given-names>A</given-names></string-name>, <string-name><surname>Molla</surname> <given-names>G</given-names></string-name>, <string-name><surname>Madad</surname> <given-names>S</given-names></string-name>, <string-name><surname>Fernandez-Granda</surname> <given-names>C</given-names></string-name> &amp; <string-name><surname>Satija</surname> <given-names>R</given-names></string-name></person-group>. (<year>2024</year>). <article-title>Dictionary learning for integrative, multimodal and scalable single-cell analysis</article-title>. <source>Nat Biotechnol</source> <volume>42</volume>, <fpage>293</fpage>–<lpage>304</lpage>.</mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Harder</surname> <given-names>DR</given-names></string-name></person-group>. (<year>1984</year>). <article-title>Pressure-dependent membrane depolarization in cat middle cerebral artery</article-title>. <source>Circulation Research</source> <volume>55</volume>, <fpage>197</fpage>–<lpage>202</lpage>.</mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Harraz</surname> <given-names>OF</given-names></string-name>, <string-name><surname>Abd El-Rahman</surname> <given-names>RR</given-names></string-name>, <string-name><surname>Bigdely-Shamloo</surname> <given-names>K</given-names></string-name>, <string-name><surname>Wilson</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Brett</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Romero</surname> <given-names>M</given-names></string-name>, <string-name><surname>Gonzales</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Earley</surname> <given-names>S</given-names></string-name>, <string-name><surname>Vigmond</surname> <given-names>EJ</given-names></string-name>, <string-name><surname>Nygren</surname> <given-names>A</given-names></string-name>, <string-name><surname>Menon</surname> <given-names>BK</given-names></string-name>, <string-name><surname>Mufti</surname> <given-names>RE</given-names></string-name>, <string-name><surname>Watson</surname> <given-names>T</given-names></string-name>, <string-name><surname>Starreveld</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Furstenhaupt</surname> <given-names>T</given-names></string-name>, <string-name><surname>Muellerleile</surname> <given-names>PR</given-names></string-name>, <string-name><surname>Kurjiaka</surname> <given-names>DT</given-names></string-name>, <string-name><surname>Kyle</surname> <given-names>BD</given-names></string-name>, <string-name><surname>Braun</surname> <given-names>AP</given-names></string-name> &amp; <string-name><surname>Welsh</surname> <given-names>DG</given-names></string-name></person-group>. (<year>2014</year>). <article-title>Ca(V)3.2 channels and the induction of negative feedback in cerebral arteries</article-title>. <source>Circ Res</source> <volume>115</volume>, <fpage>650</fpage>–<lpage>661</lpage>.</mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hwang</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Basma</surname> <given-names>N</given-names></string-name>, <string-name><surname>Sanders</surname> <given-names>KM</given-names></string-name> &amp; <string-name><surname>Ward</surname> <given-names>SM</given-names></string-name></person-group>. (<year>2016</year>). <article-title>Effects of new-generation inhibitors of the calcium-activated chloride channel anoctamin 1 on slow waves in the gastrointestinal tract</article-title>. <source>Br J Pharmacol</source> <volume>173</volume>, <fpage>1339</fpage>–<lpage>1349</lpage>.</mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jackson</surname> <given-names>WF</given-names></string-name> &amp; <string-name><surname>Boerman</surname> <given-names>EM</given-names></string-name></person-group>. (<year>2017</year>). <article-title>Regional heterogeneity in the mechanisms of myogenic tone in hamster arterioles</article-title>. <source>Am J Physiol Heart Circ Physiol</source> <volume>313</volume>, <fpage>H667</fpage>–<lpage>H675</lpage>.</mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jernigan</surname> <given-names>NL</given-names></string-name> &amp; <string-name><surname>Drummond</surname> <given-names>HA</given-names></string-name></person-group>. (<year>2005</year>). <article-title>Vascular ENaC proteins are required for renal myogenic constriction</article-title>. <source>American Journal of Physiology (Renal Physiology)</source> <volume>289</volume>, <fpage>F891</fpage>–<lpage>F901</lpage>.</mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jernigan</surname> <given-names>NL</given-names></string-name> &amp; <string-name><surname>Drummond</surname> <given-names>HA</given-names></string-name></person-group>. (<year>2006</year>). <article-title>Myogenic vasoconstriction in mouse renal interlobar arteries: role of endogenous beta and gammaENaC</article-title>. <source>American Journal of Physiology (Renal Physiology)</source> <volume>291</volume>, <fpage>F1184</fpage>–<lpage>F1191</lpage>.</mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kenney</surname> <given-names>HM</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>CL</given-names></string-name>, <string-name><surname>Loiselle</surname> <given-names>AE</given-names></string-name>, <string-name><surname>Xing</surname> <given-names>L</given-names></string-name>, <string-name><surname>Ritchlin</surname> <given-names>CT</given-names></string-name> &amp; <string-name><surname>Schwarz</surname> <given-names>EM</given-names></string-name></person-group>. (<year>2022</year>). <article-title>Single-cell transcriptomics of popliteal lymphatic vessels and peripheral veins reveals altered lymphatic muscle and immune cell populations in the TNF-Tg arthritis model</article-title>. <source>Arthritis Res Ther</source> <volume>24</volume>, <fpage>64</fpage>.</mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname> <given-names>HJ</given-names></string-name>, <string-name><surname>Li</surname> <given-names>M</given-names></string-name>, <string-name><surname>Erlich</surname> <given-names>EC</given-names></string-name>, <string-name><surname>Randolph</surname> <given-names>GJ</given-names></string-name> &amp; <string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name></person-group>. (<year>2023</year>). <article-title>ERG K(+) channels mediate a major component of action potential repolarization in lymphatic muscle</article-title>. <source>Sci Rep</source> <volume>13</volume>, <fpage>14890</fpage>.</mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname> <given-names>HJ</given-names></string-name>, <string-name><surname>Norton</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Zawieja</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Castorena-Gonzalez</surname> <given-names>JA</given-names></string-name> &amp; <string-name><surname>Davis</surname> <given-names>MJ.</given-names></string-name></person-group> (<year>2024</year>). <article-title>Acute Metabolic Stress Induces Lymphatic Dysfunction Through KATP Channel Activation</article-title>. <source>Function</source> <volume>5</volume>:<elocation-id>zqae033</elocation-id>. </mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kurtz</surname> <given-names>KH</given-names></string-name>, <string-name><surname>Souza-Smith</surname> <given-names>FM</given-names></string-name>, <string-name><surname>Moor</surname> <given-names>AN</given-names></string-name> &amp; <string-name><surname>Breslin</surname> <given-names>JW</given-names></string-name></person-group>. (<year>2014</year>). <article-title>Rho kinase enhances contractions of rat mesenteric collecting lymphatics</article-title>. <source>PLoS One</source> <volume>9</volume>, <fpage>e94082</fpage>.</mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname> <given-names>S</given-names></string-name>, <string-name><surname>Roizes</surname> <given-names>S</given-names></string-name> &amp; <string-name><surname>von der Weid</surname> <given-names>PY.</given-names></string-name></person-group> (<year>2014</year>). <article-title>Distinct roles of L- and T-type voltage-dependent Ca2+ channels in regulation of lymphatic vessel contractile activity</article-title>. <source>Journal of Physiology</source> <volume>592</volume>, <fpage>5409</fpage>–<lpage>5427</lpage>.</mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lei</surname> <given-names>PJ</given-names></string-name>, <string-name><surname>Ruscic</surname> <given-names>KJ</given-names></string-name>, <string-name><surname>Roh</surname> <given-names>K</given-names></string-name>, <string-name><surname>Rajotte</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>O’Melia</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Bouta</surname> <given-names>EM</given-names></string-name>, <string-name><surname>Marquez</surname> <given-names>M</given-names></string-name>, <string-name><surname>Pereira</surname> <given-names>ER</given-names></string-name>, <string-name><surname>Kumar</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Razavi</surname> <given-names>MS</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>H</given-names></string-name>, <string-name><surname>Menzel</surname> <given-names>L</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Kumra</surname> <given-names>H</given-names></string-name>, <string-name><surname>Duquette</surname> <given-names>M</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>P</given-names></string-name>, <string-name><surname>Baish</surname> <given-names>JW</given-names></string-name>, <string-name><surname>Munn</surname> <given-names>LL</given-names></string-name>, <string-name><surname>Kurpios</surname> <given-names>NA</given-names></string-name>, <string-name><surname>Ubellacker</surname> <given-names>JM</given-names></string-name> &amp; <string-name><surname>Padera</surname> <given-names>TP</given-names></string-name></person-group>. (<year>2025</year>). <article-title>Aging-induced changes in lymphatic muscle cell transcriptomes are associated with reduced pumping of peripheral collecting lymphatic vessels in mice</article-title>. <source>Dev Cell</source> <volume>60</volume>, <fpage>1118</fpage>–<lpage>1133.</lpage> </mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Levick</surname> <given-names>JR</given-names></string-name> &amp; <string-name><surname>Michel</surname> <given-names>CC</given-names></string-name></person-group>. (<year>2010</year>). <article-title>Microvascular fluid exchange and the revised Starling principle</article-title>. <source>Cardiovascular Research</source> <volume>87</volume>, <fpage>198</fpage>–<lpage>210</lpage>.</mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname> <given-names>H</given-names></string-name>, <string-name><surname>Wei</surname> <given-names>H</given-names></string-name>, <string-name><surname>Padera</surname> <given-names>TP</given-names></string-name>, <string-name><surname>Baish</surname> <given-names>JW</given-names></string-name> &amp; <string-name><surname>Munn</surname> <given-names>LL.</given-names></string-name></person-group> (<year>2022</year>). <article-title>Computational simulations of the effects of gravity on lymphatic transport</article-title>. <source>PNAS Nexus</source> <volume>1</volume>, <fpage>pgac237</fpage>.</mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname> <given-names>J</given-names></string-name>, <string-name><surname>Hou</surname> <given-names>B</given-names></string-name>, <string-name><surname>Tumova</surname> <given-names>S</given-names></string-name>, <string-name><surname>Muraki</surname> <given-names>K</given-names></string-name>, <string-name><surname>Bruns</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ludlow</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Sedo</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hyman</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>McKeown</surname> <given-names>L</given-names></string-name>, <string-name><surname>Young</surname> <given-names>RS</given-names></string-name>, <string-name><surname>Yuldasheva</surname> <given-names>NY</given-names></string-name>, <string-name><surname>Majeed</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Wilson</surname> <given-names>LA</given-names></string-name>, <string-name><surname>Rode</surname> <given-names>B</given-names></string-name>, <string-name><surname>Bailey</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>HR</given-names></string-name>, <string-name><surname>Fu</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Carter</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Bilton</surname> <given-names>J</given-names></string-name>, <string-name><surname>Imrie</surname> <given-names>H</given-names></string-name>, <string-name><surname>Ajuh</surname> <given-names>P</given-names></string-name>, <string-name><surname>Dear</surname> <given-names>TN</given-names></string-name>, <string-name><surname>Cubbon</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Kearney</surname> <given-names>MT</given-names></string-name>, <string-name><surname>Prasad</surname> <given-names>RK</given-names></string-name>, <string-name><surname>Evans</surname> <given-names>PC</given-names></string-name>, <string-name><surname>Ainscough</surname> <given-names>JF</given-names></string-name> &amp; <string-name><surname>Beech</surname> <given-names>DJ</given-names></string-name></person-group>. (<year>2014a</year>). <article-title>Piezo1 integration of vascular architecture with physiological force</article-title>. <source>Nature</source> <volume>515</volume>, <fpage>279</fpage>–<lpage>282</lpage>.</mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Baylie</surname> <given-names>RL</given-names></string-name>, <string-name><surname>Tavares</surname> <given-names>MJ</given-names></string-name> &amp; <string-name><surname>Brayden</surname> <given-names>JE</given-names></string-name></person-group>. (<year>2014b</year>). <article-title>TRPM4 channels couple purinergic receptor mechanoactivation and myogenic tone development in cerebral parenchymal arterioles</article-title>. <source>J Cereb Blood Flow Metab</source> <volume>34</volume>, <fpage>1706</fpage>–<lpage>1714</lpage>.</mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Longden</surname> <given-names>TA</given-names></string-name>, <string-name><surname>Dabertrand</surname> <given-names>F</given-names></string-name>, <string-name><surname>Koide</surname> <given-names>M</given-names></string-name>, <string-name><surname>Gonzales</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Tykocki</surname> <given-names>NR</given-names></string-name>, <string-name><surname>Brayden</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Hill-Eubanks</surname> <given-names>D</given-names></string-name> &amp; <string-name><surname>Nelson</surname> <given-names>MT</given-names></string-name></person-group>. (<year>2017</year>). <article-title>Capillary K(+)-sensing initiates retrograde hyperpolarization to increase local cerebral blood flow</article-title>. <source>Nat Neurosci</source> <volume>20</volume>, <fpage>717</fpage>–<lpage>726</lpage>.</mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lyashkov</surname> <given-names>AE</given-names></string-name>, <string-name><surname>Behar</surname> <given-names>J</given-names></string-name>, <string-name><surname>Lakatta</surname> <given-names>EG</given-names></string-name>, <string-name><surname>Yaniv</surname> <given-names>Y</given-names></string-name> &amp; <string-name><surname>Maltsev</surname> <given-names>VA</given-names></string-name></person-group>. (<year>2018a</year>). <article-title>Positive Feedback Mechanisms among Local Ca Releases, NCX, and I(CaL) Ignite Pacemaker Action Potentials</article-title>. <source>Biophys J</source> <volume>114</volume>, <fpage>1176</fpage>–<lpage>1189</lpage>.</mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lyashkov</surname> <given-names>AE</given-names></string-name>, <string-name><surname>Behar</surname> <given-names>J</given-names></string-name>, <string-name><surname>Lakatta</surname> <given-names>EG</given-names></string-name>, <string-name><surname>Yaniv</surname> <given-names>Y</given-names></string-name> &amp; <string-name><surname>Maltsev</surname> <given-names>VA</given-names></string-name></person-group>. (<year>2018b</year>). <article-title>Positive Feedback Mechanisms among Local Ca Releases, NCX, and ICaL Ignite Pacemaker Action Potentials</article-title>. <source>Biophys J</source> <volume>114</volume>, <fpage>2024</fpage>.</mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mader</surname> <given-names>F</given-names></string-name>, <string-name><surname>Muller</surname> <given-names>S</given-names></string-name>, <string-name><surname>Krause</surname> <given-names>L</given-names></string-name>, <string-name><surname>Springer</surname> <given-names>A</given-names></string-name>, <string-name><surname>Kernig</surname> <given-names>K</given-names></string-name>, <string-name><surname>Protzel</surname> <given-names>C</given-names></string-name>, <string-name><surname>Porath</surname> <given-names>K</given-names></string-name>, <string-name><surname>Rackow</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wittstock</surname> <given-names>T</given-names></string-name>, <string-name><surname>Frank</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hakenberg</surname> <given-names>OW</given-names></string-name>, <string-name><surname>Kohling</surname> <given-names>R</given-names></string-name> &amp; <string-name><surname>Kirschstein</surname> <given-names>T</given-names></string-name></person-group>. (<year>2018</year>). <article-title>Hyperpolarization-Activated Cyclic Nucleotide-Gated Non-selective (HCN) Ion Channels Regulate Human and Murine Urinary Bladder Contractility</article-title>. <source>Front Physiol</source> <volume>9</volume>, <fpage>753</fpage>.</mixed-citation></ref>
<ref id="c66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Majgaard</surname> <given-names>J</given-names></string-name>, <string-name><surname>Skov</surname> <given-names>FG</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hjortdal</surname> <given-names>VE</given-names></string-name> &amp; <string-name><surname>Boedtkjer</surname> <given-names>DMB</given-names></string-name></person-group>. (<year>2022</year>). <article-title>Positive chronotropic action of HCN channel antagonism in human collecting lymphatic vessels</article-title>. <source>Physiol Rep</source> <volume>10</volume>, <fpage>e15401</fpage>.</mixed-citation></ref>
<ref id="c67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mani</surname> <given-names>BK</given-names></string-name> &amp; <string-name><surname>Byron</surname> <given-names>KL</given-names></string-name></person-group>. (<year>2011</year>). <article-title>Vascular KCNQ channels in humans: the sub-threshold brake that regulates vascular tone?</article-title> <source>Br J Pharmacol</source> <volume>162</volume>, <fpage>38</fpage>–<lpage>41</lpage>.</mixed-citation></ref>
<ref id="c68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maroto</surname> <given-names>R</given-names></string-name>, <string-name><surname>Raso</surname> <given-names>A</given-names></string-name>, <string-name><surname>Wood</surname> <given-names>TG</given-names></string-name>, <string-name><surname>Kurosky</surname> <given-names>A</given-names></string-name>, <string-name><surname>Martinac</surname> <given-names>B</given-names></string-name> &amp; <string-name><surname>Hamill</surname> <given-names>OP</given-names></string-name></person-group>. (<year>2005</year>). <article-title>TRPC1 forms the stretch-activated cation channel in vertebrate cells</article-title>. <source>Nature Cell Biology</source> <volume>7</volume>, <fpage>179</fpage>–<lpage>185</lpage>.</mixed-citation></ref>
<ref id="c69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mathar</surname> <given-names>I</given-names></string-name>, <string-name><surname>Vennekens</surname> <given-names>R</given-names></string-name>, <string-name><surname>Meissner</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kees</surname> <given-names>F</given-names></string-name>, <string-name><surname>Van der Mieren</surname> <given-names>G</given-names></string-name>, <string-name><surname>Camacho Londono</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Uhl</surname> <given-names>S</given-names></string-name>, <string-name><surname>Voets</surname> <given-names>T</given-names></string-name>, <string-name><surname>Hummel</surname> <given-names>B</given-names></string-name>, <string-name><surname>van den Bergh</surname> <given-names>A</given-names></string-name>, <string-name><surname>Herijgers</surname> <given-names>P</given-names></string-name>, <string-name><surname>Nilius</surname> <given-names>B</given-names></string-name>, <string-name><surname>Flockerzi</surname> <given-names>V</given-names></string-name>, <string-name><surname>Schweda</surname> <given-names>F</given-names></string-name> &amp; <string-name><surname>Freichel</surname> <given-names>M.</given-names></string-name></person-group> (<year>2010</year>). <article-title>Increased catecholamine secretion contributes to hypertension in TRPM4-deficient mice</article-title>. <source>Journal of Clinical Investigation</source> <volume>120</volume>, <fpage>3267</fpage>–<lpage>3279</lpage>.</mixed-citation></ref>
<ref id="c70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McDuffie</surname> <given-names>EL</given-names></string-name>, <string-name><surname>Panettieri</surname> <given-names>RA</given-names>, <suffix>Jr.</suffix></string-name> &amp; <string-name><surname>Scott</surname> <given-names>CP</given-names></string-name></person-group>. (<year>2024</year>). <article-title>G(12/13) signaling in asthma</article-title>. <source>Respir Res</source> <volume>25</volume>, <fpage>295</fpage>.</mixed-citation></ref>
<ref id="c71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McGahon</surname> <given-names>MK</given-names></string-name>, <string-name><surname>Fernandez</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Dash</surname> <given-names>DP</given-names></string-name>, <string-name><surname>McKee</surname> <given-names>J</given-names></string-name>, <string-name><surname>Simpson</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Zholos</surname> <given-names>AV</given-names></string-name>, <string-name><surname>McGeown</surname> <given-names>JG</given-names></string-name> &amp; <string-name><surname>Curtis</surname> <given-names>TM.</given-names></string-name></person-group> (<year>2016</year>). <article-title>TRPV2 Channels Contribute to Stretch-Activated Cation Currents and Myogenic Constriction in Retinal Arterioles</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>57</volume>, <fpage>5637</fpage>–<lpage>5647</lpage>.</mixed-citation></ref>
<ref id="c72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mederos y Schnitzler</surname> <given-names>M</given-names></string-name>, <string-name><surname>Storch</surname> <given-names>U</given-names></string-name> &amp; <string-name><surname>Gudermann</surname> <given-names>T.</given-names></string-name></person-group> (<year>2011</year>). <article-title>AT1 receptors as mechanosensors</article-title>. <source>Curr Opin Pharmacol</source> <volume>11</volume>, <fpage>112</fpage>–<lpage>116</lpage>.</mixed-citation></ref>
<ref id="c73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mederos y Schnitzler</surname> <given-names>M</given-names></string-name>, <string-name><surname>Storch</surname> <given-names>U</given-names></string-name>, <string-name><surname>Meibers</surname> <given-names>S</given-names></string-name>, <string-name><surname>Nurwakagari</surname> <given-names>P</given-names></string-name>, <string-name><surname>Breit</surname> <given-names>A</given-names></string-name>, <string-name><surname>Essin</surname> <given-names>K</given-names></string-name>, <string-name><surname>Gollasch</surname> <given-names>M</given-names></string-name> &amp; <string-name><surname>Gudermann</surname> <given-names>T.</given-names></string-name></person-group> (<year>2008</year>). <article-title>Gq-coupled receptors as mechanosensors mediating myogenic vasoconstriction</article-title>. <source>EMBO J</source> <volume>27</volume>, <fpage>3092</fpage>–<lpage>3103</lpage>.</mixed-citation></ref>
<ref id="c74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mercado</surname> <given-names>J</given-names></string-name>, <string-name><surname>Baylie</surname> <given-names>R</given-names></string-name>, <string-name><surname>Navedo</surname> <given-names>MF</given-names></string-name>, <string-name><surname>Yuan</surname> <given-names>C</given-names></string-name>, <string-name><surname>Scott</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Nelson</surname> <given-names>MT</given-names></string-name>, <string-name><surname>Brayden</surname> <given-names>JE</given-names></string-name> &amp; <string-name><surname>Santana</surname> <given-names>LF</given-names></string-name></person-group>. (<year>2014</year>). <article-title>Local control of TRPV4 channels by AKAP150-targeted PKC in arterial smooth muscle</article-title>. <source>J Gen Physiol</source> <volume>143</volume>, <fpage>559</fpage>–<lpage>575</lpage>.</mixed-citation></ref>
<ref id="c75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Monfredi</surname> <given-names>O</given-names></string-name>, <string-name><surname>Maltseva</surname> <given-names>LA</given-names></string-name>, <string-name><surname>Spurgeon</surname> <given-names>HA</given-names></string-name>, <string-name><surname>Boyett</surname> <given-names>MR</given-names></string-name>, <string-name><surname>Lakatta</surname> <given-names>EG</given-names></string-name> &amp; <string-name><surname>Maltsev</surname> <given-names>VA</given-names></string-name></person-group>. (<year>2013</year>). <article-title>Beat-to-Beat Variation in Periodicity of Local Calcium Releases Contributes to Intrinsic Variations of Spontaneous Cycle Length in Isolated Single Sinoatrial Node Cells</article-title>. <source>PLoS One</source> <volume>8</volume>, <fpage>e67247</fpage>.</mixed-citation></ref>
<ref id="c76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Muraki</surname> <given-names>K</given-names></string-name>, <string-name><surname>Iwata</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Katanosaka</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ito</surname> <given-names>T</given-names></string-name>, <string-name><surname>Ohya</surname> <given-names>S</given-names></string-name>, <string-name><surname>Shigekawa</surname> <given-names>M</given-names></string-name> &amp; <string-name><surname>Imaizumi</surname> <given-names>Y</given-names></string-name></person-group>. (<year>2003</year>). <article-title>TRPV2 is a component of osmotically sensitive cation channels in murine aortic myocytes</article-title>. <source>Circ Res</source> <volume>93</volume>, <fpage>829</fpage>–<lpage>838</lpage>.</mixed-citation></ref>
<ref id="c77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Murthy</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Dubin</surname> <given-names>AE</given-names></string-name> &amp; <string-name><surname>Patapoutian</surname> <given-names>A</given-names></string-name></person-group>. (<year>2017</year>). <article-title>Piezos thrive under pressure: mechanically activated ion channels in health and disease</article-title>. <source>Nat Rev Mol Cell Biol</source> <volume>18</volume>, <fpage>771</fpage>–<lpage>783</lpage>.</mixed-citation></ref>
<ref id="c78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Narayanan</surname> <given-names>D</given-names></string-name>, <string-name><surname>Bulley</surname> <given-names>S</given-names></string-name>, <string-name><surname>Leo</surname> <given-names>MD</given-names></string-name>, <string-name><surname>Burris</surname> <given-names>SK</given-names></string-name>, <string-name><surname>Gabrick</surname> <given-names>KS</given-names></string-name>, <string-name><surname>Boop</surname> <given-names>FA</given-names></string-name> &amp; <string-name><surname>Jaggar</surname> <given-names>JH</given-names></string-name></person-group>. (<year>2013</year>). <article-title>Smooth muscle cell transient receptor potential polycystin-2 (TRPP2) channels contribute to the myogenic response in cerebral arteries</article-title>. <source>J Physiol</source> <volume>591</volume>, <fpage>5031</fpage>–<lpage>5046</lpage>.</mixed-citation></ref>
<ref id="c79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Narayanan</surname> <given-names>J</given-names></string-name>, <string-name><surname>Imig</surname> <given-names>M</given-names></string-name>, <string-name><surname>Roman</surname> <given-names>RJ</given-names></string-name> &amp; <string-name><surname>Harder</surname> <given-names>DR</given-names></string-name></person-group>. (<year>1994</year>). <article-title>Pressurization of isolated renal arteries increases inositol trisphosphate and diacylglycerol</article-title>. <source>American Journal of Physiology (Heart and Circulatory Physiology)</source> <volume>266</volume>, <fpage>H1840</fpage>–<lpage>H1845</lpage>.</mixed-citation></ref>
<ref id="c80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Negrini</surname> <given-names>D</given-names></string-name>, <string-name><surname>Marcozzi</surname> <given-names>C</given-names></string-name>, <string-name><surname>Solari</surname> <given-names>E</given-names></string-name>, <string-name><surname>Bossi</surname> <given-names>E</given-names></string-name>, <string-name><surname>Cinquetti</surname> <given-names>R</given-names></string-name>, <string-name><surname>Reguzzoni</surname> <given-names>M</given-names></string-name> &amp; <string-name><surname>Moriondo</surname> <given-names>A</given-names></string-name></person-group>. (<year>2016</year>). <article-title>Hyperpolarization-activated cyclic nucleotide-gated channels in peripheral diaphragmatic lymphatics</article-title>. <source>Am J Physiol Heart Circ Physiol</source> <volume>311</volume>, <fpage>H892</fpage>–<lpage>H903</lpage>.</mixed-citation></ref>
<ref id="c81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nilius</surname> <given-names>B</given-names></string-name> &amp; <string-name><surname>Droogmans</surname> <given-names>G</given-names></string-name></person-group>. (<year>2001</year>). <article-title>Ion channels and their functional role in vascular endothelium</article-title>. <source>Physiological Reviews</source> <volume>81</volume>, <fpage>1415</fpage>–<lpage>1459</lpage>.</mixed-citation></ref>
<ref id="c82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nonomura</surname> <given-names>K</given-names></string-name>, <string-name><surname>Lukacs</surname> <given-names>V</given-names></string-name>, <string-name><surname>Sweet</surname> <given-names>DT</given-names></string-name>, <string-name><surname>Goddard</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Kanie</surname> <given-names>A</given-names></string-name>, <string-name><surname>Whitwam</surname> <given-names>T</given-names></string-name>, <string-name><surname>Ranade</surname> <given-names>SS</given-names></string-name>, <string-name><surname>Fujimori</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kahn</surname> <given-names>ML</given-names></string-name> &amp; <string-name><surname>Patapoutian</surname> <given-names>A</given-names></string-name></person-group>. (<year>2018</year>). <article-title>Mechanically activated ion channel PIEZO1 is required for lymphatic valve formation</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>115</volume>, <fpage>12817</fpage>–<lpage>12822</lpage>.</mixed-citation></ref>
<ref id="c83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Olszewski</surname> <given-names>WL</given-names></string-name> &amp; <string-name><surname>Engeset</surname> <given-names>A</given-names></string-name></person-group>. (<year>1980</year>). <article-title>Intrinsic contractility of prenodal lymph vessels and lymph flow in human leg</article-title>. <source>American Journal of Physiology (Heart and Circulatory Physiology)</source> <volume>239</volume>, <fpage>H775</fpage>–<lpage>H783</lpage>.</mixed-citation></ref>
<ref id="c84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peyronnet</surname> <given-names>R</given-names></string-name>, <string-name><surname>Martins</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Duprat</surname> <given-names>F</given-names></string-name>, <string-name><surname>Demolombe</surname> <given-names>S</given-names></string-name>, <string-name><surname>Arhatte</surname> <given-names>M</given-names></string-name>, <string-name><surname>Jodar</surname> <given-names>M</given-names></string-name>, <string-name><surname>Tauc</surname> <given-names>M</given-names></string-name>, <string-name><surname>Duranton</surname> <given-names>C</given-names></string-name>, <string-name><surname>Paulais</surname> <given-names>M</given-names></string-name>, <string-name><surname>Teulon</surname> <given-names>J</given-names></string-name>, <string-name><surname>Honore</surname> <given-names>E</given-names></string-name> &amp; <string-name><surname>Patel</surname> <given-names>A</given-names></string-name></person-group>. (<year>2013</year>). <article-title>Piezo1-dependent stretch-activated channels are inhibited by Polycystin-2 in renal tubular epithelial cells</article-title>. <source>EMBO Rep</source> <volume>14</volume>, <fpage>1143</fpage>–<lpage>1148</lpage>.</mixed-citation></ref>
<ref id="c85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Phan</surname> <given-names>TX</given-names></string-name>, <string-name><surname>Ton</surname> <given-names>HT</given-names></string-name>, <string-name><surname>Gulyas</surname> <given-names>H</given-names></string-name>, <string-name><surname>Porszasz</surname> <given-names>R</given-names></string-name>, <string-name><surname>Toth</surname> <given-names>A</given-names></string-name>, <string-name><surname>Russo</surname> <given-names>R</given-names></string-name>, <string-name><surname>Kay</surname> <given-names>MW</given-names></string-name>, <string-name><surname>Sahibzada</surname> <given-names>N</given-names></string-name> &amp; <string-name><surname>Ahern</surname> <given-names>GP</given-names></string-name></person-group>. (<year>2022</year>). <article-title>TRPV1 in arteries enables a rapid myogenic tone</article-title>. <source>J Physiol</source> <volume>600</volume>, <fpage>1651</fpage>–<lpage>1666</lpage>.</mixed-citation></ref>
<ref id="c86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pires</surname> <given-names>PW</given-names></string-name>, <string-name><surname>Ko</surname> <given-names>EA</given-names></string-name>, <string-name><surname>Pritchard</surname> <given-names>HAT</given-names></string-name>, <string-name><surname>Rudokas</surname> <given-names>M</given-names></string-name>, <string-name><surname>Yamasaki</surname> <given-names>E</given-names></string-name> &amp; <string-name><surname>Earley</surname> <given-names>S</given-names></string-name></person-group>. (<year>2017</year>). <article-title>The angiotensin II receptor type 1b is the primary sensor of intraluminal pressure in cerebral artery smooth muscle cells</article-title>. <source>J Physiol</source> <volume>595</volume>, <fpage>4735</fpage>–<lpage>4753</lpage>.</mixed-citation></ref>
<ref id="c87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Price</surname> <given-names>MP</given-names></string-name>, <string-name><surname>Lewin</surname> <given-names>GR</given-names></string-name>, <string-name><surname>McIlwrath</surname> <given-names>SL</given-names></string-name>, <string-name><surname>Cheng</surname> <given-names>C</given-names></string-name>, <string-name><surname>Xie</surname> <given-names>J</given-names></string-name>, <string-name><surname>Heppenstall</surname> <given-names>PA</given-names></string-name>, <string-name><surname>Stucky</surname> <given-names>CL</given-names></string-name>, <string-name><surname>Mannsfeldt</surname> <given-names>AG</given-names></string-name>, <string-name><surname>Brennan</surname> <given-names>TJ</given-names></string-name>, <string-name><surname>Drummond</surname> <given-names>HA</given-names></string-name>, <string-name><surname>Qiao</surname> <given-names>J</given-names></string-name>, <string-name><surname>Benson</surname> <given-names>CJ</given-names></string-name>, <string-name><surname>Tarr</surname> <given-names>DE</given-names></string-name>, <string-name><surname>Hrstka</surname> <given-names>RF</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>B</given-names></string-name>, <string-name><surname>Williamson</surname> <given-names>RA</given-names></string-name> &amp; <string-name><surname>Welsh</surname> <given-names>MJ</given-names></string-name></person-group>. (<year>2000</year>). <article-title>The mammalian sodium channel BNC1 is required for normal touch sensation</article-title>. <source>Nature</source> <volume>407</volume>, <fpage>1007</fpage>–<lpage>1011</lpage>.</mixed-citation></ref>
<ref id="c88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Renkin</surname> <given-names>EM</given-names></string-name></person-group>. (<year>1986</year>). <article-title>Some consequences of capillary permeability to macromolecules: Starling’s hypothesis reconsidered</article-title>. <source>Am J Physiol</source> <volume>250</volume>, <fpage>H706</fpage>–<lpage>710</lpage>.</mixed-citation></ref>
<ref id="c89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Retailleau</surname> <given-names>K</given-names></string-name>, <string-name><surname>Duprat</surname> <given-names>F</given-names></string-name>, <string-name><surname>Arhatte</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ranade</surname> <given-names>SS</given-names></string-name>, <string-name><surname>Peyronnet</surname> <given-names>R</given-names></string-name>, <string-name><surname>Martins</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Jodar</surname> <given-names>M</given-names></string-name>, <string-name><surname>Moro</surname> <given-names>C</given-names></string-name>, <string-name><surname>Offermanns</surname> <given-names>S</given-names></string-name>, <string-name><surname>Feng</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Demolombe</surname> <given-names>S</given-names></string-name>, <string-name><surname>Patel</surname> <given-names>A</given-names></string-name> &amp; <string-name><surname>Honore</surname> <given-names>E</given-names></string-name></person-group>. (<year>2015</year>). <article-title>Piezo1 in Smooth Muscle Cells Is Involved in Hypertension-Dependent Arterial Remodeling</article-title>. <source>Cell Rep</source> <volume>13</volume>, <fpage>1161</fpage>–<lpage>1171</lpage>.</mixed-citation></ref>
<ref id="c90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sancho</surname> <given-names>M</given-names></string-name>, <string-name><surname>Fabris</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hald</surname> <given-names>BO</given-names></string-name>, <string-name><surname>Brett</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Sandow</surname> <given-names>SL</given-names></string-name>, <string-name><surname>Poepping</surname> <given-names>TL</given-names></string-name> &amp; <string-name><surname>Welsh</surname> <given-names>DG</given-names></string-name></person-group>. (<year>2019</year>). <article-title>Membrane Lipid-KIR2.x Channel Interactions Enable Hemodynamic Sensing in Cerebral Arteries</article-title>. <source>Arterioscler Thromb Vasc Biol</source> <volume>39</volume>, <fpage>1072</fpage>–<lpage>1087</lpage>.</mixed-citation></ref>
<ref id="c91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sancho</surname> <given-names>M</given-names></string-name>, <string-name><surname>Samson</surname> <given-names>NC</given-names></string-name>, <string-name><surname>Hald</surname> <given-names>BO</given-names></string-name>, <string-name><surname>Hashad</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Marrelli</surname> <given-names>SP</given-names></string-name>, <string-name><surname>Brett</surname> <given-names>SE</given-names></string-name> &amp; <string-name><surname>Welsh</surname> <given-names>DG</given-names></string-name></person-group>. (<year>2017</year>). <article-title>KIR channels tune electrical communication in cerebral arteries</article-title>. <source>J Cereb Blood Flow Metab</source> <volume>37</volume>, <fpage>2171</fpage>–<lpage>2184</lpage>.</mixed-citation></ref>
<ref id="c92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sanders</surname> <given-names>KM</given-names></string-name></person-group>. (<year>2019</year>). <article-title>Spontaneous Electrical Activity and Rhythmicity in Gastrointestinal Smooth Muscles</article-title>. <source>Adv Exp Med Biol</source> <volume>1124</volume>, <fpage>3</fpage>–<lpage>46</lpage>.</mixed-citation></ref>
<ref id="c93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scallan</surname> <given-names>JP</given-names></string-name> &amp; <string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name></person-group>. (<year>2013</year>). <article-title>Genetic removal of basal nitric oxide enhances contractile activity in isolated murine collecting lymphatic vessels</article-title>. <source>Journal of Physiology</source> <volume>591</volume>, <fpage>2139</fpage>–<lpage>2156</lpage>.</mixed-citation></ref>
<ref id="c94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scallan</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Wolpers</surname> <given-names>JH</given-names></string-name> &amp; <string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name></person-group>. (<year>2013</year>). <article-title>Constriction of isolated collecting lymphatic vessels in response to acute increases in downstream pressure</article-title>. <source>J Physiol</source> <volume>591</volume>, <fpage>443</fpage>–<lpage>459</lpage>.</mixed-citation></ref>
<ref id="c95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scallan</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Wolpers</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Muthuchamy</surname> <given-names>M</given-names></string-name>, <string-name><surname>Zawieja</surname> <given-names>DC</given-names></string-name>, <string-name><surname>Gashev</surname> <given-names>AA</given-names></string-name> &amp; <string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name></person-group>. (<year>2012</year>). <article-title>Independent and interactive effects of preload and afterload on the lymphatic pump</article-title>. <source>Am J Physiol Heart Circ Physiol</source> <volume>303</volume>, <fpage>H809</fpage>–<lpage>H824</lpage>.</mixed-citation></ref>
<ref id="c96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scallan</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Zawieja</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Castorena-Gonzalez</surname> <given-names>JA</given-names></string-name> &amp; <string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name></person-group>. (<year>2016</year>). <article-title>Lymphatic pumping: Mechanics, mechanisms and malfunction</article-title>. <source>J Physiol</source> <volume>594</volume>, <fpage>5749</fpage>–<lpage>5768</lpage>.</mixed-citation></ref>
<ref id="c97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schleifenbaum</surname> <given-names>J</given-names></string-name>, <string-name><surname>Kassmann</surname> <given-names>M</given-names></string-name>, <string-name><surname>Szijarto</surname> <given-names>I</given-names></string-name>, <string-name><surname>Hercule</surname> <given-names>H</given-names></string-name>, <string-name><surname>Tano</surname> <given-names>JY</given-names></string-name>, <string-name><surname>Weinert</surname> <given-names>S</given-names></string-name>, <string-name><surname>Heidenreich</surname> <given-names>M</given-names></string-name>, <string-name><surname>Pathan</surname> <given-names>A</given-names></string-name>, <string-name><surname>Anistan</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Alenina</surname> <given-names>N</given-names></string-name>, <string-name><surname>Rusch</surname> <given-names>N</given-names></string-name>, <string-name><surname>Jentsch</surname> <given-names>T</given-names></string-name>, <string-name><surname>Bader</surname> <given-names>M</given-names></string-name> &amp; <string-name><surname>Gollasch</surname> <given-names>M</given-names></string-name></person-group>. (<year>2014</year>). <article-title>Stretch-Activation of Angiotensin II Type 1a Receptors Contributes to the Myogenic Response of Mouse Mesenteric and Renal Arteries</article-title>. <source>Circ Res</source> <volume>115</volume>, <fpage>263</fpage>–<lpage>272</lpage>.</mixed-citation></ref>
<ref id="c98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schulz</surname> <given-names>ME</given-names></string-name>, <string-name><surname>Akerstrom</surname> <given-names>VL</given-names></string-name>, <string-name><surname>Song</surname> <given-names>K</given-names></string-name>, <string-name><surname>Broyhill</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Li</surname> <given-names>M</given-names></string-name>, <string-name><surname>Lambert</surname> <given-names>MD</given-names></string-name>, <string-name><surname>Goldberg</surname> <given-names>TB</given-names></string-name>, <string-name><surname>Kataru</surname> <given-names>RP</given-names></string-name>, <string-name><surname>Shin</surname> <given-names>J</given-names></string-name>, <string-name><surname>Braun</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Norton</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Czepielewski</surname> <given-names>RS</given-names></string-name>, <string-name><surname>Mehrara</surname> <given-names>BJ</given-names></string-name>, <string-name><surname>Domeier</surname> <given-names>TL</given-names></string-name>, <string-name><surname>Zawieja</surname> <given-names>SD</given-names></string-name> &amp; <string-name><surname>Castorena-Gonzalez</surname> <given-names>JA</given-names></string-name></person-group>. (<year>2025</year>). <article-title>Regulation of Collecting Lymphatic Vessel Contractile Function by TRPV4 Channels</article-title>. <source>Arterioscler Thromb Vasc Biol</source>.</mixed-citation></ref>
<ref id="c99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sharif-Naeini</surname> <given-names>R</given-names></string-name>, <string-name><surname>Folgering</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Bichet</surname> <given-names>D</given-names></string-name>, <string-name><surname>Duprat</surname> <given-names>F</given-names></string-name>, <string-name><surname>Lauritzen</surname> <given-names>I</given-names></string-name>, <string-name><surname>Arhatte</surname> <given-names>M</given-names></string-name>, <string-name><surname>Jodar</surname> <given-names>M</given-names></string-name>, <string-name><surname>Dedman</surname> <given-names>A</given-names></string-name>, <string-name><surname>Chatelain</surname> <given-names>FC</given-names></string-name>, <string-name><surname>Schulte</surname> <given-names>U</given-names></string-name>, <string-name><surname>Retailleau</surname> <given-names>K</given-names></string-name>, <string-name><surname>Loufrani</surname> <given-names>L</given-names></string-name>, <string-name><surname>Patel</surname> <given-names>A</given-names></string-name>, <string-name><surname>Sachs</surname> <given-names>F</given-names></string-name>, <string-name><surname>Delmas</surname> <given-names>P</given-names></string-name>, <string-name><surname>Peters</surname> <given-names>DJ</given-names></string-name> &amp; <string-name><surname>Honore</surname> <given-names>E</given-names></string-name></person-group>. (<year>2009</year>). <article-title>Polycystin-1 and -2 dosage regulates pressure sensing</article-title>. <source>Cell</source> <volume>139</volume>, <fpage>587</fpage>–<lpage>596</lpage>.</mixed-citation></ref>
<ref id="c100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Soni</surname> <given-names>H</given-names></string-name>, <string-name><surname>Peixoto-Neves</surname> <given-names>D</given-names></string-name>, <string-name><surname>Matthews</surname> <given-names>AT</given-names></string-name> &amp; <string-name><surname>Adebiyi</surname> <given-names>A</given-names></string-name></person-group>. (<year>2017</year>). <article-title>TRPV4 channels contribute to renal myogenic autoregulation in neonatal pigs</article-title>. <source>Am J Physiol Renal Physiol</source> <volume>313</volume>, <fpage>F1136</fpage>–<lpage>F1148</lpage>.</mixed-citation></ref>
<ref id="c101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Storch</surname> <given-names>U</given-names></string-name>, <string-name><surname>Blodow</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gudermann</surname> <given-names>T</given-names></string-name> &amp; <string-name><surname>Mederos</surname> <given-names>YSM</given-names></string-name></person-group>. (<year>2015</year>). <article-title>Cysteinyl leukotriene 1 receptors as novel mechanosensors mediating myogenic tone together with angiotensin II type 1 receptors-brief report</article-title>. <source>Arterioscler Thromb Vasc Biol</source> <volume>35</volume>, <fpage>121</fpage>–<lpage>126</lpage>.</mixed-citation></ref>
<ref id="c102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Storch</surname> <given-names>U</given-names></string-name>, <string-name><surname>Mederos y Schnitzler</surname> <given-names>M</given-names></string-name> &amp; <string-name><surname>Gudermann</surname> <given-names>T.</given-names></string-name></person-group> (<year>2012</year>). <article-title>G protein-mediated stretch reception</article-title>. <source>Am J Physiol Heart Circ Physiol</source> <volume>302</volume>, <fpage>H1241</fpage>–<lpage>1249</lpage>.</mixed-citation></ref>
<ref id="c103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Swain</surname> <given-names>SM</given-names></string-name> &amp; <string-name><surname>Liddle</surname> <given-names>RA</given-names></string-name></person-group>. (<year>2021</year>). <article-title>Piezo1 acts upstream of TRPV4 to induce pathological changes in endothelial cells due to shear stress</article-title>. <source>J Biol Chem</source> <volume>296</volume>, <fpage>100171</fpage>.</mixed-citation></ref>
<ref id="c104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>To</surname> <given-names>KHT</given-names></string-name>, <string-name><surname>Gui</surname> <given-names>P</given-names></string-name>, <string-name><surname>Li</surname> <given-names>M</given-names></string-name>, <string-name><surname>Zawieja</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Castorena-Gonzalez</surname> <given-names>JA</given-names></string-name> &amp; <string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name></person-group>. (<year>2020</year>). <article-title>T-type, but not L-type, voltage-gated calcium channels are dispensable for lymphatic pacemaking and spontaneous contractions</article-title>. <source>Sci Rep</source> <volume>10</volume>, <fpage>70</fpage>.</mixed-citation></ref>
<ref id="c105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>van Helden</surname> <given-names>DF.</given-names></string-name></person-group> (<year>1993</year>). <article-title>Pacemaker potentials in lymphatic smooth muscle of the guinea-pig mesentery</article-title>. <source>Journal of Physiology</source> <volume>471</volume>, <fpage>465</fpage>–<lpage>479</lpage>.</mixed-citation></ref>
<ref id="c106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vinogradova</surname> <given-names>TM</given-names></string-name>, <string-name><surname>Maltsev</surname> <given-names>VA</given-names></string-name>, <string-name><surname>Bogdanov</surname> <given-names>KY</given-names></string-name>, <string-name><surname>Lyashkov</surname> <given-names>AE</given-names></string-name> &amp; <string-name><surname>Lakatta</surname> <given-names>EG</given-names></string-name></person-group>. (<year>2005</year>). <article-title>Rhythmic Ca2+ oscillations drive sinoatrial nodal cell pacemaker function to make the heart tick</article-title>. <source>Ann N Y Acad Sci</source> <volume>1047</volume>, <fpage>138</fpage>–<lpage>156</lpage>.</mixed-citation></ref>
<ref id="c107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vinogradova</surname> <given-names>TM</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>YY</given-names></string-name>, <string-name><surname>Maltsev</surname> <given-names>V</given-names></string-name>, <string-name><surname>Lyashkov</surname> <given-names>A</given-names></string-name>, <string-name><surname>Stern</surname> <given-names>M</given-names></string-name> &amp; <string-name><surname>Lakatta</surname> <given-names>EG</given-names></string-name></person-group>. (<year>2004</year>). <article-title>Rhythmic ryanodine receptor Ca2+ releases during diastolic depolarization of sinoatrial pacemaker cells do not require membrane depolarization</article-title>. <source>Circ Res</source> <volume>94</volume>, <fpage>802</fpage>–<lpage>809</lpage>.</mixed-citation></ref>
<ref id="c108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>von der Weid</surname> <given-names>PY</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>S</given-names></string-name>, <string-name><surname>Imtiaz</surname> <given-names>MS</given-names></string-name>, <string-name><surname>Zawieja</surname> <given-names>DC</given-names></string-name> &amp; <string-name><surname>Davis</surname> <given-names>MJ.</given-names></string-name></person-group> (<year>2014</year>). <article-title>Electrophysiological properties of rat mesenteric lymphatic vessels and their regulation by stretch</article-title>. <source>Lymphat Res Biol</source> <volume>12</volume>, <fpage>66</fpage>–<lpage>75</lpage>.</mixed-citation></ref>
<ref id="c109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Warthi</surname> <given-names>G</given-names></string-name>, <string-name><surname>Faulkner</surname> <given-names>JL</given-names></string-name>, <string-name><surname>Doja</surname> <given-names>J</given-names></string-name>, <string-name><surname>Ghanam</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Gao</surname> <given-names>P</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Slivano</surname> <given-names>OJ</given-names></string-name>, <string-name><surname>Barris</surname> <given-names>CT</given-names></string-name>, <string-name><surname>Kress</surname> <given-names>TC</given-names></string-name>, <string-name><surname>Zawieja</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Griffin</surname> <given-names>SH</given-names></string-name>, <string-name><surname>Xie</surname> <given-names>X</given-names></string-name>, <string-name><surname>Ashworth</surname> <given-names>A</given-names></string-name>, <string-name><surname>Christie</surname> <given-names>CK</given-names></string-name>, <string-name><surname>Bryant</surname> <given-names>WB</given-names></string-name>, <string-name><surname>Kumar</surname> <given-names>A</given-names></string-name>, <string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Long</surname> <given-names>X</given-names></string-name>, <string-name><surname>Gan</surname> <given-names>L</given-names></string-name>, <string-name><surname>Belin de Chantemele</surname> <given-names>EJ</given-names></string-name>, <string-name><surname>Lyu</surname> <given-names>Q</given-names></string-name> &amp; <string-name><surname>Miano</surname> <given-names>JM.</given-names></string-name></person-group> (<year>2022</year>). <article-title>Generation and Comparative Analysis of an Itga8-CreER (T2) Mouse with Preferential Activity in Vascular Smooth Muscle Cells</article-title>. <source>Nat Cardiovasc Res</source> <volume>1</volume>, <fpage>1084</fpage>–<lpage>1100</lpage>.</mixed-citation></ref>
<ref id="c110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Welsh</surname> <given-names>DG</given-names></string-name>, <string-name><surname>Morielli</surname> <given-names>AD</given-names></string-name>, <string-name><surname>Nelson</surname> <given-names>MT</given-names></string-name> &amp; <string-name><surname>Brayden</surname> <given-names>JE</given-names></string-name></person-group>. (<year>2002</year>). <article-title>Transient receptor potential channels regulate myogenic tone of resistance arteries</article-title>. <source>Circulation Research</source> <volume>90</volume>, <fpage>248</fpage>–<lpage>250</lpage>.</mixed-citation></ref>
<ref id="c111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Woo</surname> <given-names>SH</given-names></string-name>, <string-name><surname>Lukacs</surname> <given-names>V</given-names></string-name>, <string-name><surname>de Nooij</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Zaytseva</surname> <given-names>D</given-names></string-name>, <string-name><surname>Criddle</surname> <given-names>CR</given-names></string-name>, <string-name><surname>Francisco</surname> <given-names>A</given-names></string-name>, <string-name><surname>Jessell</surname> <given-names>TM</given-names></string-name>, <string-name><surname>Wilkinson</surname> <given-names>KA</given-names></string-name> &amp; <string-name><surname>Patapoutian</surname> <given-names>A.</given-names></string-name></person-group> (<year>2015</year>). <article-title>Piezo2 is the principal mechanotransduction channel for proprioception</article-title>. <source>Nat Neurosci</source> <volume>18</volume>, <fpage>1756</fpage>–<lpage>1762</lpage>.</mixed-citation></ref>
<ref id="c112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Woo</surname> <given-names>SH</given-names></string-name>, <string-name><surname>Ranade</surname> <given-names>S</given-names></string-name>, <string-name><surname>Weyer</surname> <given-names>AD</given-names></string-name>, <string-name><surname>Dubin</surname> <given-names>AE</given-names></string-name>, <string-name><surname>Baba</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Qiu</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Petrus</surname> <given-names>M</given-names></string-name>, <string-name><surname>Miyamoto</surname> <given-names>T</given-names></string-name>, <string-name><surname>Reddy</surname> <given-names>K</given-names></string-name>, <string-name><surname>Lumpkin</surname> <given-names>EA</given-names></string-name>, <string-name><surname>Stucky</surname> <given-names>CL</given-names></string-name> &amp; <string-name><surname>Patapoutian</surname> <given-names>A</given-names></string-name></person-group>. (<year>2014</year>). <article-title>Piezo2 is required for Merkel-cell mechanotransduction</article-title>. <source>Nature</source> <volume>509</volume>, <fpage>622</fpage>–<lpage>626</lpage>.</mixed-citation></ref>
<ref id="c113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname> <given-names>G</given-names></string-name>, <string-name><surname>D’Agati</surname> <given-names>V</given-names></string-name>, <string-name><surname>Cai</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Markowitz</surname> <given-names>G</given-names></string-name>, <string-name><surname>Park</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Reynolds</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Maeda</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Le</surname> <given-names>TC</given-names></string-name>, <string-name><surname>Hou</surname> <given-names>H</given-names>, <suffix>Jr.</suffix></string-name>, <string-name><surname>Kucherlapati</surname> <given-names>R</given-names></string-name>, <string-name><surname>Edelmann</surname> <given-names>W</given-names></string-name> &amp; <string-name><surname>Somlo</surname> <given-names>S.</given-names></string-name></person-group> (<year>1998</year>). <article-title>Somatic inactivation of Pkd2 results in polycystic kidney disease</article-title>. <source>Cell</source> <volume>93</volume>, <fpage>177</fpage>–<lpage>188</lpage>.</mixed-citation></ref>
<ref id="c114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yamasaki</surname> <given-names>E</given-names></string-name>, <string-name><surname>Thakore</surname> <given-names>P</given-names></string-name>, <string-name><surname>Krishnan</surname> <given-names>V</given-names></string-name> &amp; <string-name><surname>Earley</surname> <given-names>S</given-names></string-name></person-group>. (<year>2020</year>). <article-title>Differential expression of angiotensin II type 1 receptor subtypes within the cerebral microvasculature</article-title>. <source>Am J Physiol Heart Circ Physiol</source> <volume>318</volume>, <fpage>H461</fpage>–<lpage>H469</lpage>.</mixed-citation></ref>
<ref id="c115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yeung</surname> <given-names>SY</given-names></string-name> &amp; <string-name><surname>Greenwood</surname> <given-names>IA</given-names></string-name></person-group>. (<year>2005</year>). <article-title>Electrophysiological and functional effects of the KCNQ channel blocker XE991 on murine portal vein smooth muscle cells</article-title>. <source>Br J Pharmacol</source> <volume>146</volume>, <fpage>585</fpage>–<lpage>595</lpage>.</mixed-citation></ref>
<ref id="c116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Young</surname> <given-names>MD</given-names></string-name> &amp; <string-name><surname>Behjati</surname> <given-names>S</given-names></string-name></person-group>. (<year>2020</year>). <article-title>SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data</article-title>. <source>Gigascience</source> <volume>9</volume>.</mixed-citation></ref>
<ref id="c117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zawieja</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Castorena-Gonzalez</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Scallan</surname> <given-names>JP</given-names></string-name> &amp; <string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name></person-group>. (<year>2018a</year>). <article-title>Differences in L-type Ca(2+) channel activity partially underlie the regional dichotomy in pumping behavior by murine peripheral and visceral lymphatic vessels</article-title>. <source>Am J Physiol Heart Circ Physiol</source> <volume>314</volume>, <fpage>H991</fpage>–<lpage>H1010</lpage>.</mixed-citation></ref>
<ref id="c118"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Zawieja</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Castorena-Gonzalez</surname> <given-names>JA</given-names></string-name>, <string-name><surname>To</surname> <given-names>KH</given-names></string-name>, <string-name><surname>Gui</surname> <given-names>P</given-names></string-name>, <string-name><surname>Domeier</surname> <given-names>TL</given-names></string-name> &amp; <string-name><surname>Davis</surname> <given-names>MJ.</given-names></string-name></person-group> (<year>2018b</year>). <chapter-title>Electrical pacemaking in lymphatic vessels</chapter-title>. In <source>Signal Transduction and Smooth Muscle</source>, ed. <person-group person-group-type="editor"><string-name><surname>Trebak</surname> <given-names>M</given-names></string-name> &amp; <string-name><surname>Earley</surname> <given-names>S</given-names></string-name></person-group>, pp. <fpage>324</fpage>–<lpage>359</lpage>. <publisher-name>CRC Press</publisher-name>, <publisher-loc>Boca Raton</publisher-loc>.</mixed-citation></ref>
<ref id="c119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zawieja</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Castorena</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Gui</surname> <given-names>P</given-names></string-name>, <string-name><surname>Li</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bulley</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Jaggar</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Rock</surname> <given-names>JR</given-names></string-name> &amp; <string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name></person-group>. (<year>2019</year>). <article-title>Ano1 mediates pressure-sensitive contraction frequency changes in mouse lymphatic collecting vessels</article-title>. <source>Journal of General Physiology</source> <volume>151</volume>, <fpage>532</fpage>–<lpage>554</lpage>.</mixed-citation></ref>
<ref id="c120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zawieja</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Pea</surname> <given-names>GA</given-names></string-name>, <string-name><surname>Broyhill</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Patro</surname> <given-names>A</given-names></string-name>, <string-name><surname>Bromert</surname> <given-names>KH</given-names></string-name>, <string-name><surname>Li</surname> <given-names>M</given-names></string-name>, <string-name><surname>Norton</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Castorena-Gonzalez</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Hancock</surname> <given-names>EJ</given-names></string-name>, <string-name><surname>Bertram</surname> <given-names>CD</given-names></string-name> &amp; <string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name></person-group>. (<year>2023</year>). <article-title>IP3R1 underlies diastolic ANO1 activation and pressure-dependent chronotropy in lymphatic collecting vessels</article-title>. <source>J Gen Physiol</source> <volume>155</volume>, <fpage>e202313358</fpage>.</mixed-citation></ref>
<ref id="c121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zawieja</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Pea</surname> <given-names>GA</given-names></string-name>, <string-name><surname>Broyhill</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Patro</surname> <given-names>A</given-names></string-name>, <string-name><surname>Bromert</surname> <given-names>KH</given-names></string-name>, <string-name><surname>Norton</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>HJ</given-names></string-name>, <string-name><surname>Sivasankaran</surname> <given-names>SK</given-names></string-name>, <string-name><surname>Li</surname> <given-names>M</given-names></string-name>, <string-name><surname>Castorena-Gonzalez</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Drumm</surname> <given-names>BT</given-names></string-name> &amp; <string-name><surname>Davis</surname> <given-names>MJ</given-names></string-name></person-group>. (<year>2025</year>). <article-title>Cellular characterization of the mouse collecting lymphatic vessels reveals that lymphatic muscle cells are the innate pacemaker cells</article-title>. <source>eLife</source> <volume>12</volume>.</mixed-citation></ref>
<ref id="c122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhong</surname> <given-names>XZ</given-names></string-name>, <string-name><surname>Harhun</surname> <given-names>MI</given-names></string-name>, <string-name><surname>Olesen</surname> <given-names>SP</given-names></string-name>, <string-name><surname>Ohya</surname> <given-names>S</given-names></string-name>, <string-name><surname>Moffatt</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Cole</surname> <given-names>WC</given-names></string-name> &amp; <string-name><surname>Greenwood</surname> <given-names>IA</given-names></string-name></person-group>. (<year>2010</year>). <article-title>Participation of KCNQ (Kv7) potassium channels in myogenic control of cerebral arterial diameter</article-title>. <source>J Physiol</source> <volume>588</volume>, <fpage>3277</fpage>–<lpage>3293</lpage>.</mixed-citation></ref>
<ref id="c123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zou</surname> <given-names>W</given-names></string-name>, <string-name><surname>Fan</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Cheng</surname> <given-names>H</given-names></string-name>, <string-name><surname>Hong</surname> <given-names>H</given-names></string-name>, <string-name><surname>Al-Sheikh</surname> <given-names>U</given-names></string-name>, <string-name><surname>Li</surname> <given-names>S</given-names></string-name>, <string-name><surname>Zhu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Li</surname> <given-names>R</given-names></string-name>, <string-name><surname>He</surname> <given-names>L</given-names></string-name>, <string-name><surname>Tang</surname> <given-names>YQ</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>G</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>F</given-names></string-name>, <string-name><surname>Zhan</surname> <given-names>R</given-names></string-name>, <string-name><surname>Zheng</surname> <given-names>X</given-names></string-name> &amp; <string-name><surname>Kang</surname> <given-names>L</given-names></string-name></person-group>. (<year>2025</year>). <article-title>Anoctamin-1 is a core component of a mechanosensory anion channel complex in C. elegans</article-title>. <source>Nat Commun</source> <volume>16</volume>, <fpage>1680</fpage>.</mixed-citation></ref>
<ref id="c124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zou</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Akazawa</surname> <given-names>H</given-names></string-name>, <string-name><surname>Qin</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Sano</surname> <given-names>M</given-names></string-name>, <string-name><surname>Takano</surname> <given-names>H</given-names></string-name>, <string-name><surname>Minamino</surname> <given-names>T</given-names></string-name>, <string-name><surname>Makita</surname> <given-names>N</given-names></string-name>, <string-name><surname>Iwanaga</surname> <given-names>K</given-names></string-name>, <string-name><surname>Zhu</surname> <given-names>W</given-names></string-name>, <string-name><surname>Kudoh</surname> <given-names>S</given-names></string-name>, <string-name><surname>Toko</surname> <given-names>H</given-names></string-name>, <string-name><surname>Tamura</surname> <given-names>K</given-names></string-name>, <string-name><surname>Kihara</surname> <given-names>M</given-names></string-name>, <string-name><surname>Nagai</surname> <given-names>T</given-names></string-name>, <string-name><surname>Fukamizu</surname> <given-names>A</given-names></string-name>, <string-name><surname>Umemura</surname> <given-names>S</given-names></string-name>, <string-name><surname>Iiri</surname> <given-names>T</given-names></string-name>, <string-name><surname>Fujita</surname> <given-names>T</given-names></string-name> &amp; <string-name><surname>Komuro</surname> <given-names>I</given-names></string-name></person-group>. (<year>2004</year>). <article-title>Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II</article-title>. <source>Nature Cell Biology</source> <volume>6</volume>, <fpage>499</fpage>–<lpage>506</lpage>.</mixed-citation></ref>
<ref id="dataref1"><mixed-citation publication-type="data" specific-use="analyzed"><person-group person-group-type="author"><string-name><surname>Zawieja SDPea GABroyhill SEPatro ABromert KHNorton CEKim HJSivasankaran SKLi MCastorena-Gonzalez JADrumm BTDavis</surname> <given-names>MJ</given-names></string-name></person-group> (<year iso-8601-date="2024">2024</year>) <article-title>Characterization of the cellular components of mouse collecting lymphatic vessels reveals that lymphatic muscle cells are the innate pacemaker cells regulating lymphatic contractions</article-title>. <source>NCBI Gene Expression Omnibus</source>. <pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277843">GSE277843</pub-id></mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.109466.1.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Trebak</surname>
<given-names>Mohamed</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/01an3r305</institution-id><institution>University of Pittsburgh</institution>
</institution-wrap>
<city>Pittsburgh</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Compelling</kwd>
<kwd>Incomplete</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Fundamental</kwd>
</kwd-group>
</front-stub>
<body>
<p>Davis and colleagues describe findings that are <bold>fundamental</bold> to the understanding of pressure mechanosensation in lymphatic vessels and are of significant importance to other areas of mechanosensory physiology. Based on many different knockout mouse models and rigorous state-of-the-art pressure myography recordings, they present <bold>compelling</bold> evidence that mechano-activation of GNAQ/GNA11-coupled GPCRs generates IP3, which induces Ca2+ release from internal stores through IP3R1 and drives depolarization through the activation of ANO1 Cl- channels to induce lymphatic vessel contractility. Nevertheless, some aspects of the manuscript are <bold>incomplete</bold>. The specific identity of the GPCR(s) involved remains to be uncovered, as evidence of frequency-pressure impairment is only demonstrated with abolition of GNAQ/GNA11action, not the receptors per se.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.109466.1.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>Davis and co-authors used many mouse models to investigate mechanisms that regulate the contractility of mouse popliteal collecting vessels, primarily chronotropy. Many of the mechanisms studied were previously shown to regulate pressure-induced constriction in small arteries. The authors use prior literature from the vasculature as a framework to test similar concepts in lymphatic vessels. The mouse models used provide evidence for and against the involvement of multiple proteins in regulating chronotropy and other contractile properties in lymphatic vessels. They propose that mechano-activation of GNAQ/GNA11-coupled GPCRs generates IP3, which induces Ca2+ release through IP3R1 and drives depolarization through the activation of ANO1 Cl- channels. Major concerns include the author's major conclusion that GNAQ/GNA11-coupled GPCRs contribute to chronotropy. This conclusion is not supported by the data presented.</p>
<p>Strengths:</p>
<p>One major strength of the study lies in the vast number of mouse knockout models that were used to test the importance of ion channels and G protein signaling pathways in the regulation of lymphatic vessel contractility. In this regard, the study is a valiant effort. The authors achieved several objectives to find that ANO1 and IP3R1 regulate chronotropy, and many other potential proteins do not regulate chronotropy. This study will have a major impact on the field if additional support for G proteins is provided.</p>
<p>Weaknesses:</p>
<p>Major conclusions concerning the involvement of G proteins are drawn from the global Gna11 knockout mouse models. This conclusion is weak. Global Gna11 knockout mice are highly likely to have a multifactorial phenotype that could create significant differences in the data. Control experiments need to be performed on vessels from the global knockout mice if these major conclusions are to be made. Similarly, pharmacological tools or alternative approaches to manipulate G proteins should be used to support the data from these mouse models to draw these major conclusions.</p>
<p>The Gnaq smKO mice are the most specific G protein model studied here. However, there is no phenotype. Do not discuss trends in the data. If the data are not significant, conclude so. If more experiments are required to reach significance, provide more data in the manuscript.</p>
<p>The conclusions repeatedly refer to a signaling pathway wherein the upstream component is GPCRs, which activate G proteins. While this may be the case, no GPCRs were identified here, and the involvement of G proteins is questionable, as the authors outline in lines 693-695 and noted above. The conclusions should be tempered, including in the abstract, unless additional experiments are performed to support the involvement of G proteins. Perhaps then the authors may be able to infer that GPCRs are involved.</p>
<p>Line 318. The point regarding the choice to use popliteal vessels versus IALVs will be unclear to the uninitiated, particularly as the authors previously used IALVs. Including additional justification in the text and/or data from IALVs in Figure 1, which compares IALVs to popliteal vessels, would better explain the logic.</p>
<p>The conclusions drawn for TRPC6 and TRPC3 are less convincing. Germline global knockout mice, which are known to undergo compensation, were used, and high data variability is apparent. Using TRPC3 and TRPC6 blockers in the mouse models studied in Figure 4 would strengthen the arguments made regarding these proteins.</p>
<p>Did you perform power analysis to ensure that experimental numbers were sufficient to conclude that no statistical difference exists between datasets? If not, this needs to be done. For example, data shown in Figure 5C for tone and 6C for frequency and tone appear to be significantly different, but are concluded not to be so.</p>
<p>At the end of each result section, a concluding statement is made regarding the effects on pressure-induced chronotrophy. In many cases, there are additional effects of manipulating protein expression on other contractile properties. One example is for TRPC3 and TRPC6 (lines 414-416), but others are TRPV4, TRPV3, ENaC, Kir, Cav3.1/3.2, etc. Some interpretation is in the Discussion, but the concluding statements at the end of each result section should be expanded to summarize what the authors think the other significant differences in the data represent.</p>
<p>Kv7.4 channels. You state you have data (not shown) with linopiridine and XE991. Why not show those results here to support the experiments with the Kcnq4 smKO mice? Otherwise, I suggest you remove the statement from the unpublished data.</p>
<p>Figure 13A. Kcnj2 is modestly expressed in LECs, but very little is present in LMCs. This likely underlies the effect of barium. If you remove the endothelium, does the effect of barium disappear? While this is not the major focus of the study, the effects of barium are dramatic, and it should be made clear whether this is due to inhibition of Kir channels in smooth muscle or endothelial cells.</p>
<p>Figure 18C tone. Several values for losartan look different but are not labelled as such. Please clarify and discuss if different.</p>
<p>The manuscript should include raw data traces in figures that show the major pathways that you conclude regulate chronotropy.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.109466.1.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>In this study, Davis et al. embarked on the quest for the molecular elements responsible for the regulation of lymphatic phasic contractile activity in response to variation of transmural pressure, a mechanism (termed pressure-induced lymphatic chronotropy by the authors) critical for drainage of interstitial fluid from the tissue and transport of lymph back to the blood circulation. Their aim was to investigate the mechanism(s) involved in the pressure-induced regulation of lymphatic pumping, and test whether activation of cation channels, shown in other systems to play mechanosensitive roles are directly at play, and/or whether mechano-activation of GNAQ/GNA11-coupled GPCRs is necessary to generate second messengers to activate those channels, as it has been suggested for the regulation of myogenic tone in arteries. To achieve their goal, the authors used their well-described, highly reliable protocols of mouse lymphatic vessel isolation, pressure myography, and data acquisition to obtain frequency-pressure relationships and other contractile function parameters from transgenic mice where specific channels or molecular elements of interest have been ablated. They combined these data with scRNAseq analysis of these gene targets to determine their respective role and levels of expression in lymphatic muscle cells. Their conclusion is that none of the exhaustive list of tested ion channels was critical, except ANO1 Cl channels, part of the contractile pacemaker mechanism, but that transmural pressure activates GNAQ/GNA11-coupled GPCRs, which generate IP3 to induce SR Ca2+ release through IP3R1 and activate ANO1-mediated depolarization.</p>
<p>Strengths:</p>
<p>The manuscript's strengths reside primarily in very robust, clean, and unequivocal pressure myography data and analysis. The research team is mastering these techniques they developed more than a decade ago and have implemented in mouse lymphatics to study their contractile properties, with consistent and convincing outcomes. They also provide data from an impressive list of transgenic mice in order to determine the role of the targeted gene in pressure-induced lymphatic chronotropy, relying on pharmacological small molecule inhibitors only when necessary. Finally, the use of scRNAseq analysis they gathered from previously published datasets brings novelty with respect to the expression of the genes of interest in all populations of cells comprising the lymphatic vessels, but more critically, to validate or contrast the potential impact of genetic alteration of the given gene on the ability of lymphatic muscles to respond to a change in pressure.</p>
<p>Weaknesses:</p>
<p>The main weakness may reside in the fact that while the authors provide a convincing demonstration that GNAQ/GNA11 are involved in the regulation of the F-P relationship, they give little evidence of the involvement of &quot;upstream&quot; receptors. Indeed, inhibition of AT1R, shown to be involved in myogenic regulation of arteries (a phenomenon the authors rightfully compare to pressure-induced lymphatic chronotropy), didn't lead toa similar effect (decrease in F-P) in lymphatic vessels. Arguably, other GPCRs might be involved in lymphatic vessels, but as such information is not provided in the manuscript, the author's conclusions should be dampened. More in-depth discussion would be required. In fact, it can be argued that the discussion is very restricted with respect to the amount of data and information the manuscript provides.</p>
<p>Overall, the authors convincingly achieved their aim by performing an impressive number of technically challenging experiments, leading to solid datasets. While these support their main conclusions, a more elaborate discussion might be required to refine them.</p>
<p>This study is likely to have an important impact on the field as it provides some answers to the lingering question of how lymphatic vessels regulate their contractile activity to variation in transmural pressure and certainly proposes an experimental means to further explore and address that question.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.109466.1.sa0</article-id>
<title-group>
<article-title>Reviewer #3 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>In this manuscript, Davis and colleagues aimed to identify the molecular sensors and signaling cascade that enable collecting lymphatic vessels to increase their spontaneous contraction frequency in response to intraluminal pressure (pressure-induced chronotropy). They tested whether the process is similar to blood vessel myogenic constriction by relying on cation channels (TRPC6, TRPM4, PKD2, PIEZO1, etc.) or instead require the activation of G-protein-coupled receptors (presumably mechanosensitive GNAQ/GNA11-coupled receptors), using ex vivo pressure myography of mouse popliteal lymphatics, smooth muscle-specific conditional knockouts, quantitative PCR validation, and single-cell RNA sequencing for target prioritization. The authors convincingly demonstrate that pressure-induced chronotropy does not require the cation channels implicated in arterial myogenic tone but is blunted by deletion of GNAQ/GNA11 or IP3 receptor 1, supporting a model of GPCR &gt; IP3 &gt; Ca2+ release &gt; Cl⁻ channel activation &gt; depolarization. The core conclusion is robust. The work redefines lymphatic pacemaking as G-protein-coupled receptor-dependent mechanotransduction, distinct from arterial mechanisms, and provides a genetically validated toolkit that is useful for studying lymphatic function and dysfunction.</p>
<p>Strengths:</p>
<p>(1) The data are of high quality and highly sensitive functional readouts</p>
<p>(2) The systematic genetic targeting is a major strength that overcomes pharmacological artifacts</p>
<p>(3) Careful quantitative analyses of frequency-pressure slopes</p>
<p>Weaknesses:</p>
<p>(1) The use of inguinal-axillary vessels for single-cell RNA sequencing rather than the popliteal segment studied functionally.</p>
<p>(2) No direct testing of the specific G-protein-coupled receptor involved.</p>
</body>
</sub-article>
<sub-article id="sa4" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.109466.1.sa4</article-id>
<title-group>
<article-title>Author response:</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Davis</surname>
<given-names>Michael J</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7992-9300</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Hae Jin</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Min</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Castorena-Gonzalez</surname>
<given-names>Jorge A</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pal</surname>
<given-names>Soumiya</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Domeier</surname>
<given-names>Timothy L</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scallan</surname>
<given-names>Joshua P</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Earley</surname>
<given-names>Scott</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zawieja</surname>
<given-names>Scott D</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>We thank the reviewers and editors for their insightful comments on our manuscript. We intend to submit a revised manuscript that addresses all concerns raised by the reviewers. A major limitation identified by the reviewers was our inability to identify one or more specific mechanosensitive GPCRs in lymphatic muscle cells (LMCs). To address this concern, we plan to include several additional figures in the revised manuscript. One figure will list the 136 GPCRs identified in LMCs by our scRNAseq analysis, based on the list of validated GPCRs in <ext-link ext-link-type="uri" xlink:href="https://esbl.nhlbi.nih.gov/Databases/GPCRs/index.html">https://esbl.nhlbi.nih.gov/Databases/GPCRs/index.html</ext-link> and olfactory GPCRs listed in <ext-link ext-link-type="uri" xlink:href="https://esbl.nhlbi.nih.gov/Databases/GPCRs/MouseHumanRatORs.html">https://esbl.nhlbi.nih.gov/Databases/GPCRs/MouseHumanRatORs.html</ext-link>. We plan to arrange the data in a hierarchical manner according to their expression level and denote their heterotrimeric GTP-binding protein alpha subunit(s), if known. To reinforce our finding that pressure-induced chronotropy in LMCs is mediated through Gq/11, we will present additional data testing the effects of acute Gq/11  inhibition with YM-254890 (a selective Gq/11 inhibitor) on the frequency-pressure relationship of popliteal vessels, as suggested by one reviewer. We will address concerns regarding the potential regional differences in lymphatic contractile regulation arising from our use of popliteal lymphatic vessels for contraction assays and expression analysis of LMCs obtained from Inguinal-Axillary lymphatic vessels (IALVs). To account for possible differences between the two, we will test pressure responses of IALVs from double Gq/11 knockout mice and test responses of wild-type IALVs to acute administration of YM-25489.</p>
<p>Our preliminary analysis of the 136 GPCRs in LMCs revealed a shorter list of 10 GPCRs that are expressed in at least 50% of LMCs (based on the IALV scRNAseq dataset). Since existing evidence from our studies, and those of other investigators, suggests that any LMC is capable of initiating pacemaking, we consider it reasonable to impose this requirement.</p>
<table-wrap id="sa4table1">
<label>Author response table 1.</label>
<graphic mime-subtype="jpg" xlink:href="elife-109466-sa4-table1.jpg" mimetype="image"/>
</table-wrap>
<p>We plan to use pharmacologic inhibitors to test as many of these candidates as possible. Unfortunately, inhibitors are not available for many of the GPCRs listed above, but we will test Npr3, Npy1R, and Ednra; a negative result for Tbxa2r has already been documented in a previous study (Schulz et al. ATVB 2025). Even if this strategy does not lead to identification of one or more specific GPCRs involved in LMC pressure transduction, it will narrow the list of possible candidates that need to be tested in future experiments.</p>
</body>
</sub-article>
</article>